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ABSTRACT 
Due to increasingly stringent legislation covering the discharge of hazardous chemicals into 
the environment, existing wastewater treatment processes need to be upgraded for their 
removal.  This thesis explores the removal of a diverse range of hazardous chemicals during 
secondary wastewater treatment with the overall aim of enhancing their removal 
simultaneously by activated sludge.   
Previous research in this field has made the broad comparison of full-scale activated sludge 
plants (ASPs) which receive varying influent sewage compositions and flow.  Consequently, 
assessing the direct impact of process operation to hazardous chemical removal has been 
difficult.  In this study, the independent impact of the process variables solids retention time 
(SRT) and hydraulic retention time (HRT) were examined using a pilot-scale ASP.  To 
measure ASP resilience for the removal of a wide range of hazardous chemicals of varied 
chemistry and preferred removal pathways steroid estrogens, nonylphenolic surfactants and 
metals were monitored. 
In pilot plant trials where SRT was varied and HRT fixed, the highest SRT studied (27 days) 
achieved the greatest removal of all hazardous chemicals collectively.  Interestingly, 
significantly greater estrogen biodegradation per viable bacterial cell was observed as SRT 
increased.  To demonstrate, estrogen biodegradations were 499, 1,361 and 1,750 ng 1 x 10
12
 
viable cells
-1
 d
-1
 for 3, 10 and 27 day SRTs respectively, suggesting a more responsive 
bacteria or an improved efficiency of the same bacteria at higher SRTs.  Successful 
implementation of higher SRT at full-scale ASPs requires more control over process 
operation.  The use of in-situ suspended solids probes and real-time flow measurements could 
achieve this.  In trials investigating the impact of altering HRT (whilst at a fixed SRT of 27 
days), lengthening HRT was beneficial to the biodegradation of the organic hazardous 
chemicals.  To demonstrate, estrogen biodegradations were 90 ±2 %, 93 ±1 % and 96 ±2 % 
for 8, 16 and 24 hour HRTs, respectively.  Most significantly, 17α-ethinylestradiol exhibited 
removals of 65 ±19 % at the 24 hour HRT condition, the highest observed in these studies.  
Furthermore, nonylphenol removals were greater (63-70 %) at longer HRTs.  However, 
longer HRT resulted in increased solubilisation of particulate metals.  This is of concern as 
only dissolved concentrations are considered for environmental compliance.  Consequently, 
any operational change to lengthen HRT for organic hazardous chemicals removal requires 
suitable provisions to enhance the removal of particle bound metals during primary treatment.  
It has been demonstrated that ASP operation can be modified to specifically target the 
removal of a diverse range of hazardous chemicals.  
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1. INTRODUCTION 
1.1. BACKGROUND 
The most well-known impact of hazardous chemicals presence in the aquatic environment is 
the feminisation of fish.  Evidence of this has been observed in surface waters in the UK 
(Jobling et al., 1998) and globally (Hashimoto et al., 2000; McArdle et al., 2000; Solé et al., 
2003; Barnhoorn et al., 2004).  Further concerns include the possible adverse implications for 
water re-use (Martin et al., 2008).  Due to the risks posed, the European Union has established 
environmental quality standards (EQS) and proposed legislative targets for a wide range of 
hazardous chemicals present in surface waters (European Commission, 2008; European 
Commission, 2012).  Their presence in the aquatic environment is attributed to their 
incomplete removal during wastewater treatment (Kirk et al., 2002).  Therefore it is essential 
to monitor removal performance of wastewater treatment works (WwTWs) and to improve 
process operation to enhance hazardous chemical removal.  This relies on the application of 
robust analytical methodologies to measure hazardous chemical concentrations.  However, 
hazardous chemicals tend to be in the ng l
-1
 to sub ng l
-1
 range and the high complexity of 
environmental matrices makes their analysis difficult.  This can result in a number of analysis 
being below the method reporting limit (Braga et al., 2005; Chimchirian et al., 2007; Stanford 
and Weinberg, 2007; Koh et al., 2009; Kumar et al., 2009) leading to a poor understanding of 
hazardous chemical fate and removal.  Furthermore, significant concentrations of hazardous 
chemicals can be associated with the particulate fraction of wastewaters (Koh et al., 2008; 
Baker and Kasprzyk-Hordern, 2011a).  Therefore, to better understand fate, monitoring here 
is essential.  However, there is a lack of analysis undertaken in the particulate fraction of 
wastewater due to the greater labour requirements and the complex nature of the matrix.  
The current operations of widely implemented secondary WwTWs do not enable EQS and 
proposed EQS compliance despite accounting for typical riverine dilution ratios (Gardner et 
al., 2012).  A possible solution is to upgrade WwTWs with advanced treatment processes 
(e.g., granular activated carbon) to improve hazardous chemical removals.  However, such 
processes require significant capital and operational costs, and with increased energy 
consumptions required, make existing secondary WwTWs improvement desirable (Jones et 
al., 2007a).  Activated sludge is a widely implemented secondary process with a proven 
ability to remove hazardous chemicals (Kreuzinger et al., 2004; Clara et al., 2005; McAdam 
et al., 2010; McAdam et al., 2011).  Hazardous chemical removal is mainly attributed to 
activated sludge sorption and biodegradation (Andersen et al., 2005; Langford et al., 2005).  
Therefore improved process operation is needed to facilitate the removal of hazardous 
chemicals exhibiting extremities of propensity to these mechanisms.  Natural and synthetic 
steroid estrogens, pharmaceuticals, nonylphenolic surfactants and metals encompass such 
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diversity.  These can be described as biodegradable and refractory organics and non-
biodegradable inorganics.   
Hazardous chemical removal is considered to be influenced by the activated sludge process 
variables, solids retention time (SRT) and hydraulic retention time (HRT) (Johnson et al., 
2005).  However, it remains unclear whether operation can be modified to achieve maximum 
removals of all hazardous chemicals simultaneously.  To illustrate, an extended SRT (≥10 
days) is considered necessary to augment removal of those biodegradable chemicals 
(Kreuzinger et al., 2004; Clara et al., 2005; McAdam et al., 2010), whilst these conditions are 
hypothesised to be detrimental to metals removal (Santos et al., 2010).  Also, previous 
research in this area has focussed on the comparison of different full-scale WwTWs 
(Kreuzinger et al., 2004; Clara et al., 2005; Johnson et al., 2005; McAdam et al., 2010; 
McAdam et al., 2011).  Full-scale processes tend to suffer from poor process control and 
significant variations in receiving wastewater flow and composition.  This results in a 
dynamic system with substantial variations in both SRT and HRT.  Therefore, understanding 
the impact of SRT and HRT to hazardous chemical removal has been difficult.   
 
1.2. AIMS AND OBJECTIVES 
The thesis reports research funded by the Engineering and Physical Sciences Research 
Council (EPSRC), Anglian Water, Northumbrian Water, Severn Trent Water, United Utilities 
and Yorkshire Water.  The research aims to understand the fate and behaviour of a diverse 
range of hazardous chemicals during secondary wastewater treatment and to enhance their 
removal simultaneously during activated sludge treatment.  Consequently, the following 
objectives were identified: 
1. To review analytical methodologies used for the determination of organic hazardous 
chemicals in complex environmental matrices.   
2. To determine the benefits of using ultra-performance liquid chromatography (UPLC) for 
environmental analysis over conventional high-performance liquid chromatography 
(HPLC). 
3. To assess EQS compliance and the impact of hazardous chemical precursors present in 
wastewaters. 
4. To address the importance of undertaking particulate phase analysis of wastewaters to 
better understand hazardous chemical fate and pathways of removal.  
5. To evaluate the impact of changing process operation to the mechanisms of hazardous 
chemicals removal.  
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6. To examine the prospect of enhancing the removal of a diverse range of hazardous 
chemicals simultaneously by modifying activated sludge operation using a pilot-scale 
plant to enable close control of SRT and HRT. 
 
1.3. THESIS PLAN 
This thesis is presented in paper format.  All papers were written by the first author Bruce 
Petrie and edited by Professor Elise Cartmell, Dr Ewan J. McAdam and Professor John N. 
Lester.  All laboratory work was undertaken by Bruce Petrie with exception to Chapter 6 
where the bacterial viability determinations were conducted by another PhD student (the third 
author). 
The linkage between various chapters of the thesis is presented in Figure 1.1.  The thesis 
begins with a review of the literature on methods of analysis used to determine the fate of 
organic hazardous chemicals (pharmaceutical drugs) in environmental matrices (Chapter 2, 
published in Trends in Analytical Chemistry 49 (2013) pages 145-159 - Bruce Petrie, Ewan J. 
McAdam, Mark D. Scrimshaw, John N. Lester, Elise Cartmell.  Fate of drugs during 
wastewater treatment). 
Chapter 3 compares the use of UPLC over HPLC for the determination of hazardous 
chemicals in environmental matrices (Chapter 3, in press in International Journal of 
Environmental Analytical Chemistry - Bruce Petrie, Ewan J. McAdam, Keith H. Richards, 
John N. Lester, Elise Cartmell.  Application of ultra-performance liquid chromatography-
tandem mass spectrometry for the determination of steroid estrogens in wastewater).  
Chapter 4 investigates the impact of hazardous chemicals precursors in wastewaters to EQS 
compliance.  This includes the determination of nonylphenol and its precursors in wastewater 
matrices and modelling the possible impact of typically observed precursor concentrations in 
final effluents (Chapter 4, published in Analytical and Bioanalytical Chemistry 405 (2013) 
pages 3243-3253 - Bruce Petrie, Ewan J. McAdam, Mick J. Whelan, John N. Lester, Elise 
Cartmell.  The determination of nonylphenol and its precursors in a trickling filter 
wastewater treatment process). 
Chapter 5 determines the importance of undertaking particulate phase analysis for 
understanding hazardous chemical fate.  This includes the development of an analytical 
methodology for the determination of pharmaceuticals in the aqueous and particulate fractions 
of wastewaters (Chapter 5, in preparation for Environmental Science and Pollution Research - 
Bruce Petrie, Markus Lutz, Ewan J. McAdam, John N. Lester, Elise Cartmell. A multi-residue 
method to determine the fate and behaviour of pharmaceuticals during secondary wastewater 
treatment). 
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Chapter 6 is a study on the mechanisms of hazardous chemical removal during activated 
sludge treatment, focussed on the impact of SRT to steroid estrogen sorption and 
biodegradation (Chapter 6, submitted to Chemosphere - Bruce Petrie, Ewan J. McAdam, 
Francis Hassard, Tom Stephenson, John N. Lester, Elise Cartmell.  Diagnostic investigation 
of steroid estrogen removal by activated sludge at varying solids retention time).  
Chapter 7 assesses the impact of activated sludge operational variables (SRT and HRT) to the 
simultaneous removal of steroid estrogens, nonylphenolic surfactants and metals (Chapter 7, 
in preparation for Water Research - Bruce Petrie, Ewan J. McAdam, John N. Lester, Elise 
Cartmell.  Simultaneous removal of a diverse range of hazardous chemicals from wastewater 
by activated sludge). 
 Chapter 8 is the overall discussion of the research. 
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ABSTRACT 
Recent trends for the determination of pharmaceutical drugs in wastewaters focus on the 
development of rapid multi-residue methods.  These encompass a large number of drugs (up 
to 90) of varying physico-chemical composition (hydrophobicity, molecular weight etc) at ng 
l
-1
 concentrations in the aqueous phase of complex heterogeneous matrices.  These are well 
suited for drug determination in secondary effluents which contain notable concentrations of 
pharmaceuticals.  Drugs are not routinely monitored for in particulate phases of wastewaters 
despite being essential for fate determination, particularly in secondary processes receiving 
relatively high concentrations of suspended solids.  Secondary effluents tend to contain 
multiple drugs, often above their proposed legislative targets for consent.  Thus, tertiary 
processing may be considered to enhance drug removal and provide additional environmental 
protection.  However, current analytical methods do not enable the efficacy of tertiary 
processes to be fully ascertained due to the inherently lower drug concentrations achieved.  
Existing method improvement is required to lower detection capabilities for tertiary process 
monitoring.  This would aid the understanding of breakdown reaction completeness and the 
criticality between parent drug and degradation product concentrations.  Numerous 
degradation products are formed by biological and chemical processes which can exhibit 
toxicity.  The complimentary use of biological assays here would improve understanding of 
the synergistic toxicological effect of multiple drugs and their degradation products at low 
concentration.  Additionally, tertiary processes receive secondary effluents comprising 
comparatively high concentrations of dissolved organics (e.g., colloids).  However, 
knowledge of drug behaviour in the charged colloidal fraction of wastewater and its impact to 
treatment is limited.  Monitoring and understanding here is needed to develop tertiary process 
diagnosis and optimisation. 
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2.1. INTRODUCTION 
It is well established that wastewater contains a diverse range of anthropogenic chemicals 
(Bedding et al., 1982) and that their quantitative analysis poses numerous problems 
analytically, both in terms of extraction efficiency (Buisson et al., 1984) and interference 
from co-extractives (Robertson and Lester, 1994).  Through medical use large numbers of 
drugs are now included in this group of determinants (Jones et al., 2001; Jones et al., 2003; 
Kreuzinger et al., 2004; Clara et al., 2005).  A clear trend in legislation has been a lowering of 
acceptable environmental concentrations (e.g., 17α-ethinylestradiol (EE2)) and analytical 
method development has become an iterative process to achieve ever lower detection limits 
(Gomes et al., 2003; Gomes et al., 2004a) as further potential environmental health issues 
emerge (Gomes et al., 2004b). A growing understanding of the possible environmental impact 
to aquatic ecosystems has led to the proposal of diclofenac and the steroid estrogen EE2 as 
priority hazardous chemicals (European Commission, 2008; European Commission, 2012).  
These drugs have proposed environmental quality standards (EQS) of 100 ng l
-1
 and 0.035 ng 
l
-1
 respectively, and require monitoring to ensure compliance to ‘good’ water status (European 
Commission, 2008; European Commission, 2012).  The effects of EE2, which results in 
intersex in male fish, are the most studied of the drugs in the environment (Sumpter and 
Jobling, 2013).  Concentrations of EE2 below 1 ng l
-1
 are known to cause intersex and 
vitellogenin induction in male fish during laboratory studies.  The environmental impact of 
other drugs and mixtures is less clear.  However, it has been demonstrated that a mixture of 
acetaminophen, carbamazepine, gemfibrozil and venlaflaxine (in the low µg l
-1
 range) had a 
significant impact to fish embryo development in the short term (Galus et al., 2013).  The 
chronic impact of drugs (i.e., ecological and evolutionary), either individually or as mixtures, 
remains unknown (Brodin et al., 2013).  Without such information it is desirable to limit entry 
of these chemicals into the aquatic environment.  A total of 12 drugs of varying therapeutic 
class (ibuprofen, diclofenac, naproxen, ketoprofen, carbamazepine, bezafibrate, propranolol, 
fluoxetine, EE2, ofloxacin, erythromycin and oxytetracycline) are highlighted in this review 
to represent a variety of physico-chemical compositions (e.g., molecular size, hydrophobicity) 
(Table 2.1).  This includes those most studied in the literature (Clara et al., 2005; López-Serna 
et al., 2011; Gros et al., 2012) and those in national studies (i.e., the UK Chemical 
Investigations Programme (CIP)) (Gardner et al., 2012).  The CIP found diclofenac, 
propranolol, fluoxetine, EE2, erythromycin and oxytetracycline above their indicative 
legislative targets for consent (10 ng l
-1
 for those not listed as priority hazardous substances) 
in over 50 % of effluents studied (Gardner et al., 2012).  Consequently, a variety of drugs 
have been observed in surface waters in the ng l
-1
 range (Table 2.2).  This underpins the need 
to understand drug fate during wastewater treatment for process/strategy improvement.   
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Table 2.1. Physico-chemical properties of pharmaceutical drugs present in crude wastewaters 
and secondary effluents (EPI Suite, 2013) 
Drug 
MW 
(g mol
-1
) 
Water solubility  
(mg l
-1
) 
Henry’s law  
(atm m
3
 mol
-1
) 
VP  
(mm Hg) 
pKa Log Kow Log Koc 
Ibuprofen 206.30 21.0 1.52.10
-7
 1.86.10
-4
 4.91 3.79-3.97 2.35 
Diclofenac 296.15 2.4 4.73.10
-12
 2.18.10
-6
 4.15 4.02-4.51 2.61 
Naproxen 230.26 15.9 3.39.10
-10
 1.27.10
-6
 4.15 3.10-3.18 1.97 
Ketoprofen 254.28 51.0 2.12.10
-11
 6.81.10
-6
 4.45 3.00-3.12 2.08 
Carbamazepine 236.27 112 1.08.10
-10
 8.80.10
-8
 - 2.25-2.45 2.23 
Bezafibrate 361.82 7.9 2.12.10
-15
 6.12.10
-11
 - 4.25 2.31 
Propranolol 259.35 61.7 7.98.10
-13
 9.44.10
-8
 9.42 2.60-3.48 2.45 
Fluoxetine 309.33 60.3 8.90.10
-8
 2.52.10
-5
 - 4.05-4.65 4.97 
EE2 296.40 11.3 7.94.10
-12
 1.95.10
-9
 - 3.67-4.12 4.65 
Ofloxacin 361.37 2.8.10
4
 4.98.10
-20
 9.84.10
-13
 - <0 1.09 
Erythromycin 733.94 0.5 5.42.10
-29
 2.12.10
-25
 8.88 2.48-3.06 2.75 
Oxytetracycline 460.43 313 1.70.10
-25
 9.05.10
-23
 3.27 <0 1.87 
Key: MW, molecular weight; VP, vapour pressure; pKa, acid dissociation constant; log Kow, octanol-
water coefficient; log Koc, organic carbon-water coefficient 
Determining drug fate during wastewater treatment relies on the application of robust 
analytical methodologies.  These require the ability to simultaneously determine a number of 
drugs, of differing physico-chemical properties, within environmental matrices comprised of 
comparatively high concentrations of complex bulk organics (Petrie et al., in press).  The high 
complexity of environmental matrices underlines the analytical challenge posed.  Drugs and 
their metabolites were first reported in wastewater effluents in the 1970’s (Hignite et al., 
1977).  Hignite et al (1977) measured chlorophenoxyisobutyrate and salicylic acid in 
wastewater effluents at relatively high mean concentrations of 7 µg l
-1
 and 29 µg l
-1
, 
respectively.  Ion exchange chromatography was used for extraction followed by gas 
chromatography-mass spectrometry (GC-MS).  Numerous other drugs have been given 
significant attention recently due to the development of sophisticated analytical 
methodologies (Gracia-Lor et al., 2011; López-Serna et al., 2011; Gros et al., 2012).  
Extraction media enabling simultaneous retention of acidic, basic and neutral species of 
varying polarities has aided this.  Furthermore, the coupling of liquid chromatography (LC), 
and particularly ultra-performance liquid chromatography (UPLC) to MS has seen significant 
reductions in sample pre-treatment requirements and instrument analysis time (Petrie et al., in 
press).  Other than analytical difficulties, the variety of physico-chemical behaviour (e.g., 
hydrophobicity) exhibited by drugs results in significant differences in their fate and removal 
during wastewater treatment (Kreuzinger et al., 2004; Lishman et al., 2006).  Tertiary 
treatment processes are being considered to enhance hazardous chemical removal to levels 
which comply with proposed EQS’s (McAdam et al., 2011) as are the analytical methods 
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capable of supporting their diagnosis and optimisation for this critical group of emerging 
chemicals.  This review addresses recent analytical trends for drug determination in 
environmental matrices used to facilitate fate studies.  Analytical requirements for further fate 
evaluation and tertiary process selection/optimisation are also discussed. 
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Table 2.2.  Recently reported occurrence of pharmaceutical drugs in surface waters  
Drug of 
interest 
Class Chemical structure 
Proposed 
legislative 
target (ng l
-1
) 
Surface 
water
a
 (ng l
-1
) 
Location 
Ibuprofen NSAID 
 
10
b
 
<0.3-56 
<6.4-542 
21-2,796 
UK 
Mainland Europe 
North America 
Diclofenac NSAID 
 
100
c
 
<0.5-261 
<12-154 
17-42 
UK 
Mainland Europe 
North America 
Naproxen NSAID 
 
- 
<0.3-55 
<3.1-109 
22 
UK 
Mainland Europe 
North America 
Ketoprofen NSAID 
 
- 
<0.5-4 
<15-517 
- 
UK 
Mainland Europe 
North America 
Carbamazepine Anti-epileptic 
 
- 
0.5-495 
<1.5-54 
1-1,238 
UK 
Mainland Europe 
North America 
Bezafibrate 
Lipid 
regulator 
 
- 
<10-66 
<2.0-26 
- 
UK 
Mainland Europe 
North America 
Propranolol Beta blocker 
 
10
b
 
<0.5-27 
<0.4-39 
53 
UK 
Mainland Europe 
North America 
Fluoxetine 
Anti-
depressant 
 
10
b
 
- 
<7.4-24 
<1.3-65 
UK 
Mainland Europe 
North America 
EE2 Contraceptive 
 
0.035
c
 
- 
- 
- 
UK 
Mainland Europe 
North America 
Ofloxacin Antibiotic 
 
10
b
 
- 
4.8-105 
- 
UK 
Mainland Europe 
North America 
Erythromycin Antibiotic 
 
10
b
 
<0.5-20 
<28-52 
2-438 
UK 
Mainland Europe 
North America 
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Oxytetracycline Antibiotic 
 
10
b
 
- 
<12-37 
- 
UK 
Mainland Europe 
North America 
a
occurence data taken from: UK-(Kasprzyk-Hordern et al., 2009) Mainland Europe-(López-Serna et 
al., 2011) North America-(Wu et al., 2009; Ferrer et al., 2012), 
b
UK Chemicals Investigation 
Programme (Gardner et al., 2012), 
c
(European Commission, 2012) 
Key: NSAID, non-steroidal anti-inflammatory drug 
 
 
2.2. ANALYTICAL STRATEGIES FOR FATE EVALUATION 
Prior to laboratory work, the first step for drug determination in wastewaters is sampling. This 
process is fundamental to any strategy for monitoring, and careful consideration of sampling 
equipment, sample handling and types of samples is needed. It is beyond the scope of this 
review to examine further; however an excellent overview of sampling strategies has been 
given by Ort et al (2010a; 2010b).  Nevertheless, it is important to highlight that to fully 
understand fate during wastewater treatment, determination in both aqueous and particulate 
phases of wastewaters is essential (Gomes et al., 2004a; Baker and Kasprzyk-Hordern, 
2011a). 
Trace determination of drugs in aqueous wastewater fractions (typically 0.45 µm filtered) 
requires an enrichment step followed by chromatographic separation and mass spectrometry 
(MS) detection.  Sample pre-concentration and clean up commonly involves solid phase 
extraction (SPE), and can be undertaken off-line (using extraction systems not linked to 
analytical equipment) or on-line, where extraction and quantification are automated and 
linked together.  Off-line analysis tends to use up to 1 litre of sample, and Gros et al (2006) 
investigated the efficacy of various SPE sorbents (Oasis HLB, Oasis MCX, Isolute C18 and 
Isolute ENV+) for the simultaneous extraction of 13 pharmaceutical drugs of varying 
physico-chemical composition.  The Oasis HLB sorbent (polystyrene-devinylbenzene-N-
vinylpyrrolidone terpolymer) (Radjenović et al., 2007a) (without pH adjustment) exhibited 
superior performance, utilising both hydrophilic and lipophilic retention mechanisms.  
Consequently, a full suite of drugs (up to 90) can be extracted simultaneously off-line using 
this sorbent (Gracia-Lor et al., 2011; López-Serna et al., 2011; Grabic et al., 2012; Gros et al., 
2012).  The introduction of fully automated methods further reduces sample processing 
restrictions (López-Serna et al., 2010; Huntscha et al., 2012).  At present these are emerging 
techniques whose use are not widespread.  Their reproducibility and ability to use smaller 
total sample volumes mean they will supersede traditional labour intensive SPE protocols in 
commercial laboratories in the future.  Drug determination in the particulate phase of 
wastewaters is not routinely monitored but those methods which do, use ultrasonic solvent 
extraction (USE) (Ternes et al., 2005) or most commonly, accelerated solvent extraction 
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(ASE) (Nieto et al., 2010; Baker and Kasprzyk-Hordern, 2011a; Jelic et al., 2011; Silva et al., 
2011; Chen et al., 2013).  The application of pressure enables the use of extraction solvents 
(e.g., methanol) at temperatures much higher than their boiling point, increasing solubility and 
mass transfer (Zuloaga et al., 2012).  Following extraction the solvent can be diluted in water 
to <5 % (v/v) and subjected to SPE as an aqueous fraction (Jelic et al., 2011; Silva et al., 
2011).  
Gas chromatography-mass spectrometry is well established for quantification of chemicals in 
environmental samples, achieving method quantitation limits (MQLs) ≤10 ng l-1 for some 
drugs (Zhao et al., 2009; Samaras et al., 2010).  However, derivatization of more polar drugs 
with toxic chemicals is required prior to analysis to improve volatility, thermal stability and 
sensitivity of detection, increasing cost and time of sample preparation.  A further 
disadvantage is the run time required for analysis; often up to 1 hour per sample (Zhao et al., 
2009; Samaras et al., 2010).  This has been a rate limiting step of such research in the past, 
severely restricting sample numbers which can be analysed.  Despite these limitations, 
methods report the ability to simultaneously measure ≥63 drugs of varying therapeutic class 
from a single injection by GC-MS following derivatization (Sebok et al., 2009; Andrási et al., 
2011).  The use of LC coupled to tandem MS detection (MS/MS) improves sample 
throughput without the need for additional sample preparation (Barceló and Petrovic, 2007).  
Furthermore, the introduction of UPLC offers additional reductions in run times, whilst 
improving sensitivity over conventional LC (Petrie et al., in press).  For UPLC, run times are 
generally less than 10 minutes with MQLs <100 ng l
-1
 for most drugs (Gracia-Lor et al., 2011; 
López-Serna et al., 2011; Gros et al., 2012).  However, a well-known problem of 
environmental sample analysis by LC-MS, with electrospray ionisation (ESI) source 
particularly, is the quenching influence (ionisation suppression) of sample matrix on analyte 
signal strength (Petrie et al., 2013a; Petrie et al., in press).  The commercial availability of 
deuterated surrogates now offers substantial improvements in minimising the impact of 
matrix interferences, improving accuracy of analysis and up to 50 isotopic labelled standards 
are used in some multi-residue methods (Huntscha et al., 2012).    
The selection of MS/MS detector type is critical for analysis type (i.e., qualitative or 
quantitative). Quantitative analysis commonly employs a triple quadrupole (QqQ) due to its 
high sensitivity.  The use of hybrid detectors such as quadrupole time of flight (QqTOF) 
offers the ability to screen and identify unknown degradation products/metabolites.  Its full 
scan sensitivity, high selectivity and specificity enable structural elucidation of non-target 
species (Radjenović et al., 2007a).  This is a significant advance in the determination of drug 
fate where degradation products in both biological and chemical processes are formed; 
enabling degradation pathways to be identified.  However, data processing can be time 
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consuming due to the lack of searchable libraries, often requiring manual spectral 
interpretation (Barceló and Petrovic, 2007; Radjenović et al., 2007a).  A further disadvantage 
of TOF detection is it generally offers lower sensitivity (3 to 5 times) than conventional 
MS/MS such as QqQ (Marchese et al., 2003).  Thus, the ever increasing requirement to 
reduce MQLs for trace analysis confines its use to qualitative fate evaluation.  Alternatively, 
hybrid linear ion trap (LIT) Orbitrap instrumentation offers high sensitivity for environmental 
quantitation (as offered by QqQ) and the ability to perform accurate mass determinations for 
drug identification (as offered by TOF) (Barceló and Petrovic, 2007).  Although Orbitrap 
technology has been used to screen environmental samples for unknowns (Chiaia-Hernandez 
et al., 2013), unequivocal confirmation of degradation products observed by non-target 
MS/MS screening requires a complementary analytical technique or use of analytical 
reference standards (Helbling et al., 2010).  However, as degradation products are often not 
known, there is a subsequent lack of standards for these.  Further opportunities are offered by 
Fourier transform-MS which demonstrates unrivalled mass accuracy, rapid data collection, 
good dynamic range and, high sensitivity and resolution.  However, the high cost of such 
instrumentation limits its widespread application.   
Overall, recent trends for drug determination in wastewaters tend to use a single stage Oasis 
HLB off-line SPE followed by UPLC with detection by QqQ (Gracia-Lor et al., 2011; López-
Serna et al., 2011; Grabic et al., 2012) or LIT (Gros et al., 2012) (Table 2.3).  These methods 
are well suited for the determination of multiple drugs in the aqueous phase of crude 
wastewaters and secondary effluents where their concentrations are relatively high.  However, 
monitoring EE2 at environmentally relevant levels requires devoted clean up protocols which 
can be laborious due to its inherently lower concentrations (Petrie et al., in press).  
Nevertheless, there is a lack of particulate phase analysis undertaken and the concentrations 
present in tertiary effluents continue to pose an analytical challenge.   
15 
 
Table 2.3. Recently validated LC-MS/MS methods applied for the quantitation of drugs in environmental matrices 
No. of 
drugs 
Sample SPE Chromatography Detector 
Run 
time  
(min
-1
) 
SE 
recovery 
(%) 
SE MQL 
(ng l
-1
) 
No. of drugs quantified in 
methods application Method 
benefits 
Method 
limitations 
Reference 
Crude 
WW 
SE TE SW 
81 Aq. Oasis HLB UPLC QqLIT 
4
a
 
7
b
 
22-146 0.6-51 57
c
 59 28 45 √ XX  Gros et al., 2012 
47 Aq. Oasis HLB UPLC QqQ 10 49-127 0.8-170 - 37 - 31 √ X Gracia-Lor et al., 2011 
74 Aq. Oasis HLB UPLC QqQ 
8
a
 
5
b
 
0-174 0.1-378 - - - 73 √ 
X 
 XX 
López-Serna et al., 2011 
90 Aq. Oasis HLB HPLC QqQ 25 5-246 0.1-78 - 63 - - √ X Grabic et al.,2012 
33
d
 Aq. 
Oasis HLB 
+ 3 sorbents 
HPLC QqQ 36
e
 64-166 2.3-186 - - - 16 
√√ 
√√√ 
X Huntscha et al., 2012 
87 Aq. 
TurboFlow 
column 
HPLC QqQ 22
e
 12-345 0.1-164 - - - 44 
√ 
√√  
√√√ 
X 
XX 
López-Serna et al., 2010 
14 Part. Oasis HLB HPLC QqQ - 70-120 0.6-19
f,g
 - 11
g
 - - √√√√ X Chen et al., 2013 
60 Part. Oasis MCX UPLC QqQ 20 7-142
e
 0.1-20
f,h
 30
f
 - - - √ X 
Baker and Kasprzyk-
Hordern, 2011a 
5 
Aq. 
Part. 
MIP HPLC QqQ 25 
95-105 
77-91 
4-12 
4-10
f,i
 
- 5
j
 - 4
f,i
 √√√√ 
X 
XXX 
Duan et al., 2013 
1
k
 
(EE2) 
Aq. 
Part. 
C18, NH2
 
Silica, NH2 
UPLC QqQ 9 
96
 
97 
0.06
 
2.96
f
 
1 1 - - 
√√√√ 
√√√√√ 
X 
XXXX 
Petrie et al., in press 
a
positive ionisation mode
 b
negative ionisation mode
 c
application is not a sequential train of processes 
 d
includes additional 55 chemicals in method
 e
includes on-line SPE time 
f
ng g
-1  g
de-watered sludge
 h
settled sewage
 i
sediment 
j
aqueous only 
k
includes 4 natural estrogens in method 
Key: MQL, method quantitation limit; SPE, solid phase extraction; SE, secondary effluent, WW, wastewater; TE, tertiary effluent; SW, surface water; Aq., aqueous; Part., 
particulate; QqLIT, linear ion trap; QqQ, triple quadrupole; MIP, molecularly imprinted polymer; √, high number of drugs varying in physicochemical composition; √√, 
includes some known degradation products; √√√, fully automated, small sample requirements; √√√√, high recoveries for all drugs measured; √√√√√, very low MQL; X, 
application to real samples limited; XX, numerous drugs reported <MQL; XXX, limited to drugs of specific physicochemical composition; XXXX, extensive sample pre-
treatment required 
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2.3. DRUG REMOVAL BY CONVENTIONAL WASTEWATER 
TREATMENT; THE CURRENT PROBLEM 
Activated sludge is an extensively implemented secondary wastewater treatment process, 
effective for carbonaceous material removal and can be adapted for nutrient removal. 
Removals of many drugs (and other chemicals of anthropogenic origin) are also observed 
(Kreuzinger et al., 2004; Clara et al., 2005).  Removal of drugs and other hazardous 
chemicals during treatment is attributed to biological degradation and sorption onto biomass 
(Langford et al., 2005; Urase et al., 2005; Khunjar and Love, 2011).  Pharmaceutical drugs 
have low vapour pressures and pKa’s ranging from 3 to 10 (Table 2.1) restricting any removal 
by volatilisation.  The relative resistance to biodegradation and/or sorption of some drugs 
makes enhancing removal by such processes difficult.  Ibuprofen, diclofenac and 
carbamazepine encompass extremities in susceptibility to biodegradation and sorption.  These 
represent drugs reasonably amenable to sorption and biodegradation (ibuprofen), sorption 
only (diclofenac) and neither sorption or biodegradation (carbamazepine), respectively.  
Consequently, removal differs between one another during activated sludge treatment 
(Kreuzinger et al., 2004; Clara et al., 2005).  Solids retention time (SRT) (which is 
proportional to the food: micro-organism (F: M) ratio) is the simplest way of manipulating 
existing activated sludge operation in the short term and, is considered critical to the removal 
of non-drug derived hazardous chemicals (Kreuzinger et al., 2004; Clara et al., 2005; 
McAdam et al., 2011).  An increased SRT (>10 days) is often cited as the condition required 
to achieve greatest hazardous chemical removal (Kreuzinger et al., 2004; Clara et al., 2005) 
but has little effect to removals of these drugs (Figure 2.1, Table 2.4).  Generally, diclofenac 
is removed by ≤50 % and any carbamazepine removal is negligible.  Negative drug removals 
are also observed during treatment and are considered attributable to the deconjugation of 
metabolites present in the crude stream (Lishman et al., 2006).  Conjugates and intermediate 
chemicals tend to go undetermined by current analytical approaches.  Parent drugs are often 
above their legislative targets for consent in secondary effluents despite accounting for typical 
dilution ratios in the environment (Gardner et al., 2012).  Source control would limit drug 
entry into wastewater, similar to what has been achieved with nonylphenol (Petrie et al., 
2013a).  Without the availability of substitute drugs, less persistent and with a less 
burdensome environmental impact, this will not be achievable.  However, the possibility of 
separate treatment of urine streams may be an effective solution in some circumstances 
(Maurer et al., 2006).  Additionally, membrane bioreactor systems generally achieve greater 
drug removals than conventional secondary processes (Kimura et al., 2007; Radjenović et al., 
2007a; Radjenović et al., 2007b).  Without their application, the remaining alternative to 
enhance drug removal is the addition of a tertiary process or processes to an existing 
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conventional secondary treatment asset (e.g., activated sludge).  This requires a process not 
excessively space consuming and can treat secondary effluents at relatively short contact 
times.  Some available options suiting these criteria include; biofiltration (sand or trickling 
filters), chemical (ozone) and adsorption (granular activated carbon) processes.  The fate and 
removal of drugs differ substantially between these systems.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Removals of ibuprofen (■, n=36), diclofenac (□, n=19) and carbamazepine (▲, n=25) 
by activated sludge operating at varying solids retention time.  Ibuprofen, diclofenac and 
carbamazepine represent drugs reasonably amenable to sorption and biodegradation, sorption 
only and neither sorption or biodegradation, respectively.  Inset, octanol-water coefficients, 
partition coefficients and degradation rate constants – aEPI suite, 2013 bUrase et al., 2005   
(removal data obtained from: Metcalfe et al., 2003; Kreuzinger et al., 2004; Clara et al., 2005; Joss et 
al., 2005; Bernhard et al., 2006; Lishman et al., 2006; Nakada et al., 2006; Jones et al., 2007b; Kimura 
et al., 2007; Radjenović et al., 2007b; Zorita et al., 2009 – Table 2.4, no data reported as <MDL) 
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Table 2.4. Removal of ibuprofen, diclofenac and carbamazepine in activated sludge at varying SRT 
Drug Flow rate  
(m
3
 d
-1
) 
SRT (d
-1
) HRT(h
-1
) MLSS (mg l
-1
) COD (mg l
-1
) SS conc. (ng l
-1
) SE conc. (ng l
-1
) Removal (%) Reference 
Ibuprofen 
- 0.3 - - - - - -1.0 Kreuzinger et al., 2004 
- 1 - - - - - 9.0 Kreuzinger et al., 2004 
626,000 1.9 7 - - 50,700 24,600 51.5 Metcalfe et al., 2003 
- 2 1.9 4,000 - 2,300 2,400 -4.2 Clara et al., 2005 
47,860 2.2 13 - - 14,200 21,700 -52.8 Metcalfe et al., 2003 
185,000 2.7 12 - - 27,900 5,400 80.6 Metcalfe et al., 2003 
585,667 2.7 14 - - 58,200 6,200 89.3 Metcalfe et al., 2003 
3,967 3 10 3,030 113* - - 94.0 Lishman et al., 2006 
22,000 3 12 - 508.2 13,355-17,585 1,420-6,056 82.5 Radjenović et al., 2007b 
645,000 3.8 8.6 - - 909 86.7 90.5 Nakada et al., 2006 
1,984 4.5 15 2,482 113* - - 94.0 Lishman et al., 2006 
409,000 4.6 8.0 - - 593 21.0 96.4 Nakada et al., 2006 
125,248 4.7 13 - - 21,800 300 98.6 Metcalfe et al., 2003 
1,199,000 5.0 7.1 - - 578 14.3 97.5 Nakada et al., 2006 
- 5.0 - - - - - 96.0 Kreuzinger et al., 2004 
5,506 5.5 15 2,836 205* - - 95.0 Lishman et al., 2006 
15,300 5.5 15 1,743 154* - - 94.0 Lishman et al., 2006 
19,260 6 22 2,084 128* - - 98.0 Lishman et al., 2006 
125,000 7 12 2,000 - 1,966 40.0 98.0 Kimura et al., 2007 
20,000 6-10 35 - 510-680 5,700 88.5 98.4 Zorita et al., 2009 
210,000 8.4 8.9 - - 595 8.0 98.7 Nakada et al., 2006 
68,498 9.6 15 - - 27,300 2,700 90.1 Metcalfe et al., 2003 
- 9.6 - - - - - 92.0 Kreuzinger et al., 2004 
17,994 10.5 13 2,105 51* - - 91.0 Lishman et al., 2006 
- 10-12 7.3 - - - - 91-99 Joss et al., 2005 
366,898 12.6 23 - - 39,100 50.0 >99.9 Metcalfe et al., 2003 
60,000 12-14 22 5,000-6,000 - 6,242 194 97.0 Bernhard et al., 2006 
11,783 13 13.5 2,740 143-160 - - 86.0 Jones et al., 2007b 
- 17.0 - - - - - 99.0 Kreuzinger et al., 2004 
- 22-24 16.8 - - - - 96-98 Joss et al., 2005 
- 23.6 - - - - - 98.0 Kreuzinger et al., 2004 
- 24.0 - - - - - 99.0 Kreuzinger et al., 2004 
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- 35.0 - - - - - 99.0 Kreuzinger et al., 2004 
5,074 35.3 27 - - 58,900 50.0 >99.9 Metcalfe et al., 2003 
- 46 28.8 3,100 - 1,200 24.0 98.0 Clara et al., 2005 
- 52 326 4,000 - 2,448 20.0 99.2 Clara et al., 2005 
Diclofenac 
- 1.0 - - - - - 0.0 Kreuzinger et al., 2004 
- 2 1.9 4,000 - 1,400 1,300 7.1 Clara et al., 2005 
3,967 3 10 3,030 113* - - 28.0 Lishman et al., 2006 
105,300 5 16 2,450 127* - - 22.0 Lishman et al., 2006 
- 5.0 - - - - - 36.0 Kreuzinger et al., 2004 
5,506 5.5 15 2,836 205* - - -88.0 Lishman et al., 2006 
15,300 5.5 15 1,743 154* - - -103 Lishman et al., 2006 
19,260 6 22 2,084 128* - - 30.0 Lishman et al., 2006 
20,000 6-10 35 - 510-680 100 485 -79.4 Zorita et al., 2009 
- 9.6 - - - - - 9.0 Kreuzinger et al., 2004 
17,994 10.5 13 2,105 51* - - -143.0 Lishman et al., 2006 
- 10-12 7.3 - - - - 22-33 Joss et al., 2005 
- 17.0 - - - - - 13.0 Kreuzinger et al., 2004 
- 22-24 16.8 - - - - 30-34 Joss et al., 2005 
- 23.6 - - - - - 13.0 Kreuzinger et al., 2004 
- 24.0 - - - - - 52.0 Kreuzinger et al., 2004 
4,554 30 23 4,554 178* - - 77.0 Lishman et al., 2006 
- 35.0 - - - - - 3.0 Kreuzinger et al., 2004 
- 46 28.8 3,100 - 905 780 13.8 Clara et al., 2005 
- 52 326 4,000 - 3,190 1,680 47.3 Clara et al., 2005 
Carbamazepine 
- 0.3 - - - - - 0.0 Kreuzinger et al., 2004 
17,364 0.9 12 - - 1,300 800 38.5 Metcalfe et al., 2003 
- 1.0 - - - - - -9.0 Kreuzinger et al., 2004 
626,000 1.9 7 - - 800 700 12.5 Metcalfe et al., 2003 
- 2 1.9 4,000 - 670 690 -3.0 Clara et al., 2005 
47,860 2.2 13 - - 1,100 2,300 -109.1 Metcalfe et al., 2003 
185,000 2.7 12 - - 1,200 1,700 -41.7 Metcalfe et al., 2003 
585,667 2.7 14 - - 600 800 -33.3 Metcalfe et al., 2003 
645,000 3.8 8.6 - - 55.9 32.1 42.6 Nakada et al., 2006 
6,243 4.1 14 - - 1,000 500 50.0 Metcalfe et al., 2003 
409,000 4.6 8.0 - - 43.1 46.9 -8.6 Nakada et al., 2006 
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125,248 4.7 13 - - 700 800 -14.3 Metcalfe et al., 2003 
1,199,000 5.0 7.1 - - 50.5 45.4 10.2 Nakada et al., 2006 
- 5.0 - - - - - 6.0 Kreuzinger et al., 2004 
210,000 8.4 8.9 - - 173 117 32.4 Nakada et al., 2006 
68,498 9.6 15 - - 700 700 0.0 Metcalfe et al., 2003 
- 9.6 - - - - - 9.0 Kreuzinger et al., 2004 
- 10-12 7.3 - - - - 0-18 Joss et al., 2005 
366,898 12.6 23 - - 900 1,700 -88.9 Metcalfe et al., 2003 
- 17.0 - - - - - -11.0 Kreuzinger et al., 2004 
- 22-24 16.8 - - - - 0-5 Joss et al., 2005 
- 35.0 - - - - - 1.0 Kreuzinger et al., 2004 
5,074 35.3 27 - - 1,000 900 10.0 Metcalfe et al., 2003 
- 46 28.8 3,100 - 325 426 -31.1 Clara et al., 2005 
- 52 326 4,000 - 704 952 -26.1 Clara et al., 2005 
*Biological oxygen demand 
Key: SRT, solids retention time; HRT, hydraulic retention time; MLSS, mixed liquor suspended solids; COD, chemical oxygen demand; SS, settled sewage; SE, secondary 
effluent 
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2.4. DRUG FATE AND REMOVAL IN TERTIARY PROCESSES 
2.4.1. Biologically active sand filters 
Drug removal by biofiltration processes (tertiary sand or trickling filters) is by physical and 
biological mechanisms.  Total removals by sand filters vary from 2 % for carbamazepine to 
>95 % for ibuprofen (Zearley and Summers, 2012) (Figure 2.2, Table 2.5), similar to those 
achieved by activated sludge.  Despite treating different wastewaters of differing composition, 
activated sludge and tertiary sand filters essentially rely on the same mechanisms.  Sand 
filters depend on a fixed biofilm comprised of a diverse community of micro-organisms 
embedded within a matrix of extracellular polymeric substances (EPS) consisting of proteins, 
nucleic acids, polysaccharides and amphiphilic polymeric compounds (Wagner et al., 2009).  
The composition of EPS shifts with biofilm age (Wagner et al., 2009), and is known to 
influence EE2 uptake (Khunjar and Love, 2011).  The high tendency of some drugs to 
partition to solid organic matter, similar to biofilms has been confirmed by ASE followed by 
LC-MS/MS analysis (Baker and Kasprzyk-Hordern, 2011; Jelic et al., 2011; Silva et al., 
2011; Chen et al., 2013).  Those hydrophobic drugs with a comparatively high log Kow (>4) 
(e.g., diclofenac and fluoxetine) are considered to have a tendancy to sorb to solid organic 
surfaces such as biofilms (Jones et al., 2005; Wunder et al., 2011).  However, sorption cannot 
be predicted by hydrophobicity alone (Hӧrsing et al., 2011; Wunder et al., 2011) other 
properties such as molecular weight and ionic speciation are of known importance (Wunder et 
al., 2011), as is the nature of other dissolved species with which they may interact (Gong et 
al., 2012).  Extracellular polymeric substances offer both anionic and cationic functional 
groups for the exchange of charged species (Wunder et al., 2011).  At a pH typical of 
municipal wastewaters (e.g., 7-8), EPS is negatively charged (Wunder et al., 2011) with 
pKa’s generally ranging from 6.2 to 10.1 (Guibaud et al., 2005).  Those drugs whose pKa is 
<7 (e.g., ibuprofen, diclofenac, naproxen, ketoprofen and oxytetracyline) (Table 2.1) may 
themselves be negatively charged and repulsion with the biofilm could restrict sorption.  
Removal will also be influenced by biofilm porosity.  Drugs whose molecular size is 
comparatively large (e.g., erythromycin), will have a reduced rate of mass transfer between 
the liquid medium and the biofilm, limiting partitioning (Wunder et al., 2011).  Drugs which 
are comparatively smaller (<300 g mol
-1
) and relatively hydrophobic in nature (log Kow’s >3) 
(e.g., ibuprofen, diclofenac, naproxen, ketoprofen, propranolol and EE2, Table 2.1) are 
expected to partition well within the biofilm matrix.   
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Figure 2.2. Removals of ibuprofen, diclofenac and carbamazepine reported in the literature for 
biofiltration, chemical and adsorption processes.  Ibuprofen, diclofenac and carbamazepine 
represent drugs reasonably amenable to sorption and biodegradation, sorption only and neither 
sorption or biodegradation, respectively (removal data obtained from: (Huber et al., 2003; Ternes et 
al., 2003; Kim et al., 2007; Matamaros et al., 2007; Nakada et al., 2007; Snyder et al., 2007; Rosal et 
al., 2010; Schaar et al., 2010; Grover et al., 2011; Reungoat et al., 2011; Yang et al., 2011; Zearley and 
Summers, 2012 - Table 2.5, 2.6 and 2.7) 
a
1/3 removed <MQL 
b
2/3 removed <MQL 
c
3/4 removed 
<MQL 
d
4/5 removed <MQL 
 
Sorption is also considered to be an intermediate step in biodegradation (Langford et al., 
2005; Khunjar and Love, 2011).  Assuming similar behaviour to EE2 and other hazardous 
chemicals in biological processes, drug biodegradation is likely to be mediated on the surface 
and/or within intact bacterial cells (Langford et al., 2005; Khunjar and Love, 2011; Bagnall et 
al., 2012).  Free ammonia mono-oxygenase enzymes released by lysis extracellularly are not 
likely to be involved in biodegradation (Langford et al., 2005; Bagnall et al., 2012). Gaulke et 
al (2008) observed that EE2 removal in nitrifying batch studies was not by nitrifying bacteria 
activity, dismissing the hypothesis that nitrification augments EE2 removals (Vader et al., 
2000).  The synthesis of nitro-EE2 confirmed that EE2 is nitrated at high ammonia feed 
concentrations caused by the high production of nitrates; EE2 removal here is an artefact of 
laboratory scale investigation.  Biodegradation at environmentally representative conditions is 
by heterotrophic micro-organisms, capable of scavenging a broad range of organic material 
(Bagnall et al., 2012).  Interestingly, differences in biodegradation are observed for drugs 
which sorb similarly to biomass (e.g., ibuprofen and diclofenac, Figure 2.1) suggesting 
chemical structure controls susceptibility to biological attack.  The structure of ibuprofen is 
comparatively simpler than that of diclofenac (i.e., single aromatic ring and non-halogenated, 
Table 2.2) which may aid its biodegradation.  Drugs of increasing structural complexity and 
elemental diversity such as antibiotics (e.g., ofloxacin, erythromycin and oxytetracycline) 
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may be less favourable to biodegradation especially considering their possible toxicity to 
bacteria.  However, ‘biodegradation’ here is not indicative of complete mineralisation. Drugs 
rich in functional groups provide more possible sites for biological attack, inducing a change 
to the parent structure.  Kosjek et al (2009) investigated the degradation products of 
diclofenac, utilising Oasis HLB SPE and UPLC separations to ensure adequate sensitivity 
required by QqTOF.  In full scan mode the total ion chromatogram (TIC) was screened and a 
protonated compound was then selected for further product ion scans (Kosjek et al., 2009).  
Accurate mass measurements and in-source fragmentation enabled chemical structure 
elucidation of three biotransformation products (Figure 2.3A).  Similarly Helbling et al (2010) 
used LIT-Orbitrap MS to identify five degradation products of bezafibrate (Figure 2.3B).  The 
dehydrogenation product (DP1) is structurally similar to the parent drug indicating it may 
behave similarly in the environment. 
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Table 2.5. Removal of drugs from environmental waters by biofiltration processes 
Drug Process Temperature (°C) HRT (h
-1
) 
Wastewater 
type 
Upfront 
process 
SE. conc. (ng l
-1
) 
TE conc.  
(ng l
-1
) 
Removal (%) Reference 
Ibuprofen 
SF - 4-6 Municipal - 11,700
a
 1,170 90 Matamaros et al., 2007 
SF - 0.3 River - 276 <14 >95 Zearley and Summers, 2012 
SF - 1 Municipal ASP - - 73
b
 Nakada et al., 2007 
Diclofenac 
SF - 4-6 Municipal - 820
a
 197 76 Matamaros et al., 2007 
SF - 0.3 River - 252 181 28 Zearley and Summers, 2012 
SF 22 2 Municipal - - - 23 Reungoat et al., 2011 
Carbamazepine 
SF - 4-6 Municipal - 2,060
a
 1,833 11 Matamaros et al., 2007 
SF - 0.3 River - 85 84 2 Zearley and Summers, 2012 
SF - 1 Municipal ASP - - 22
b
 Nakada et al., 2007 
Naproxen 
SF - 4-6 Municipal - 1,570
a
 314 80 Matamaros et al., 2007 
SF - 0.3 River - 170 24 86 Zearley and Summers, 2012 
SF - 1 Municipal ASP - - 32
b
 Nakada et al., 2007 
Ketoprofen SF - 1 Municipal ASP - - 16
b
 Nakada et al., 2007 
EE2 
SF - 0.3 River - 316 246 22 Zearley and Summers, 2012 
SF 18 - Municipal ASP - 0.2 82 Gunnarsson et al., 2009 
SF - - Municipal ASP - - 7 Ifelebuegu, 2011 
SF - - Municipal OD - - 9 Ifelebuegu, 2011 
SF 22-25 - Municipal - 109 64 41 Ho et al., 2011 
Erythromycin 
SF - 0.3 River - 104 75 28 Zearley and Summers, 2012 
SF 19-22 0.4 Municipal ASP - - 20 Gӧbel et al., 2007 
SF 22 2 Municipal - - - 20 Reungoat et al., 2011 
Key: HRT, hydraulic retention time; SE, secondary effluent; TE, tertiary effluent; SF, sand filter; ASP, activated sludge plant; OD, oxidation ditch  
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Figure 2.3.  Biological degradation products (DP) of diclofenac (A, adapted from Kosjek et al., 
2009) and the proposed biotransformation pathway of bezafibrate (B, adapted from Helbling et 
al., 2010)  
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2.4.2. Chemical Oxidation 
Titanium dioxide photocatalysis (Carbonaro et al., 2013) and Fenton chemistry (i.e., catalytic 
oxidation of hydrogen peroxide) (Chen et al., 2012) have been applied to water treatment 
however ozone is the most well established and studied of the chemical processes for drug 
removal.  Ozone treatment enhances the removal of all drugs including carbamazepine where 
removals of ≥96 % are observed (Ternes et al., 2003; Rosal et al., 2010; Schaar et al., 2010; 
Reungoat et al., 2011; Yang et al., 2011) (Figure 2.2, Table 2.6).  However, typical ozone 
doses applied during water treatment often do not enable full mineralisation of drugs (Huber 
et al., 2004), likely to be caused by the clouding influence of the matrix.  Wastewaters contain 
relatively high concentrations of bulk organics which can shield targeted chemicals from 
removal, quenching the ozone dose.  Furthermore, Huber et al (2004) observed that following 
removal of EE2 from clean water by a high ozone dose, a slow re-appearance of the drug 
(0.1-0.5 % of the initial concentration) occurred.  It is hypothesised that some EE2 is in the 
form of hydroperoxides which are not readily reactive to ozone.  This could be greater in 
wastewater where clouding will reduce reaction kinetics and this will hinder the complete 
mineralisation of the parent drug.  Degradation by ozonation can occur selectively by direct 
ozone attack itself and non-selectively by hydroxyl radicals formed upon ozone decay (Huber 
et al., 2004).  Ozone reacts rapidly with phenols at neutral or basic pH (Hoigne and Bader, 
1983) therefore it will readily attack the phenolate anion of EE2 and oxytetracycline.  It also 
selectively attacks amines and double bonds of aliphatic chemicals (Snyder et al., 2003).  The 
chemical structure of all the drugs considered here (except ibuprofen) are highly susceptible 
to direct ozone attack (Table 2.2).  Hydroxyl radicals are less selective and react with a range 
of chemical functional groups.  The non-selective behaviour of the hydroxyl radicals can 
induce complex reaction pathways (Huber et al., 2004).  Numerous authors observed high 
removals of various drugs by ozone treatment, often to concentrations below their MQLs 
(Ternes et al., 2003; Rosal et al., 2010; Schaar et al., 2010).  However, complete removal of 
the parent drug does not necessarily represent removal of toxicity.  Structurally similar 
degradation products of potential toxicity can be formed and remain undetected using 
conventional MS/MS (i.e., QqQ).  A large number of degradation products for various drugs 
have been observed (Huber et al., 2004; Coelho et al., 2009).  Non-target screening of ozone 
treated water enabled determination of 17 degradation products of diclofenac (Coelho et al., 
2009) (Figure 2.4).  The majority of these products are structurally similar to the parent drug 
indicating similar behaviour in the receiving environment.  Again these were identified by 
Oasis HLB extraction and QqTOF detection.  Accurate mass spectra were collected at mass to 
charge (m/z) ratios >50 encompassing all degradation products of notable size.  
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Figure 2.4.  Degradation intermediates formed by ozone treatment of diclofenac and proposed 
degradation pathways (adapted from Coelho et al., 2009). Position of some functional groups not 
defined. 
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Table 2.6. Removal of drugs from environmental waters by ozone treatment 
Drug Process Chemical dose HRT (h
-1
) Wastewater type 
Upfront 
process 
SE. conc. 
(ng l
-1
) 
TE conc. 
(ng l
-1
) 
Removal (%) Reference 
Ibuprofen 
Ozone 10-15 mg l
-1
 0.3 Municipal ASP 130 <50 >62 Ternes et al., 2003 
Ozone 2 mg l
-1
 0.2 Surface waters - - - 40-77 Huber et al., 2003 
Ozone 3 mg l
-1
 0.5 Municipal ASP + SF - - >46
a
 Nakada et al., 2007 
Diclofenac 
Ozone 0.6 g O3 g DOC0
−1
 - Municipal ASP 2,000 <10 >99 Schaar et al., 2010 
Ozone 3 mg l
-1
 0.3 Municipal - - - 92 Reungoat et al., 2011 
Ozone 50 µM <0.1 Municipal - 433 <1 >99 Rosal et al., 2010 
Ozone 10-15 mg l
-1
 0.3 Municipal ASP 1,300 <50 >96 Ternes et al., 2003 
Carbamazepine 
Ozone 0.6 g O3 g DOC0
−1
 - Municipal ASP 900 <1 >99 Schaar et al., 2010 
Ozone 3 mg l
-1
 0.3 Municipal - - - 96 Reungoat et al., 2011 
Ozone 130 µM 0.1 Municipal - 106 <1 >99 Rosal et al., 2010 
Ozone 1 mg l
-1
 - Municipal GAC 67 1 99 Yang et al., 2011 
Ozone 10-15 mg l
-1
 0.3 Municipal ASP 2,100 <50 >98 Ternes et al., 2003 
Naproxen Ozone 3 mg l
-1
 0.5 Municipal ASP + SF - - >99
a
 Nakada et al., 2007 
Ozone 10-15 mg l
-1
 0.3 Municipal ASP 100 <50 >50 Ternes et al., 2003 
Bezafibrate 
Ozone 0.6 g O3 g DOC0
−1
 - Municipal ASP 1,500 345 77 Schaar et al., 2010 
Ozone 340 µM 0.3 Municipal - 115 4 97 Rosal et al., 2010 
Ozone 2 mg l
-1
 0.2 Surface waters - - - >98 Huber et al., 2003 
Fluoxetine Ozone 50 µM <0.1 Municipal - 17 <2 >88 Rosal et al., 2010 
Ketoprofen Ozone 3 mg l
-1
 0.5 Municipal ASP + SF - - 73
a
 Nakada et al., 2007 
Ozone 340 µM 0.3 Municipal - 162 3 98 Rosal et al., 2010 
EE2 
Ozone 7.5 mg l
-1
 0.3 Municipal ASP + SF 7.4 <2.1 >72.0 Schaar et al., 2010 
Ozone 1 mg l
-1
 0.3 Municipal ASP 200
b
 <20.0 >90.0 Hashimoto et al., 2006 
Ozone 3 mg l
-1
 0.3 Municipal ASP 200
b
 <0.7 >99.6 Hashimoto et al., 2006 
Ozone 15 mg l
-1
 0.5 Municipal ASP + SF 0.2 <0.1 >50.0 Gunnarsson et al., 2009 
Ofloxacin Ozone 340 µM 0.3 Municipal - 3,594 10 >99 Rosal et al., 2010 
Erythromycin 
Ozone 90 µM <0.1 Municipal - 72 <10 >86 Rosal et al., 2010 
Ozone 1 mg l
-1
 - Municipal GAC 28 2 93 Yang et al., 2011 
Ozone 10-15 mg l
-1
 0.3 Municipal ASP 620 <50 >92 Ternes et al., 2003 
Propranolol Ozone 10-15 mg l
-1
 0.3 Municipal ASP 180 <50 >72 Ternes et al., 2003 
a
average of four sampling campaigns 
b
spiked concentration 
Key: HRT, hydraulic retention time; SE, secondary effluent; TE, tertiary effluent; ASP, activated sludge plant; SF, sand filter; GAC, granular activated carbon 
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2.4.3. Adsorption by activated carbon 
Activated carbon often contained in a packed bed or filter is a highly porous medium offering 
a large internal surface area for sorption to take place.  Performance is dependent on activated 
carbon properties (e.g., pore size, surface charge) and solute characteristics (e.g., shape, size) 
(Snyder et al., 2007).  Preferential attraction to the activated carbon surface is by hydrogen 
bonding and London forces creating a strong binding affinity.  Even moderately hydrophobic 
chemicals (log Kow >2) have a high propensity to removal (Snyder et al., 2003).  The 
availability of some drugs as anions causes them to be attracted to the carbon surface.  As a 
result substantial removals of hydrophobic and hydrophilic drugs have been observed by 
granular activated carbon (GAC) (Kim et al., 2007; Reungoat et al., 2011; Yang et al., 2011) 
(Figure 2.2, Table 2.7).  Carbamazepine removals up to 97 % have been achieved (Reungoat 
et al., 2011).  Despite the very hydrophilic nature of oxytetracycline (Table 2.1), its large 
molecular size is likely to be entrapped within the highly porous structure of the activated 
carbon.  At full-scale treatment processes low removals have been observed for some drugs; 
ibuprofen (16 %) (Snyder et al., 2007), carbamazepine (16-23 %) (Snyder et al., 2007; Grover 
et al., 2011) and propranolol (17 %) (Grover et al., 2011) (Table 2.7).  The quality of the 
secondary effluent will have a significant influence on the performance of GAC through the 
competition for available sorption sites (Snyder et al., 2007).  The frequency of 
replacement/regeneration of the activated carbon medium is another controlling factor to its 
success, especially whilst treating wastewaters comprising relatively high concentrations of 
bulk organics.  This may account for large variations in drug removals observed between 
processes.  Chiu et al (2013) demonstrated the possibility of in-situ catalytic regeneration of 
GAC using iron nano-catalysts.  This could provide an effective means of regeneration in the 
future, limiting variations in performance currently observed.  
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  Table 2.7. Removal of drugs from environmental waters by adsorption processes 
Drug Process HRT (h
-1
) Wastewater type Upfront process 
SE. conc.  
(ng l
-1
) 
TE conc. 
(ng l
-1
) 
Removal 
(%) 
Reference 
Ibuprofen 
GAC 0.3 Municipal ASP 64 <10 >84 Yang et al., 2011 
GAC - Raw water - 23 <1 >96 Kim et al., 2007 
GAC - Surface water - 1.1 <1 >10 Snyder et al., 2007 
GAC - - SF 8,760 7,325 16 Snyder et al., 2007 
Diclofenac 
GAC 0.3 Municipal ASP 99 <10 >90 Yang et al., 2011 
GAC - Municipal ASP - - >98 Grover et al., 2011 
BAC 2.0 Municipal MBR - - 92 Reungoat et al., 2011 
GAC - - SF 3.2 <1 >69 Snyder et al., 2007 
Carbamazepine 
GAC 0.3 Municipal ASP 250 67 73 Yang et al., 2011 
GAC - Municipal ASP - - 23 Grover et al., 2011 
BAC 2.0 Municipal MBR - - 97 Reungoat et al., 2011 
GAC - Raw water - 8 <1 >87 Kim et al., 2007 
GAC - Surface water - 2.2 <1 >55 Snyder et al., 2007 
GAC - - SF 199 168 16 Snyder et al., 2007 
Propranolol GAC - Municipal ASP - - 17 Grover et al., 2011 
EE2 GAC - Municipal ASP - - >43 Grover et al., 2011 
Erythromycin GAC 0.3 Municipal ASP 270 28 90 Yang et al., 2011 
BAC 2.0 Municipal MBR - - 92 Reungoat et al., 2011 
Key: HRT, hydraulic retention time; SE, secondary effluent; TE, tertiary effluent; ASP, activated sludge plant; GAC, granular activated carbon; BAC, biologically activated 
carbon; MBR, membrane bioreactor 
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2.5. FUTURE TRENDS 
Secondary effluents typically demand analytical MQLs in the low ng l
-1
 range to determine 
most drugs.  Reported analytical methods are well suited for determining drugs in the aqueous 
phase of secondary effluents.  To demonstrate, no data in Figure 2.1 (and Table 2.4) was 
reported <MQL (n=80).  Despite proposed legislative targets being applied to the aqueous 
phase of wastewaters (i.e., a pre-filtered sample); suspended solids can provide a pathway to 
their release into the environment (Baker and Kasprzyk-Hordern, 2011a).  Their 
determination in the particulate phase is also essential for fate evaluation.  Suspended solids 
are ubiquitous to wastewaters and can vary spatially and temporally.  Particulate bound drugs 
often go undetermined (Table 2.3), owing to the complexity of the matrix and the additional 
analytical requirements it demands.  The proposed requirement to undertake particulate phase 
analysis to determine drug fate is most pertinent to secondary processes which receive 
relatively high concentrations of suspended solids.  The relatively hydrophobic nature of 
some drugs can cause them to partition well to solids.  For example crude wastewaters can 
contain >50 % of fluoxetine bound to particulates (Baker and Kasprzyk-Hordern, 2011a).  
Monitoring here enables complete process mass balances to be determined, aiding fate and 
performance understanding.  Particulate fate understanding may indicate a clouding influence 
during treatment which limits removal.  Activated sludge sorption and biodegradation may be 
restricted for drugs associated with particulates in the receiving wastewater.  This could lead 
to conventional process optimisation to enhance drug removal.  For example, the use of 
micro-screens in place of conventional primary sedimentation tanks could enhance 
particulates removal from the crude stream.  However, there is a substantial gap between drug 
concentrations achieved by the current operations of existing secondary assets and proposed 
legislative targets (Gardner et al., 2012) (Table 2.2, Table 2.4).  Therefore there is an 
expectant need for tertiary treatment technologies to target these specific chemicals.    
Tertiary treatment processes enhance drug removal, significantly reducing effluent 
concentrations.  To fully ascertain tertiary process performance, analytical methods require 
MQLs <10 ng l
-1 
(Rosal et al., 2010; Schaar et al., 2010; Yang et al., 2011; Zearley and 
Summers, 2012), and ideally <1 ng l
-1
 (Kim et al., 2007; Snyder et al., 2007; Rosal et al., 
2010; Schaar et al., 2010) (Tables 2.5, 2.6 and 2.7).  This poses a further analytical challenge 
as such concentrations cannot be ascertained for the majority of drugs with current MQLs.  To 
illustrate, concentrations of the representative drugs; ibuprofen, diclofenac and carbamazepine 
in sand filtration, ozone and activated carbon treated effluents were reported below MQL in 
49 % of cases (n=35) (Figure 2.2).  Despite these being below proposed legislative targets for 
most drugs (Table 2.2), monitoring at these concentrations is needed as the cumulative 
toxicological effect of drugs is not known.  This could result in a future reduction in 
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legislative requirements.  To illustrate, the previous EE2 predicted no effect concentration 
(PNEC) in the UK was 0.1 ng l
-1
 (Environment Agency, 2000).  The proposed EQS is now 
0.035 ng l
-1
 following its proposal as a priority hazardous chemical (European Commission, 
2012).  This has created a serious analytical burden as such concentrations are now beyond 
current analytical capabilities (Petrie et al., in press).  Lowering current MQLs is also needed 
to assess breakdown reaction completeness.  The first stage of this is to determine parent drug 
removal.  Further investigation of specific breakdown mechanisms to understand the 
criticality between parent drug final concentration, and degradation product production is 
needed.  Methodologies to quantify the full range degradation products will be restricted in 
the short term by the lack of unique reference standards available for these.  However, the 
identification of numerous degradation products in both biological and chemical processes 
has brought attention to their presence and created a demand for their commercial availability 
(Figures 2.3 and 2.4).  The complimentary use of biological assays would improve 
understanding of the synergistic toxicological effect of multiple drugs and their degradation 
products at low concentration.  Process design and operation must integrate the removal of 
these intermediates which can be of greater concern than the parent chemical due to their 
subsequent transformation to more toxic chemicals in the environment (Petrie et al., 2013a).     
Lowering drug MQLs requires existing analytical method optimisation.  The low recoveries 
(<50 %) typically stipulated prior to internal standard correction (Gracia-Lor et al., 2011), can 
be improved to reduce the achievable MQL.  Baker and Kasprzyk-Hordern (2011b) gave an 
excellent account of sample preparations parameters which can influence recovery.  For 
example drugs can be adsorbed onto glassware surfaces during handling and processing.  
Using silanised SPE extract vials gave recoveries six times higher than non-silanised vials for 
some drugs.  All glassware used during sample collection and processing requires silanisation 
to ensure maximum recoveries.  Silanisation of glassware is not mentioned in the procedures 
of most reported analytical methods (Gracia-Lor et al., 2011; López-Serna et al., 2011; 
Grabic et al., 2012; Gros et al., 2012).  Improving chromatographic separations could also 
significantly increase detection capabilities. Incorporating a large number of drugs into a 
single short UPLC run (<10 minutes) results in a number of co-eluting peaks (Gracia-Lor et 
al., 2011; López-Serna et al., 2011; Gros et al., 2012).  Despite the use of mass scanning 
windows which typically range from 0.3 to 2 minutes in length for UPLC separations (López-
Serna et al., 2011; Gros et al., 2012), sensitivity can be lost whilst simultaneously scanning 
for a number of transitions registered at the same time (López-Serna et al., 2011).  To 
demonstrate, Gros et al (2012) reports up to 10 drugs co-eluting within a 0.1 minute time 
period with scanning windows of 0.5 minutes.  Thus, only monitoring for one drug (of most 
criticality) in this time period could increase sensitivity and notably reduce the MQL.   
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Tertiary processes receive secondary effluents comprising comparatively high concentrations 
of dissolved organics (e.g., colloids).  However, knowledge of drug behaviour in the charged 
colloidal fraction of wastewater is limited.  Shen et al (2012) successfully showed humic acid, 
a small molecular weight charged species could effectively retain the hormone, estrone in 
solution.  This can restrict sorption in tertiary processes characterised by very short contact 
times.  Furthermore, the complexity of the colloidal fraction and its interaction with the drugs 
could also lead to incomplete breakdown reactions in both biological and chemical processes.  
A fractionation step during sample pre-treatment to separate dissolved colloids by molecular 
weight will aid this.  It is postulated that drugs will preferentially be in specific size fractions.  
This is likely to vary between drugs due to the range of physico-chemical behaviour they 
exhibit.  Understanding drug fate in the colloidal fraction of wastewater is essential for 
tertiary process selection, diagnosis and optimisation.      
 
2.6. CONCLUSION 
Advances in both quantitative and qualitative determinations of pharmaceutical drugs have 
aided the understanding of their occurrence and fate during wastewater treatment.  A robust 
understanding of tertiary process performance is now needed by improving analytical focus.  
An appropriate treatment strategy could then be implemented to ensure adequate protection of 
the aquatic environment is achieved.  
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DETERMINATION OF STEROID ESTROGENS IN WASTEWATERS 
 
Bruce Petrie, Ewan J. McAdam, Keith H. Richards, John N. Lester, Elise Cartmell 
Cranfield Water Science Institute, Cranfield University, Bedfordshire, MK43 0AL 
 
ABSTRACT 
An ultra-performance liquid chromatography method using a triple quadrupole mass 
spectrometer was developed and validated for the determination of steroid estrogens in 
wastewater matrices.  To date, analytical methods established in the literature for 17α-
ethinylestradiol have been unable to achieve the proposed predicted no effect concentration of 
0.1 ng l
-1
.  The extensive sample pre-treatment and analytical methodology proposed herein 
enables 17α-ethinylestradiol to be determined at very low background concentrations with a 
theoretical method detection limit of 0.06 ng l
-1 
which has been applied in real environmental 
matrices. During the validation process, a trickling filter wastewater treatment works was 
monitored to demonstrate the methods application.  Estrogen removal across the filters 
demonstrated good removals of natural free estrogens (≥62.0 %) with lower removals of the 
synthetic estrogen 17α-ethinylestradiol (29.2 %) from wastewaters at 10 °C.  The methods 
application illustrates its capability of detecting estrogen concentrations in real wastewater 
samples comprising complex organics of comparatively high concentration.  Furthermore, a 
complete process mass balance for 17α-ethinylestradiol is now attainable which has 
previously posed a challenge due to the low environmental concentrations typically exhibited, 
but more significantly as a result of the lower sensitivity inherent in previously reported 
analytical methods. 
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3.1. INTRODUCTION 
Steroid estrogens present in the aquatic environment at ng l
-1
 concentrations can act as 
endocrine disrupting chemicals (Lai et al., 2002a; Urbatzka et al., 2012) (EDCs) which exert 
adverse health effects on the sexual characteristics of fish (Solé et al., 203; Kidd et al., 2007; 
Woods et al., 2011).  It is estimated that substantial estrogenic activity in surface waters is 
attributable to the presence of free steroid estrogens which are discharged in sewage effluents 
(Chui et al., 2009).  Estrogens detected in municipal wastewaters are: estrone (E1), 17β-
estradiol (E2), estriol (E3), 17α-ethinylestradiol (EE2) and the conjugate, estrone 1-3 sulphate 
(E1-3S) (Gomes et al., 2004a; Gomes et al., 2005; Kumar et al., 2009).  Wastewater treatment 
works (WwTWs) are critical to controlling the discharge of hazardous substances, including 
estrogens, to the aquatic environment (Bedding et al., 1982).  Aerobic biological WwTWs are 
a major process type used in the UK with a significant portion of these being fixed film 
processes.  Three of the main water utilities in England and Wales use fixed film processes at 
70 % of their sites (Xuo and Hickey, 2007; UKWIR, 2009) and this is mirrored 
internationally (Tilley, 2011).  Interestingly, there is a paucity of data in the literature 
regarding the factors controlling the fate and behaviour of estrogens in such processes.  
Undoubtedly the analytical difficulties of determining these types of compounds in such 
complex matrices at environmental concentrations (ng l
-1
) has been a major constraint on such 
research (Buisson et al., 1984; Robertson and Lester, 1994).  Determining the removal of 
estrogens across WwTWs and the concentrations discharged into the receiving environment is 
essential for environmental protection and monitoring plant performance. 
The analysis of estrogens in environmental matrices requires sophisticated analytical 
methodologies, involving extraction and clean-up sample pre-treatments.  Such extensive 
clean-up of samples is required due to the complex heterogeneous composition of 
wastewaters.  The synthetic estrogen EE2 is of most environmental concern despite its low 
wastewater concentrations due to its high estrogenic potency and relative persistence to 
biodegradation in wastewaters and surface waters.  There are continuing requirements to 
lower the EE2 detecting capabilities of analytical methodologies.  The lowest reported 
method detection limit (MDL) of this compound in aqueous wastewater matrices is 0.2 ng l
-1
 
(Koh et al., 2007).  This is currently insufficient to monitor background concentrations of 
EE2 at and below the predicted no effect concentration (PNEC) of 0.1 ng l
-1
 proposed by the 
Environment Agency of England and Wales (Environment Agency, 2000).  High performance 
liquid chromatography (HPLC) with mass spectrometry detection is favoured for analysis due 
to the low detection limits attainable and further sample pretreatments such as chemical 
derivatization are not needed (Stanford and Weinberg, 2007).  However, the desire to improve 
analysis time, sensitivity and separation efficiency has led to the introduction of ultra-
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performance liquid chromatography (UPLC) (Farré et al., 2007; Kasprzyk-Hordern et al., 
2009).  Here column efficiency is inversely proportional to stationary phase particle size as 
described by the van deemter equation (de Villiers et al., 2006).  Ultra performance liquid 
chromatography delivers high pressures which enables columns packed with smaller particle 
sizes to approach their theoretical performance.  This cannot be exploited by HPLC due to the 
limited operating pressures inherent of such instruments (Swartz, 2005).  This study develops 
a UPLC method for the analysis of steroid estrogens in wastewater matrices 
(aqueous/particulate) using existing extraction methodology.  The advances of utilising UPLC 
as the analytical separation method were assessed by comparing the performance to an 
existing HPLC method.  The method was applied to determine the performance of a trickling 
filter for the removal of steroid estrogens during low temperature operation. 
3.2. EXPERIMENTAL 
3.2.1. Materials 
All steroid estrogens (>98 % purity) were purchased from Sigma-Aldrich (Dorset, UK).  
Deuterated internal standards; estrone-2,4,16,16-d4 (E1-d4), 17β-estradiol-2,4,16,16,17-d5 
(E2-d5), estriol-2,4,17-d3 (E3-d3), 17α-ethynylestradiol-2,4,16,16-d4 (EE2-d4) and sodium 
estrone-2,4,16,16-d4 sulfate (E1-3S-d4) were obtained from QMX laboratories (Thaxted, UK).  
Individual stock solutions of 1 mg ml
-1
 were prepared in methanol (MeOH) and stored at -20 
°C.  Working standard mixtures of estrogen concentrations; 0, 1, 5, 10, 25, 50, 75 and 100 ng 
ml
-1
, containing 75 ng ml
-1
 of the deuterated surrogates were prepared daily.  Methanol, 
dichloromethane (DCM), ethyl acetate (EtOAc) and hexane were obtained from Rathburn 
Chemicals (Walkerburn, UK) and were HPLC grade.  Ammonium hydroxide (NH4OH) of 
ACS grade was purchased from Sigma Aldrich (Dorset, UK) and UP water of 18.2 MΩ 
quality (Elga, Marlow, UK) was used in the preparation of mobile phases.  Wastewater 
samples (settled sewage and final effluent) were collected in borosilicate glass vessels with 
teflon lined caps from a trickling filter site of population equivalent 3,000 in the East of 
England, UK.  Corresponding grab samples of settled sewage and filter effluent were 
collected over a 3 day period to determine process performance.  Samples were filtered and 
loaded onto solid phase extraction (SPE) cartridges within 30 minutes of collection and once 
dried, stored at -20 °C prior to further clean up.    
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3.2.2. Extraction process 
Settled sewage and final effluent samples (1 l) were filtered under vacuum through 1.2 µm 
GF/C filters (VWR, Lutterworth, UK) prior to SPE.  Filter papers with retained solids were 
frozen before extraction.  The aqueous phase was loaded onto 500 mg: 6 cc tC18 cartridges 
(Waters, Elstree, UK) preconditioned with 5 ml MeOH then 5 ml UP water.  Cartridges 
changes were made after 500 ml to avoid cartridge saturation.  The flow rate was controlled 
between 5 ml min
-1
 and 10 ml min
-1 
using a vacuum manifold.  The cartridge was then washed 
with 5 ml UP H2O and dried for 60 minutes under vacuum.  Analytes were eluted using 10 ml 
MeOH followed by 10 ml DCM.  Extracts were concentrated to 1 ml by rotary evaporation 
(Heidolph Instruments, Schwabach, Germany) then to complete dryness under a gentle stream 
of nitrogen gas.  The dried sample was reconstituted in 0.2 ml DCM: MeOH (90: 10).  The 
sample was then subject to clean up by gel permeation chromatography (GPC) by injection 
onto a 5 µm, 300 mm x 7.5 mm gel permeation size exclusion column (Varian, Oxford, UK) 
under isocratic conditions (DCM: MeOH, 90: 10 v/v) at a constant flow rate of 1 ml min
-1
 and 
the fraction between 5.5 minutes and 11.5 minutes collected.  The 6.0 ml fraction was 
evaporated to approximately 0.2 ml under a nitrogen stream then reconstituted to 2 ml with 
hexane.  This was loaded onto a preconditioned (2 ml hexane) 500 mg: 6 cc NH2 SPE 
cartridge (Varian, Oxford, UK), at a flow rate between 5 ml min
-1 
and 10 ml min
-1
.  The 
cartridge was then washed using 4 ml EtOAc: hexane (10: 90).  Non polar steroids (E1, E2 
and EE2) were eluted using 6 ml EtOAc.  The polar steroids (E1-3S and E3) were eluted 
separately using 6 ml of 3 % NH4OH in MeOH.  Separate eluants were blown to dryness 
under a gentle stream of nitrogen gas, then reconstituted with 0.2 ml UP H2O: MeOH (80: 20) 
containing 0.1 % NH4OH and divided between two identical autosampler vials prior to 
quantification by HPLC-MS/MS and UPLC-MS/MS.  Prior to extraction the aqueous phase 
samples were spiked with 15 ng l
-1
 deuterated estrogens.  These were used to monitor the 
extraction process and to correct for any variability in detector response.  To ensure analytical 
reliability; both low (2 ng l
-1
) and high (15 ng l
-1
) spikes of additional mixed estrogens were 
used to determine recoveries.  These spike levels represent estrogen concentrations 
approximately 1 order of magnitude greater than the MDL, and those concentrations expected 
to be found in real sample matrices (Koh et al., 2007; McAdam et al., 2010). 
For the settled sewage and final effluent samples, filter papers were freeze-dried, shredded 
and extracted using 10-20 ml EtOAc whilst being mechanically agitated using a multi-reax 
system (Heidolph Instruments, Schwabach, Germany) in a 25 ml Teflon tube for 60 minutes.  
This was followed by centrifugation at 1500 x g for 10 minutes.  The extraction was repeated 
twice then the combined supernatants were evaporated to approximately 0.2 ml and 
reconstituted to 2 ml with hexane.  The sample was subjected to SPE by passing through a 
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500 mg: 3 ml silica cartridge (Waters Ltd., Watford, UK) preconditioned with 2 ml hexane at 
constant flow rates of between 5 ml min
-1
 and 10 ml min
-1
.  Analytes were eluted using 3 ml 
EtOAc followed by 2 ml MeOH ensuring the cartridge media remained saturated and then 
evaporated to dryness on a rotary evaporator prior to reconstitution in 0.2 ml DCM: MeOH 
(90: 10).  The extracts were then subject to the same clean up procedure as the aqueous 
samples by GPC and normal phase SPE.  To ensure analytical reliability all samples prior to 
freeze drying were spiked with deuterated (75 ng g
-1
) estrogens and both low (10 ng g
-1
) and 
high spikes (75 ng g
-1
) to determine recoveries.  A summarised representation of the 
extraction procedure for aqueous and particulate phases is outlined (Figure 3.1).     
 
 
Figure 3.1. Summarised extraction methodology for aqueous and particulate phases 
 
 
 
 
 
 
Aqueous phase Particulate phase 
1 litre sewage sample 
Solvent extraction with EtOAc 
Silica SPE 
C18 SPE 
Filtration (1.2 μm) 
Filter papers freeze dried 
Centrifugation 
Gel permeation chromatography 
NH2 SPE 
E1, E2, EE2 elution E3, E1-3S elution 
EtOAc 3% NH4OH in MeOH 
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3.2.3. High performance liquid chromatography 
High performance liquid chromatography was performed using a Waters Alliance 2695 
system (Waters, Manchester, UK).  Separations were achieved using a Gemini C18 column 
(100 mm x 2.0 mm i.d., 3.0 µm particle size; Phenomenex, Macclesfield, UK) maintained at 
35 °C.  A gradient separation was achieved using water containing 0.1 % NH4OH (A) and 
methanol containing 0.1 % NH4OH (B) at a constant flow rate of 0.2 ml min
-1
.  Initial 
conditions of 80 % A and 20 % B were increased to 50 % B over 3.5 minutes and then further 
increased to 60 %. This was maintained for 9 minutes before returning to starting conditions 
over 3 minutes and held for 2.5 minutes for equilibration.  The total run time was 18 minutes 
and an injection volume of 20 µl was used.  This method has been previously validated and 
applied to quantify the concentration of steroid estrogens in wastewater matrices (Koh et al., 
2007; Chiu et al., 2009; McAdam et al., 2010).   
 
3.2.4. Ultra-performance liquid chromatography 
Ultra performance liquid chromatography method development was performed using a 
Waters Acquity UPLC (Waters, Manchester, UK).  Separations were achieved using an 
Acquity UPLC BEH C18 column (100 mm x 2.1 mm i.d., 1.7 µm particle size; Waters, 
Manchester, UK) maintained at 45 ˚C.  A gradient separation of two mobile phases was 
utilised consisting of water containing 0.1 % NH4OH (A) and methanol containing 0.1 % 
NH4OH (B) at a constant flow rate of 0.2 ml min
-1
.  Gradient elutions were tested to 
determine which would give adequate separation of the analytes and matrix not removed by 
the extraction and clean up processes.  Initial conditions of 80 % A and 20 % B were 
increased gradually to 80 % B over 6 minutes and maintained for 1 minute.  This was then 
returned to starting conditions for 2 minutes for equilibration.  These conditions gave 
adequate separation of analytes in a reduced run time of 9 minutes.  The maximum injection 
volume which did not result in band broadening and loss of efficiency was 10 µl and was used 
throughout the investigation.   
 
3.2.5. MS/MS detection 
Detection was achieved by a Waters Quattro Premier XE mass spectrometer with a Z-spray 
ESI interface (Micromass, Watford, UK) for both HPLC and UPLC separations.  This was 
operated in the negative electrospray ionisation mode utilising multiple reaction monitoring 
(MRM).  Two MRM transitions were monitored for each estrogen compound; the most 
sensitive transition monitored for quantitation and the second for analyte confirmation.  The 
optimised MS/MS conditions for the detection of steroid estrogens are outlined (Table 3.1).  
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To maximise sensitivity the detection of estrogens was divided into two acquisition periods. 
Period 1 monitored for E1-3S and E3 and period 2 for those later eluting, less polar estrogens; 
E1, E2 and EE2.  The parameters for detection by the mass spectrometer were as follows: 
capillary voltage, 3.20 kV; multiplier voltage, 650 V; desolvation gas flow, 1000 l h
-1
; cone, -
55 V; RF lens, 0.2 V; cone gas flow, 49 l h 
-1
; desolvation temperature, 350 °C and source 
temperature, 120 °C (Koh et al., 2007). 
Table 3.1.  Optimised LC-MS/MS parameters for MRM transitions of steroid estrogens 
Compound 
Molecular 
formula 
Molecular 
weight  
(g mol
-1
) 
MRM
a
 (m/z) 
Dwell 
time 
(ms) 
Collision 
energy (V) 
Cone 
(V) 
E1
d
 C18H22O2 270.37 269.10 > 144.85 85 
85 
40 
45 
70 
70    269.10 > 158.80
b
 
E2
d
 C18H24O2 272.38 271.10 > 144.85 85 
85 
45 
40 
60 
60    271.10 > 158.80
b
 
E3
c
 C18H24O3 288.39 287.10 > 170.85 95 
95 
50 
50 
55 
55    287.10 > 144.85
b
 
EE2
d
 C20H24O3 296.40 295.15 > 144.85 85 
85 
40 
40 
60 
60    295.15 > 158.80
b
 
E1-3S
c
 C18H22O5S 350.50 349.05 > 144.85 60 
60 
65 
40 
50 
50    349.05 > 269.00
b
 
E1-d4
d
 C18D4H18O2 274.40 273.10 > 146.85 85 45 60 
E2-d5
d
 C18D5H19O2 277.42 276.10 > 146.85 85 50 55 
E3-d3
c
 C18D3H24O3 291.40 290.15 > 146.85 90 65 50 
EE2-d4
d
 C20D4H20O2 300.43 299.15 > 146.85 85 50 60 
E1-3S-d4
c
 C18D4H17SNaO5 376.44 353.10 > 146.85 60 65 50 
a
[M-H]
-
 
b
confirmatory transition 
c
Transition period 1 
d
Transition period 2 
 
3.3. RESULTS 
3.3.1. Instrument performance comparison 
Utilising UPLC, in comparison to HPLC, offered reductions in the time required for 
chromatographic separations, with total run times of 9 minutes versus 18 minutes, 
respectively (Table 3.2).  In terms of chromatographic separations, UPLC allowed efficiencies 
of 11,500 theoretical plates in comparison to HPLC and 4,500 theoretical plates.  Similarly 
solvent consumption and sample volume requirements were reduced by 50 % with the use of 
UPLC. A total of 3.6 ml of mobile phase was required for an analysis run by HPLC whereas 
UPLC required 1.8 ml.  At these reduced analysis times, sensitivities were superior to those 
achieved by HPLC.  The signal to noise ratio (S: N) of analyte responses were generally 
improved by two fold offering improved instrument detection limits (IDLs) and precision 
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(Table 3.2).  Replicate measurements of calibration standards (1 ng ml
-1 
and 10 ng ml
-1
) gave 
RSDs of ≤10.2 % for all steroid estrogens by UPLC in comparison to ≤16.4 % for HPLC.  
Trueness expressed as bias varied from -6.3 % to 7.3 % for HPLC and from -0.5 % to 6.7 % 
for UPLC.  Calibration curves were linear over the range of 1 ng ml
-1
 to 100 ng ml
-1
 with 
correlation coefficients >0.995 for all analytes for both HPLC and UPLC separations (Table 
3.2).  
 
Table 3.2.  Instrumental detail for the determination of steroid estrogens by HPLC-MS/MS and 
UPLC-MS/MS 
Method 
Steroid 
estrogen 
Retention 
time (min) 
r
2
 
Precision
a
 (%) Trueness
a
 (bias %) IDL
b
 
(pg) 
1 ng ml
-1
 10 ng ml
-1
 1 ng ml
-1
 10 ng ml
-1
 
 E1 13.1 0.999 12.4 1.0 -6.3 -3.6 10.1 
 E2 13.6 0.999 4.2 3.3 4.9 -2.0 16.6 
HPLC E3 9.1 0.997 16.4 1.7 7.3 2.3 12.4 
 EE2 13.8 0.997 5.6 2.1 6.0 -2.5 11.3 
 E1-3S 7.1 0.999 0.1 0.6 -5.3 -1.1 6.4 
 E1 6.7 0.999 5.1 0.1 3.7 -0.5 2.4 
 E2 6.8 0.995 4.2 1.2 5.7 1.8 6.4 
UPLC E3 5.0 0.999 4.3 0.6 6.7 4.3 4.5 
 EE2 6.9 0.999 10.2 3.0 0.1 2.8 2.7 
 E1-3S 4.1 0.999 5.1 0.6 1.3 0.1 1.1 
a
Replicate (n=3) inter-day measurements of quality control samples 
b
3 times the standard deviation of 
replicate (n=7) UP water extractions spiked at 1 ng l
-1
  
Note:
 
IDL=instrument detection limit 
 
3.3.2. Environmental matrices 
The MRM chromatograms of all estrogens in settled sewage spiked at 2 ng l
-1
 by HPLC-
MS/MS and UPLC-MS/MS illustrate the differences in their respective chromatography 
(Figure 3.2).  The improved sensitivity of UPLC offers reduced peak widths and apparent 
background noise.  Those peaks produced using HPLC displayed baseline widths of ≥30 
seconds in contrast to UPLC where widths of ≤15 seconds were noted.  As a result those 
peaks produced by UPLC were ‘sharper’ and presented a Gaussian distribution enabling more 
reproducible quantitation of peak response in environmental matrices.  Mean recoveries 
determined by UPLC and HPLC were 94.1 (+/- 5.6) % and 93.6 (+/-7.6) %, with RSDs up to 
22.8 % and 24.5 % respectively (Table 3.3).   
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Figure 3.2. MRM chromatograms of estrogens by HPLC-MS/MS (A) and UPLC MS/MS (B) 
(settled sewage spiked at 2 ng l
-1
).  Note: S: N=signal to noise ratio 
 
 
 
 
 
 
 
 
(A) 
E1-3S 
S:N - 57 
E3 
S:N - 58 
E1 
S:N - 172 
E2 
S:N - 65 
EE2 
S:N - 23 
349.05 > 144.85 
287.10 > 170.85 
269.10 > 144.85 
295.15 > 144.85 
271.10 > 144.85 
(B) 
E1-3S 
S:N - 177 
E3 
S:N - 88 
E1 
S:N - 337 
E2 
S:N - 108 
EE2 
S:N - 50 
349.05 > 144.85 
287.10 > 170.85 
269.10 > 144.85 
271.1 > 144.85 
295.15 > 144.85 
Retention time (min) 
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Table 3.3.  Method recoveries (%) and relative standard deviations (RSD %) from settled sewage 
and final effluent matrices using high (15 ng l
-1
) and low (2 ng l
-1
) spikes 
Method 
Steroid 
estrogen 
Aqueous phase recoveries  
(RSD %) 
Particulate phase recoveries 
(RSD %) 
Settled sewage Final effluent Settled sewage 
Final 
effluent 
 E1 100.3 (2.8) 93.9 (13.1) 99.2 (7.3) 103.2 (0.5) 
 E2 100.9 (4.3) 97.6 (6.1) 96.8 (11.3) 85.9 (24.5) 
HPLC E3 92.2 (11.0) 96.2 (7.5) 80.5 (9.0) 103.6 (0.7) 
 EE2 92.2 (5.6) 91.6 (3.7) 90.6 (9.9) 100.2 (2.4) 
 E1-3S 71.3 (6.4) 99.4 (16.7) 68.9 (5.0) 107.5 (5.0) 
 E1 100.7 (0.6) 97.6 (0.4) 99.0 (2.3) 101.0 (4.2) 
 E2 91.1 (6.5) 96.7 (8.2) 87.9 (2.8) 87.4 (3.8) 
UPLC E3 86.8 (6.0) 88.6 (9.1) 97.4 (22.8) 104.6 (5.5) 
 EE2 100.8 (6.4) 96.3 (5.4) 103.0 (2.1) 97.2 (5.3) 
 E1-3S 81.9 (4.7) 93.9 (6.6) 69.6 (5.0) 101.3 (5.0) 
 
The effect of the sample matrix on analyte signals was determined for both aqueous and 
particulate extractions using the algorithm reported by Vieno et al (2006).  A maximum of 7.4 
% signal suppression was observed for both polar (E3 and E1-3S) and non-polar (E1, E2, and 
EE2) analytes in final effluent extracts by UPLC.  In contrast HPLC gave signal suppressions 
of between 6.8 % and 11.7 % for polar analytes and between 4.2 % and 25.9 % for non-polar 
analytes in final effluent extracts.  In settled sewage, analyte signal suppressions of between 
2.0 % and 11.4 % for polar analytes and between 5.7 % and 23.4 % for non-polar analytes 
were observed by UPLC.  Signal suppressions of 5.1 % to 9.1 % for polar analytes and 5.2 % 
to 29.7 % for non-polar analytes were determined by HPLC.  
The use of UPLC offered the advantage of reduced MDLs for all analytes in settled sewage 
and final effluent phases (Table 3.4).  Method detection limits were calculated and corrected 
for matrix interferences using (Vieno et al., 2006): 
M)(100
100
.
(R.C)
IDL.100
MDL

        (3.1) 
Where IDL is instrument detection limit (ng l
-1
), R is recovery (%), C is concentration factor 
and M is matrix suppression (%).  High performance liquid chromatography provided MDLs 
of 0.08 ng l
-1
 to 0.18 ng l
-1
 for estrogens in aqueous phases and between 3.20 ng g
-1
 and 11.58 
ng g
-1
 for particulate phases.  In comparison UPLC gave MDLs ranging from 0.02 ng l
-1
 to 
0.17 ng l
-1
 in aqueous phases and 1.12 ng g
-1
 to 8.85 ng g
-1
 in particulate phases.  The MDLs 
in the aqueous phase of final effluents are of most significance due to the majority of 
estrogens being present in this phase. The MDLs achieved in this study superseded those 
45 
 
previously reported (Table 3.5).  Considering the MDLs reported for EE2 they follow the 
order based on the separation and detection method; UPLC-MS/MS<HPLC-MS/MS<GC-
MS/MS<GC-MS, although differences in extraction methodology may in part account for 
this.  Importantly, the UPLC MDLs reported in this study are below their PNECs proposed by 
the Environment Agency of England and Wales (Environment Agency, 2000).   
 
Table 3.4.  Method detection limits of steroid estrogens in wastewater matrices  
Method 
Steroid 
estrogen 
MDL in settled sewage MDL in final effluent 
Aqueous (ng l
-1
) Part. (ng g
-1
) Aqueous (ng l
-1
) Part (ng g
-1
) 
 E1 0.11 5.58 0.12 5.12 
 E2 0.18 10.93 0.18 11.58 
HPLC E3 0.14 8.20 0.14 6.50 
 EE2 0.14 8.95 0.14 7.68 
 E1-3S 0.10 4.89 0.08 3.20 
 E1 0.05 3.02 0.05 2.48 
 E2 0.17 8.85 0.14 8.14 
UPLC E3 0.11 5.02 0.10 4.27 
 EE2 0.06 3.42 0.06 2.96 
 E1-3S 0.03 1.61 0.02 1.12 
Part.=particulate  
 
Table 3.5.  Comparison of steroid estrogen PNECs and MDLs (ng l
-1
) in wastewaters (aqueous 
phase)  
Steroid 
estrogen 
PNEC 
(Environment 
Agency, 2000)  
MDL  
this study 
FE 
MDL  
Koh et al 
FE 
(2007)
a
 
MDL  
Liu et al 
FE 
(2011)
b
 
MDL  
Belfroid et al 
FE  
(1999)
c
 
MDL  
 Gibson et al 
WW  
(2007)
d
 
E1 3.0 0.05 0.12 0.05 0.3-1.0 1.0 
E2 1.0 0.14 0.20 0.29 0.5-2.4 0.5 
E3 - 0.10 0.22 - - - 
EE2 0.1 0.06 0.16 0.49 0.3-1.8 2.5 
E1-3S - 0.02 0.09 - - - 
a
Two stage SPE, size exclusion chromatography and HPLC-MS/MS 
b
Two stage SPE and rapid 
resolution LC-MS/MS 
c
Three stage SPE, HPLC clean up, silylation and GC-MS/MS 
d
SPE, 
derivatization and GC-MS  
Note: PNEC = predicted no effect concentration, FE = final effluent, WW=wastewater 
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3.3.3. Application of UPLC to evaluate the removal and biodegradation across a 
trickling filter 
The UPLC method developed was applied to the determination of steroid estrogens in 
wastewaters pre and post trickling filter treatment to examine removal efficiency.  
Corresponding grab samples were collected for settled sewage and filter effluent to 
compensate for any intraday variation in receiving concentration.  Over the three day period, 
mean removals of the free natural estrogens were ≥62.0 % whereas 29.2 % of the synthetic 
estrogen EE2 was removed.  No removal of the conjugate E1-3S was observed (Table 3.6).  
Estrogens were found to be predominantly distributed in the aqueous phase of wastewater 
(>78 %) with the exception to EE2 which had a greater proportion found in the particulate 
phase.  The distribution of estrogens between solid and aqueous phases (log Kd) of secondary 
effluent was calculated using:   
A
P
Kd           (3.2) 
Where P is the concentration of the analyte in the particulate phase (ng kg
-1
) and A is the 
concentration in the aqueous phase (ng l
-1
).  The determined log Kd of estrogens in secondary 
effluent was found to range from 2.3 to 3.5 for E1-3S and EE2, respectively.   
 
Table 3.6.  Determination of steroid estrogens in wastewater at 10 (+/- 0.5) °C from a trickling filter 
wastewater treatment works over a three day period  
Steroid 
estrogen 
Settled sewage (ng l
-1
) Secondary effluent (ng l
-1
) Mean 
removal
a
 
(%) 
Log 
Kow
b
 
Log Kd
c 
Aqueous Particulate Aqueous Particulate 
E1 106.2 2.3 32.4 1.3 69.0 3.1-3.4 2.5 
E2 16.3 1.2 5.5 1.2 62.0 3.9-4.0 3.2 
E3 66.5 0.4 16.7 0.5 74.2 2.5-2.8 2.4 
EE2 0.6 0.4 0.5 0.2 29.2 3.7-4.2 3.5 
E1-3S 59.2 0.9 64.0 1.7 - NA 2.3 
aRemoval (%)=((∑in-∑out)/∑in) x 100 %  
b
Octanol:water partition coefficient (Lai et al., 2000a; Liu et 
al., 2009)
 c
Secondary effluent partition coefficient  
Note:
 
NA = not available 
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3.4. DISCUSSION 
3.4.1. Instrument performance  
A substantial improvement in analytical performance was achieved by utilising UPLC in 
comparison to HPLC with the reduction in analysis time enabling a faster sample throughput 
doubling the number of samples which can be analysed.  Ultra-performance liquid 
chromatography also offered the advantage of lowering solvent consumptions by 50 % which 
presents significant economic benefits to analytical resources in comparison to conventional 
HPLC (Koh et al., 2007).  The UPLC chromatography exhibited considerable improvements 
in peak shape with reduced peak widths.  Superior signal to noise allows greater 
reproducibility of peak integration particularly at reduced analyte concentrations and 
consequently a greater reliability in estrogen quantitation (Swartz, 2005; de Villiers et al., 
2006).  This improved sensitivity of UPLC offers reduced IDLs which will aid in the 
determination of steroid estrogens in wastewater matrices often present at concentrations <5 
ng l
-1
 (Gomes et al., 2004a; Gomes et al., 2005; Chui et al., 2009; McAdam et al., 2010; Zhou 
et al., 2012).   
 
3.4.2. Method performance 
The success of removing background interferences in the sample clean up stages is apparent 
in all chromatograms.  Reported recoveries were similar to those previously reported in the 
literature (Koh et al., 2007).  The recoveries of estrogens in aqueous and particulate phases of 
settled sewage and final effluent matrices determined by UPLC and HPLC were found to be 
similar.  The small discrepancies observed between recoveries determined by HPLC and 
UPLC are attributed to analytical variability.  The MDLs reported for HPLC are comparable 
to a previous study which utilised the same methodology attaining limits varying from 0.1 ng 
l
-1
 to 0.2 ng l
-1
 for all estrogens in final effluent and settled sewage aqueous phases (Koh et 
al., 2007).  The current HPLC MDL of EE2 in final effluent is 0.14 ng l
-1
 which is above the 
PNEC of 0.1 ng l
-1
 (Environment Agency, 2000).  This estrogen is of greatest environmental 
concern due to its high estrogenic potency.  It is important that these compounds can be 
monitored at concentrations below their respective PNECs to ensure environmental 
protection.  The UPLC method developed; along with the 3 stage sample extraction process 
achieved a MDL in final effluent of 0.06 ng l
-1
 for EE2 which offers the opportunity to 
determine EE2 concentrations at and below the PNEC with greater reliability and confidence.  
The improved chromatographic separation efficiencies reduced the effect of matrix 
interference on analyte signal intensity, thus aiding sensitivity and providing the means to 
monitor and manage estrogens not only in final effluent but also in receiving waters and other 
exposed environment matrices (Lai et al., 2002a; Gomes et al., 2004a).  The reduction in 
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matrix interferences by UPLC will be particularly advantageous when estrogen concentrations 
are close to the MDL and analyte signal suppression is most critical.  There are numerous 
publications which have been restricted by the detection capabilities of their methods in 
monitoring environmental EE2 concentrations across WwTWs (Braga et al., 2005; 
Chimchirian et al., 2007; Stanford and Weinberg, 2007; Kumar et al., 2009; Zorita et al., 
2009; Zhou et al., 2012).  Although this method required a three stage sample extraction and 
clean up procedure, the benefits of this sample pretreatment were substantial considering the 
MDLs achieved.   
 
3.4.3. Removal of estrogens across a trickling filter 
Sewage treatment works are critical points in determining the environmental distribution of 
estrogens and hence their environmental (Bedding et al., 1982; Lai et al., 2002) and 
ecological impact (Gomes et al., 2003). The trickling filter achieved relatively good removals 
(≥62.0 %) of the natural free steroid estrogens in wastewater at 10 °C.  Trickling filters are 
widely implemented offering a low energy wastewater treatment technology which has the 
potential to substantially reduce the concentration of free natural estrogens in wastewaters 
(Chimchirian et al., 2007; Koh et al., 2007; Dagnino et al., 2009).  Removals of the synthetic 
estrogen EE2, across the trickling filter are typical to those previously reported (Koh et al., 
2007), with 29.2 % removed reiterating its more recalcitrant nature.  The effluent 
concentrations of E1, E2 and EE2 were greater than their PNECs of 3.0, 1.0 and 0.1 ng l
-1
, 
respectively (Environment Agency, 2000), which indicates that wastewater treatment by 
stand-alone trickling filters is unlikely to reach proposed estrogen PNECs.  Although 
substantial removals of estrogens were achieved using trickling filters, reaching PNEC targets 
in the future may require additional tertiary treatment to further enhance removals.  However, 
care must be taken in tertiary treatment process selection so as not to cause overall 
environmental harm or excessive cost (Jones et al., 2007a). The presence of E1-3S in both 
settled sewage and secondary effluent at relatively high concentrations (circa 60 ng l
-1
) during 
periods of low ambient temperature (10 ºC) demonstrates the need to monitor this compound 
considering its possible deconjugation to E1 during wastewater treatment and in the 
environment.  The recalcitrance of E1-3S has been previously observed in trickling filters 
(Koh et al., 2007) and activated sludge (Gomes et al., 2009).  
The majority of estrogens were found to be distributed in the aqueous phase of wastewaters 
yet their presence in the particulate phase makes a notable contribution to their total 
concentration.  In settled sewage, 40 % of EE2 was found to be present in the particulate 
phase in contrast to E3 which had <1 % of the total concentration present in the particulate 
phase.  The high proportion of EE2 bound to particulate matter reiterates its hydrophobicity 
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and the need to monitor the concentration of estrogens in this phase.  Estrogen log Kd 
coefficients in secondary effluent correspond to their relative polarities and respective log Kow 
values.  The most lipophilic compound (EE2) had the greatest solid/liquid partition coefficient 
of the compounds studied in contrast to E1-3S which was most likely to be distributed in the 
aqueous phase of wastewater matrices.                 
 
3.5. CONCLUSION 
The validated UPLC-MS/MS method was suitable for the determination of steroid estrogens 
at typical environmental concentrations found in wastewater matrices.  The superior 
sensitivity and selectivity of UPLC was exploited following extensive sample cleanup.  Ultra-
performance liquid chromatography offers advantages over HPLC in terms of speed, (with a 
reduction in run time from 18 minutes to 9 minutes) improvements in analyte response and in 
the reduction of interferences caused by the sample matrix.  Method detection limits of steroid 
estrogens in the aqueous phase of final effluents were determined to range from 0.02 ng l
-1
 to 
0.13 ng l
-1
, lower than their respective proposed PNEC values.  The UPLC method was 
applied to monitor estrogen removal across a trickling filter.  Relatively high removals of the 
natural free estrogens (≥62.0 %) were demonstrated with lower removals observed for EE2 
(29.2 %).  Secondary effluent concentrations of all estrogens were above their respective 
PNEC limits. 
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4. THE DETERMINATION OF NONYLPHENOL AND ITS PRECURSORS IN A 
TRICKLING FILTER WASTEWATER TREATMENT PROCESS 
 
Bruce Petrie, Ewan J. McAdam, Mick J. Whelan, John N. Lester, Elise Cartmell 
Cranfield Water Science Institute, Cranfield University, Bedfordshire, MK43 0AL 
 
ABSTRACT 
An ultra-performance liquid chromatography method coupled to a triple quadrupole mass 
spectrometer was developed to determine nonylphenol and 15 of its possible precursors 
(nonylphenol ethoxylates and nonylphenol carboxylates) in aqueous and particulate 
wastewater matrices.  Final effluent method detection limits for all compounds ranged from 
1.4 ng l
-1
 to 17.4 ng l
-1
 in aqueous phases and from 1.4 ng g
-1
 to 39.4 ng g
-1
 in particulate 
phases of samples.  The method was used to measure the performance of a trickling filter 
wastewater treatment works, which are not routinely monitored despite their extensive usage.  
Relatively good removals of nonylphenol were observed over the biological secondary 
treatment process, accounting for a 53 % reduction.  However, only an 8 % reduction in total 
nonylphenolic compound load was observed.  This was explained by a shortening in 
ethoxylate chain length which initiated production of shorter polyethoxylates ranging from 1 
to 4 ethoxylate units in length in final effluents.  Modelling the possible impact of trickling 
filter discharge demonstrated that the nonylphenol environmental quality standard may be 
exceeded in receiving waters with low dilution ratios.  In addition, there is a possibility that 
the environmental quality standard can be exceeded several kilometres downstream of the 
mixing zone due to the biotransformation of readily degradable short chained precursors.  
This accentuates the need to monitor ‘non priority’ parent compounds in wastewater treatment 
works since monitoring nonylphenol alone can give a false indication of process performance.  
It is thus recommended that future process performance monitoring and optimisation is 
undertaken using the full suite of nonylphenolic moieties which this method can facilitate.     
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4.1. INTRODUCTION 
Nonylphenol (NP) is a xenoestrogen which exhibits estrogenic activity in aquatic 
environments.  Identification of the possible toxic effects to aquatic organisms (Christiansen 
et al., 1998; Lye et al., 1999) prompted NP to be classified as a priority hazardous substance 
in 2000 (European Commission, 2000) leading to restrictions on NP and nonylphenol 
ethoxylate (NPEO) use throughout Europe (European Commission, 2003a) and the US 
(Soares et al., 2008; Lara-Martin et al., 2012).  However, more than a decade later, NP 
remains detectable in treated wastewater and environmental waters in these regions at 
concentrations above the environmental quality standard (EQS) of 300 ng l
-1
 (Christiansen et 
al., 1998; Soares et al., 2008; Stanford and Weinberg, 2010; McAdam et al., 2011; Barber et 
al., 2012).  A source of NP occurrence in wastewaters and river waters is attributed to the 
breakdown of the longer chained NPEOs.  Under appropriate environmental conditions these 
parent compounds biotransform to shorter chained metabolites which exhibit estrogenic 
activity (Giger et al., 1984; McAdam et al., 2011; Lara-Martin et al., 2012).  Compounds 
comprising 1 to 3 ethoxylate units exhibit estrogenic activity whereas those with greater than 
3 units display very little, if any estrogenic activity (White et al., 1994).  Wastewater 
treatment works (WwTWs) are critical in controlling the discharge of these hazardous 
substances to the aquatic environment (Bedding et al., 1982).  The removal of organic 
hazardous chemicals during secondary wastewater treatment is mainly attributed to biological 
and physical processes (Langford et al., 2005; Soares et al., 2008).  There is limited 
information regarding the factors which control the breakdown mechanism of parent NPEO 
compounds into NP; information vital for understanding their fate in WwTWs.  In activated 
sludge processing it has been cited that amphiphilic NPEO biodegradation proceeds 
preferentially, followed by attack of the lipophilic NP moiety (McAdam et al., 2011) which 
can result in their accumulation during secondary biological treatment.  Interestingly there is a 
paucity of information on the fate of NP and its parent compounds in trickling filters even 
though these processes are utilised extensively.  Throughout England and Wales, three of the 
major water utilities employ fixed film processes at 70 % of their sites (Huo and Hickey, 
2007; UKWIR, 2009), and this is reflected internationally (Tilley, 2011).  These offer a 
relatively low energy process type characterised by shorter hydraulic retention times (HRT) 
than typical activated sludge processes.  Considering the widespread usage of trickling filters, 
a greater understanding of NPEO behaviour here is essential.         
Historically, most monitoring has employed analysis solely for NP and not for its precursor 
compounds, given that NP is listed as a substance of priority concern, due to its higher 
toxicity, along with the complication of incorporating a number of compounds into the same 
extraction and analysis method (Chang et al., 2004; Ghanem et al., 2007; Gomez et al., 2007; 
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Langdon et al., 2011; Moreira et al., 2011).  Furthermore, the analytical difficulty of 
measuring these determinands at ng l
-1
 concentrations in such complex environmental 
matrices (Buisson et al., 1984; Robertson and Lester, 1994; Gomes et al., 2004a) has been a 
major constraint.  As a result large numbers of studies have determined NP independently in 
WwTWs (Gomez et al., 2007; Leusch et al., 2006; Ifelebuegu, 2011), sewage sludges 
(Ghanem et al., 2007; Kouloumbos et al., 2008) sediments (Chang et al., 2004; Yuan et al., 
2004; Sarmah et al., 2008), river waters (Moreira et al., 2011; Tao et al., 2011) and soils 
(Brown et al., 2009; Langdon et al., 2011).  Analytical methodologies recently reported in the 
literature for monitoring trace levels of NP in wastewaters typically utilise high-performance 
liquid chromatography (HPLC) with mass spectrometry (MS) detection (Jahnke et al., 2004; 
Loos et al., 2007; Koh et al., 2008).  Detection capabilities of such methods are suitable for 
determining complete NP mass balances at and below the EQS of 300 ng l
-1 
(Jahnke et al., 
2004; Loos et al., 2007; Koh et al., 2008).  However the desire to improve sensitivity, solvent 
consumption and sample run time has led to the introduction of ultra-performance 
chromatography (UPLC) (Lara-Martin et al., 2012).  A further advantage of utilising UPLC 
for environmental applications is the improved separation efficiencies obtainable by operation 
at high pressures and reduced column particle sizes.  This aids the reduction of matrix 
interferences known to suppress analyte signal strength (Vieno et al., 2006; Petrie et al., in 
press).  Minimising these interferences is vital in matrices containing comparably high 
concentrations of complex organics.  The work herein describes the development of a method 
for the analysis of NP, short chained carboxylates (NP1-3EC) and NPEOs of varying chain 
length (NP1-12EO) in aqueous and particulate phases of wastewater matrices using UPLC.  
The ability to monitor these precursor compounds in WwTWs will enable future process 
optimisation.  This methodology was applied to determine trickling filter performance under 
low temperature operation (~10 °C).  Finally, the possible impact of trickling filter effluent on 
compliance with water quality standards in a hypothetical river system was explored using a 
simple numerical model. 
 
4.2. MATERIALS AND METHODS 
4.2.1. Chemicals 
Technical 4-nonylphenol, 4-nonylphenol-monoethoxylate (NP1EO), the diethoxylate 
compound (NP2EO) and the long chain NPEOs were purchased from Sigma Aldrich (Dorset, 
UK).  Long chain NPEOs were purchased as the technical mixtures CO210, CO520 and 
CO720.  Nonyl-phenoxy acetic acid (NP1EC) was obtained from QMX laboratories (Thaxted, 
UK).  All chemicals were quantified externally.  As unique standards were not available for 
NP2EC and NP3EC these were quantified assuming a similar response to their respective 
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NPEO.  Names, abbreviations and chemical structures of the nonylphenolic moieties studied 
are provided (Table 4.1).  Methanol (MeOH), dichloromethane (DCM), ethylacetate (EtOAc) 
and hexane were obtained from Rathburn Chemicals (Walkerburn, UK) and were HPLC 
grade.  Ammonium hydroxide (NH4OH) and acetic acid of ACS grade was purchased from 
Sigma Aldrich (Dorset, UK) and ultrapure (UP) water of 18.2 MΩ quality (Elga, Marlow, 
UK) was used in the preparation of mobile phases.     
Table 4.1.  Name and structures of the nonylphenolic chemicals 
Name Abbreviation CAS 
Molecular 
formula 
Chemical structure 
Nonylphenol NP 104-40-5 C15H24O 
 
Nonylphenol 
monoethoxylate 
NP1EO 104-35-8 C17H28O2 
 
Nonylphenol 
diethoxylate 
NP2EO 20427-84-3 C19H32O3 
 
Nonylphenol 
polyethoxylate 
NP3-12EO 68412-54-4 - 
 
Nonylphenoxy 
acetic acid 
NP1EC 3115-49-9 C17H26O3 
 
Nonylphenoxy 
monoethoxy 
acetic acid 
NP2EC 106807-78-7 C19H30O4 
 
Nonylphenoxy 
diethoxy acetic 
acid 
NP3EC 108149-59-3 C21H34O5 
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4.2.2. Site description 
The trickling filter plant is situated in the east of England serving a population equivalent 
(PE) of 2,800.  The site has an average daily flow of 650 m
3
 d
-1
 of which <10 % is attributed 
to a local airfield.  The trickling filter consists of a roughing filter for bulk biochemical 
oxygen demand (BOD) removal followed by two duplex filters for further BOD removals and 
nitrification.  Corresponding grab samples of settled sewage and final effluent were collected 
in 2.5 l borosilicate glass bottles with Teflon lined caps over a three day period.  Collected 
samples were filtered and loaded onto solid phase extraction (SPE) cartridges within 30 
minutes of collection and once dried, stored at -20 °C prior to extraction.  Sampling was 
completed in January and the wastewater temperature was 10 (±0.5) °C during the study. 
 
4.2.3. Extraction procedure 
Settled sewage (100 ml) and final effluents (250 ml) were filtered through 1.2 µm GF/C 
filters (VWR, Lutterworth, UK) prior to solid phase extraction (SPE).  The aqueous phase 
was loaded onto 500 mg: 3 cc tC18 cartridges (Waters, Elstree, UK) preconditioned with 5 ml 
MeOH then 5 ml UP water.  The sample was loaded at a flow rate of between 5 and 10 ml 
min
-1
 using a vacuum manifold.  A 5 ml aliquot of UP water was then used to wash the 
cartridge.  The cartridge was then dried for at least an hour under vacuum prior to elution.  
Analytes were eluted using 5 ml EtOAc, 5 ml 0.1 % acetic acid in MeOH and then 5 ml 
DCM.  Extracts were then concentrated to approximately 1 ml by rotary evaporation 
(Heidolph Instruments, Schwabach, Germany) to complete dryness under a gentle stream of 
nitrogen gas.  Once dried the extract was reconstituted in 0.25 ml of UP water: MeOH (80: 
20).  This was transferred to an autosampler vial prior to quantification by UPLC-MS/MS.  
To ensure analytical reliability, prior to extraction; both low (100 ng l
-1
) and high (1,000 ng l
-
1
) spikes of all compounds were used to determine recoveries.  These selected spike levels 
represent concentrations approximately one order of magnitude greater than the method 
detection limit (MDL), and those concentrations anticipated to be present in real samples 
(Koh et al., 2008; McAdam et al., 2011). 
Particulate phase analysis was performed by solvent extraction of filter papers containing 
suspended solids from filtering 1 litre of settled sewage or final effluent.  These were freeze 
dried, shredded and extracted using 10 ml acetone and 10 ml MeOH by mechanically 
agitating using a multi-reax system (Heidolph Instruments, Schwabach, Germany) in a 25 ml 
Teflon tube for 30 minutes.  The extracts were centrifuged at 1500 x g for 10 minutes then 
decanted off.  This process was repeated and the extracts combined and concentrated to 0.2 
ml.  These were reconstituted to 2 ml with hexane and loaded onto a 500 mg: 3 ml silica 
cartridge (Waters Ltd., Watford, UK) preconditioned with 2 ml hexane.  Analytes were eluted 
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using 10 ml of 10 % acetic acid in MeOH then dried and reconstituted in 0.25 ml of UP water: 
methanol (80: 20) prior to quantification by UPLC-MS/MS.  Before freeze drying, selected 
samples received either low (100 ng g
-1
) or high spikes (1,000 ng g
-1
) of all compounds to 
determine recoveries 
 
4.2.4. UPLC-MS/MS 
Ultra-performance liquid chromatography was performed using a Waters Acquity UPLC 
(Waters, Manchester, UK).  Chromatographic separations were achieved using an Acquity 
UPLC BEH C18 column (100 mm x 2.1 mm i.d., 1.7 µm particle size; Waters, Manchester, 
UK) controlled at 30 ˚C.  A gradient elution of 0.1 % NH4OH in UP water (A) and 0.1 % 
NH4OH in MeOH (B) at a flow rate of 0.4 ml min
-1 
was used.  Initial conditions of 20 % B 
were maintained for 4 minutes prior to gradually increasing to 80 % over 5 minutes.  This was 
maintained for 12 minutes then returned to starting conditions over 3 minutes.  The total run 
time was 26 minutes and an injection volume of 10 µl was used.  Detection was achieved 
using a Waters Quattro Premier XE mass spectrometer with a Z-spray ESI interface 
(Micromass, Watford, UK).  This was operated in the negative and positive electrospray 
ionisation mode utilising multiple reaction monitoring (MRM).  The optimised MS/MS 
conditions for detection are detailed (Table 4.2).  The parameters for detection by the mass 
spectrometer were as follows: capillary voltage, 3.20 kV (positive mode) and -2.3 kV 
(negative mode); extractor lens; 3.0 V, multiplier voltage, 650 V; desolvation gas flow, 1000 l 
h
-1
; RF lens, 0.5 V (positive mode) and 1.0 V (negative) mode; cone gas flow, 50 l h 
-1
; 
desolvation temperature, 350 °C and source temperature, 120 °C (Koh et al., 2008). 
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Table 4.2.  Chromatographic detail and MS/MS parameters of NP, NPECs and NPEOs 
Compound 
Retention time 
(minutes) 
m/z precursor  
Product ions (collision 
potential) 
Cone 
(V) 
IDL  
(pg) 
NP 11.4 219
a
 132.5(30), 106(20) 30 82 
NP1EC 8.2 263.5
a
 205(20), 106(30) 20 98 
NP2EC 8.4 307
a
 205(20) 20 - 
NP3EC 8.7 351
a
 205(20) 20 - 
NP1EO 11.7 282
b
 127(25), 265(25)  25 118 
NP2EO 12.0 326
b
 183(40), 121(40) 40 27 
NP3EO 12.1 370
b
 353(10), 226.5(20)  40 8 
NP4EO 12.2 414
b
 397(14), 270(20)  30 60 
NP5EO 12.2 458
b
 440(20), 315(25) 30 20 
NP6EO 12.2 502
b
 485(20), 359(30) 30 28 
NP7EO 12.3 546
b
 529(23), 403(25) 30 21 
NP8EO 12.3 590
b
 573(25), 447(27)  30 12 
NP9EO 12.3 634
b
 617(25), 335(30) 30 17 
NP10EO 12.4 678
b
 661(25), 132.5(40)  30 20 
NP11EO 12.4 722
b
 705(25), 291(40) 30 23 
NP12EO 12.4 766
b
 749(30), 291(35) 30 69 
a
[M-H]
- b
[M+NH4]
+
 
Note: IDL; instrument detection limit, calculated by replicate (n=7) extractions of 250 ml of spiked (50 
ng l
-1
) UP water 
 
4.2.5. Modelling 
The potential for exceeding the NP EQS in receiving waters was explored by applying a 
simple mathematical model based on Whelan et al (1999) of riverine mixing, in-stream 
dilution and degradation for a range of feasible scenarios.  The potential biodegradability of 
the range of different compounds in the final effluent were assessed using BIOWIN v4.10 
(Howard et al., 2005) estimation software, which is part of EPI Suite
TM
 v4.10 (EPI Suite, 
2013).  BIOWIN uses chemical structure to predict the likelihood of a compound to pass a 
standardised “ready” biodegradability test (OECD, 1992) (60% complete mineralisation of an 
organic compound added to a vessel within 28 days).  Those compounds which pass a ready 
test are likely to degrade rapidly in the natural environment.  Here, we assume that those 
compounds which are predicted to pass the ready test will yield NP as an intermediate 
reaction product in the receiving system.  The model considers two substance types A and B.  
Substance type A represents any organic compound which is readily biodegradable and which 
can yield NP as an intermediate metabolite in the degradation process.  Substance type B 
represents NP.  Both substance types are assumed to degrade according to first order kinetics 
as follows: 
58 
 
AA
A C.k
dt
dC
         (4.1) 
BBAA
B C.kC.k
dt
dC
         (4.2) 
where CA and CB are, respectively, the molar concentrations of substance types A and B, t is 
time and where kA and kB are first order rate constants.  This assumes that 100 % of the 
substance A which degrades is converted into NP.  This is unlikely to be the case and the 
model is, therefore, conservative with respect to CB.  These equations can be solved as 
follows: 
)τ.kexp().(C.
)τ(Q
Q
)τ(C AAA  0
0       (4.3) 
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          (4.4) 
where Q() is the river discharge at a point corresponding to flow time , Q0 is the river 
discharge at the point of emission (i.e., at flow time 0), CA() and CB() are the concentrations 
of substance types A and B at flow time t and CA(0) and CB(0) are the concentrations of 
substance types A and B at flow time 0 which are, in turn, calculated from the effluent 
concentrations (CEA and CEB) and a dilution factor (DF) via: 
DF
C
)(C EAA 0          (4.5) 
DF
C
)(C EBB 0          (4.6) 
We assume that CEA and CEB are the observed molar concentrations in the trickling filter 
effluent (see Figure 4.4).  All solutes are assumed to move entirely by advection in one 
dimension (i.e., hydrodynamic dispersion is neglected).  This assumption has been shown to 
hold for low frequency emission variations, such as time-constant emission, which approach a 
steady state by Gandolfi et al (2001).  Some of the compounds are relatively hydrophobic 
which means that they will have a propensity to sorb to sediment solids.  The assumption of 
zero interaction with the sediment is based on an a priori assumption of steady state under 
which it is likely that an equilibrium will have established between chemical in the sediment 
and chemical in the overlying water along the entire reach considered, such that the net 
exchange (and thus net removal from the water column) will be zero (Schwarzenbach, 2003).  
Flow time is calculated from the reach distance divided by the river velocity, which was 
assumed to be constant with distance downstream.  River discharge, however, was assumed to 
increase linearly with distance (0.01 km
-1
 i.e., a 50 % increase in Q over 50 km) to represent 
increased dilution resulting from additional inputs of water from an increasing contributing 
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catchment area.  The range of half lives considered for substance type A were derived from 
the range reported for the primary degradation of another readily degradable substance, linear 
alkyl benzene sulphonate (LAS), in field studies (Whelan et al., 1999; Fox et al., 2000; 
Whelan et al., 2007) conducted on rivers and streams of different dimensions.  To our 
knowledge no field-based studies of NP precursor die away have been published in the 
international peer reviewed literature.  Scenario 1, 2 and 3 represent river velocities of 0.03, 
0.1 and 0.9 m s
-1
, respectively, typical of the range observed in lowland streams (Richards, 
1982).  Further model parameters are outlined (Tables 4.3 and 4.4). 
 
Table 4.3.  Key model parameters of three hypothetical river scenarios 
Model parameter 
Hypothetical scenario 
1 2 3 
Readily degradable precursor t½ (h) 3 7 14 
NP t½ (h) 240 240 240 
River v (m/s) 0.03 0.1 0.9 
Initial dilution factor 10 10 10 
Dilution increase per km 0.01 0.01 0.01 
Key: t½, half-life; NP, v, velocity  
 
Table 4.4. Reported LAS half lives in river systems 
River Country Q (m
3
 s
-1
) t½ (h
-1
) v (m s
-1
) Reference 
Red Beck UK 0.1
a
 2.2-2.7 0.01-0.03
c
 Fox et al., 2000 
Houay Mak Hiao Laos 0.8
a
 7.0 0.08
c
 Whelan et al., 2007 
Lambro Italy 5.0
b
 13.9 0.9
d
 Whelan et al., 1999 
a
Discharge reported for monitoring period, 
b
mean annual discharge at one station in monitored reach, 
c
velocity calculated from tracer travel time, 
d
velocity calculated from empirical velocity-discharge 
relationship at one station at mean annual discharge 
Key: Q, discharge; t½, half-life; v, velocity 
 
4.3. RESULTS 
4.3.1. Method performance 
The extraction process gave mean recoveries of all compounds collectively from aqueous 
phases of 54-99 % and 56-99 % for settled sewage and final effluents, respectively.  Similarly 
particulate phase recoveries were 37-89 % and 35-102 % for settled sewage and final 
effluents.  Generally recoveries were poorer for the long chained ethoxylates and NP1EC, 
compared to NP and the short chained ethoxylates (Table 4.5).  Relative standard deviations 
(RSD) of recoveries were below 20 % for all compounds in all matrices.  Chromatography 
from the extracted samples showed Gaussian distribution for all compounds as exhibited for 
NP, the short chained ethoxylates (Figure 4.1) and the NPECs (Figure 4.2).   
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Table 4.5. Method recoveries (%) and relative standard deviations (RSD %) of NP, NPEC and 
NPEOs in wastewater matrices (n=6)  
Compound 
Aqueous recoveries (RSD %) Particulate recoveries (RSD %) 
Settled sewage Final effluent Settled sewage Final effluent 
NP 99.3 (4.3) 98.8 (3.2) 85.8 (10.5) 73.2 (15.3) 
NP1EC 53.8 (10.3) 80.0 (4.8) 36.8 (3.4) 34.7 (4.2) 
NP1EO 96.0 (4.3) 84.1 (7.3) 83.2 (8.7) 90.8 (6.3) 
NP2EO 67.2 (9.3) 93.0 (1.2) 89.0 (3.2) 89.7 (2.3) 
NP3EO 61.0 (12.2) 62.8 (5.7) 53.5 (4.3) 69.8 (7.8) 
NP4EO 54.5 (9.9) 56.0 (13.1) 56.5 (14.8) 80.5 (5.3) 
NP5EO 57.2 (12.4) 75.2 (8.9) 62.0 (8.8) 88.0 (3.7) 
NP6EO 58.2 (6.2) 72.7 (4.9) 69.5 (12.0) 101.5 (7.6) 
NP7EO 66.3 (5.3) 73.2 (3.2) 73.7 (6.9) 88.2 (4.3) 
NP8EO 65.3 (8.3) 81.3 (4.5) 75.7 (9.5) 93.3 (8.8) 
NP9EO 62.2 (5.5) 75.8 (3.1) 75.0 (16.3) 83.2 (6.9) 
NP10EO 70.3 (7.1) 76.2 (1.9) 76.3 (8.8) 92.2 (7.6) 
NP11EO 56.3 (13.5) 62.7 (8.3) 81.0 (19.4) 86.0 (8.1) 
NP12EO 57.8 (7.3) 64.5 (5.4) 86.5 (9.9) 81.5 (2.0) 
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Figure 4.1.  Multiple reaction monitoring chromatograms of NP, NP1EO and NP2EO in final 
effluent 
 
 
Figure 4.2.  Multiple reaction monitoring chromatograms of NP1EC, NP2EC and NP3EC in final 
effluent 
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Method detection limits were calculated using (Vieno et al., 2006; Petrie et al., in press): 
M)(100
100
.
(R.C)
IDL.100
MDL
-
=        (4.7) 
where IDL is the instrument detection limit (ng l
-1
), R is the recovery (%), C is the 
concentration factor and M is the matrix suppression (%).  Final effluent MDLs of the short 
chained ethoxylates (NP1-2EO) ranged from 3.2 to 14.7 ng l
-1
 and the longer chained NPEOs 
were between 1.4 and 11.2 ng l
-1
.  Greater MDLs in settled sewage were observed; up to a 
maximum of 32.0 ng l
-1
 and 33.0 ng l
-1
 for short and long chained ethoxylates respectively.  
The majority of compounds have MDLs below 15 ng g
-1
 in the particulate phase of both 
settled sewage and final effluent (Table 4.6).  Method detection limits were greatest for 
NP1EC; a consequence of lower recovery and greater matrix suppression. 
   
Table 4.6. Method detection limits of NP, NPEC and NPEOs in wastewater matrices 
Compound 
Aqueous MDL / ng l
-1
 Particulate MDL / ng g
-1
 
Settled sewage Final effluent Settled sewage Final effluent 
NP 24.6 9.0 11.8 13.4 
NP1EC 45.3 17.4 38.5 39.4 
NP1EO 32.0 14.7 18.8 13.9 
NP2EO 12.0 3.2 3.9 3.8 
NP3EO 4.0 1.4 2.1 1.4 
NP4EO 28.7 11.2 13.3 8.3 
NP5EO 11.0 2.9 4.1 4.1 
NP6EO 13.4 3.9 5.2 3.6 
NP7EO 8.0 3.0 3.2 2.9 
NP8EO 5.3 1.6 1.8 1.4 
NP9EO 8.3 2.3 2.8 2.8 
NP10EO 8.4 2.9 3.1 2.7 
NP11EO 11.2 3.8 3.5 3.1 
NP12EO 33.0 11.1 9.6 11.0 
Note: MDL, method detection limit. 
 
4.3.2. Matrix suppression 
The full scan analysis of an extracted wastewater sample provides a subjective insight into the 
possible influence of remaining matrix in the sample extracts on analyte response.  The full 
scan profile of extracted settled sewage showed a relatively large quantity of unwanted 
material remaining in the sample extract (Figure 4.3).  In the negative ion monitoring mode, 
the majority of the extracted material eluted between 5 and 10 minutes.  Nonylphenol and the 
NPEOs elute after this, however the NPECs do so between 8 and 9 minutes.  Matrix 
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suppressions were quantified using the algorithm reported by Vieno et al. (2006).  Signal 
suppressions of NP1EC were between 29 % and 31 % in particulate matrices.  In the positive 
monitoring mode NP1-12EO elutes around 12 minutes and after the majority of the matrix.  In 
aqueous samples, signal suppressions of the ethoxylates were between 0 % and 10 %, and 2 % 
and 21 % for final effluent and settled sewage, respectively.  Greater matrix effects were 
observed in particulate phases ranging from 9 % to 27 % in final effluent and 12 % to 28 % in 
settled sewage.      
 
Figure 4.3.  Full scan (50-1500 amu) base peak intensity plots of settled sewage in negative ion (a) 
and positive ion (b) monitoring modes 
 
4.3.3. Nonylphenol and precursor removal in trickling filters 
Corresponding grab samples of settled sewage and final effluent were collected to negate any 
intraday variation in receiving compound concentration.  The presence of NPEOs in the 
sewage stream is mainly attributed to a local airfield.  Nonylphenol ethoxylates have been 
previously observed in aircraft maintenance formulations such as de-icer and anti-icer (Corsi 
et al., 2003).  The molar balance of all nonylphenolic moieties showed NP had the greatest 
molar concentration in settled sewage.  In final effluent NP1-2EO predominated (Figure 4.4).   
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Figure 4.4. Molar concentration (corrected for extraction recoveries) of NP and its precursors in 
settled sewage and final effluent. Note: errors bars represent the standard deviation of the total 
sample concentration 
 
In settled sewage a total of 602 ng l
-1
 of NP12EO was present, demonstrating the presence of 
longer chained compounds.  A high concentration of NP (2,146 ng l
-1
), relative to the other 
compounds was observed.  The partitioning behaviour of the compounds was determined by 
calculating their partition coefficients (log Kd): 
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where P is the concentration of the analyte in the particulate phase (ng kg
-1
) and A is the 
concentration in the aqueous phase (ng l
-1
).  Of the total NP settled sewage concentration, 38 
% was found bound to particulate matter with a log Kd of 4.1 l kg
-1
.  This reduced with 
increasing ethoxylate chain length to 0.5 for NP12EO which is the most hydrophilic of the 
ethoxylates monitored.  The final effluent profile showed a reduction in concentration of NP 
by 53 % to a concentration of 1,017 ng l
-1
.  Nonylphenol removal across trickling filters in the 
literature varies greatly from -103 % to 86 % (Moreira et al., 2011; Barber et al., 2012) (Table 
4.7).  Similarly effluent concentrations vary from 6 ng l
-1
 to 1,820 ng l
-1
.  The removal of 
individual compounds across the trickling filter showed an interesting trend reducing from 
NP12EO to NP2EO and a negative removal, which then increased to a positive removal for NP 
(Figure 4.5).   
Figure 4.5. Removal of NP and its precursors by a trickling filter 
 
Concentrations of the longer chained polyethoxylates (NP5-12EO) showed reductions of 
between 42 % and 67 %.  Conversely the concentrations of NP1-4EO increased during 
treatment.  The mono and diethoxylate compounds displayed the greatest increase in 
concentration to 3,210 ng l
-1
 which accounted for 49 % of the total molar nonylphenolic load 
discharged in final effluent.  The concentration of the NPECs in final effluent was 594 ng l
-1
; 
an increase of 33 % during treatment.  Both short chained NPECs and NPEOs have 
previously been observed in final effluent following trickling filter treatment (Table 4.7).  
Only an 8 % reduction in total nonylphenolic load was observed; caused by the accumulation 
of short chained NPECs and NPEOs.   
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Table 4.7. Removal of NP, NPECs and NPEOs by trickling filters  
Compound Configuration Design Media type PE 
Flow rate 
(m
3
 d
-1
) 
SS 
(ng l
-1
) 
FE 
(ng l
-1
) 
Removal 
(%) 
Reference 
NP 
NP1-3EC 
NP1-2EO 
NP3-12EO 
Nitrifying filter / 2 BOD 
filters 
Diameter, 12 m; 
depth, 1.8 m 
Plastic 2,800 650 
2146 
447 
1556 
4422 
1017 
594 
3210 
2490 
52 
-33 
-106 
44 
This study 
NP 
NP1-4EC 
NP1-2EO 
- 2 x 379 m
3
 - - - 
2,400 
39,600 
<1,850 
340 
155,600 
6,270 
86 
-293 
-239 
Barber et al., 2012 
NP Tertiary process to an OD - - 41,043 9,447 3.1
a
 6.3 -103 Ifelebuegu, 2011 
NP 
NP1-3EC 
NP1-2EO 
NP3-12EO 
Nitrifying filter / 2 BOD 
filters / tertiary filter 
Diameter, 12 m; 
depth, 1.8 m; Tertiary 
5 x 10 x 4 m 
Plastic/stone 
(tertiary) 
2,800 650 
100 
94 
305 
5,513 
88 
2308 
253 
1309 
12 
-2355 
17 
76 
Koh et al., 2008 
NP - - - 3,200 525 1,050 1,220 -16 Moreira et al., 2011 
NP - - - 2,200 - 10,200
b
 1,820 82 Leusch et al., 2006 
a
oxidation ditch effluent 
b
raw sewage 
Note: PE, population equivalent; SS, settled sewage; FE, final effluent; TF, trickling filter; OD, oxidation ditch; BOD, biochemical oxygen demand.
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4.3.4. River predictions 
Although the concentrations of NP observed in the effluents exceed the EQS for receiving 
waters, actual non-compliance would depend on the dilution factor and the potential in-stream 
formation of NP from various precursor compounds.  Five compounds which were detected in 
the effluent streams were predicted to be readily biodegradable by BIOWIN (NP1-3EC and 
NP1-2EO) and were denoted as substance type A.  Nonylphenol was predicted not to be 
readily degradable by BIOWIN and is, therefore, assumed to degrade much more slowly in 
the river environment (substance type B).  In each of the three scenarios, the effluent is 
assumed to mix completely and instantaneously with the flow of the receiving system with an 
initial dilution factor of 10 (European Commssion, 2003b).  It should be noted that the 
dilution factor will vary significantly spatially (i.e., between wastewater treatment plants) and 
temporally (as flows change in the effluent stream and the receiving water body).  Predicted 
changes in the concentrations of NP originating from the effluent, the total concentration of 
compounds assumed to behave as substance A and the total concentration of NP (i.e., the sum 
of the remaining NP concentration originating from the effluent and the concentration of new 
NP formed from the degradation of substance A) with distance downstream of the outfall are 
shown in Figure 4.6 for the three scenarios.  Molar concentrations are used in order to 
facilitate the calculation of total concentrations of different compounds and the conversion of 
precursor compounds to NP.  The concentration of the effluent-derived NP reduces 
exponentially with distance downstream as a consequence of degradation and dilution and is 
always well below the NP EQS.  The concentration of the original NP present is predicted to 
reduce by between 31 % (for Scenario 3) and 75 % (for Scenario 1) over a 40 km reach.  
Concentrations of the readily degradable precursors were initially higher than the 
concentration of NP but decreased relatively rapidly with distance downstream owing to the 
high rate constants assumed.  By 10 km, the predicted total concentration of readily 
degradable precursors varies between 0 % (Scenario 1) and 79 % (Scenario 3) of the initial 
concentration.  This rapid degradation of precursors in Scenarios 1 and 2 is predicted to result 
in a total NP concentration which exceeds the EQS in the river over reach lengths of 6.6 and 
10.2 km respectively.  A peak NP concentration of 1.64 µmol m
-3
 (362 ng l
-1
) was predicted 
for Scenario 1.  The relatively slow degradation of readily degradable precursors in Scenario 
3 resulted in predicted total NP concentrations which were below the EQS over the entire 40 
km reach considered.     
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Figure 4.6.  Predicted changes in riverine concentrations of NP and readily degradabale 
precursors with distance downstream of a wastewater outfall applying three hypothetical 
scenarios (1 – 0.03 m s-1 (Fox et al., 2000), 2 – 0.1 m s-1 (Whelan et al., 2007) and 3 – 0.9 m s-1 
(Whelan et al., 1999). In all cases the dilution factor was 10. 
 
4.4. DISCUSSION 
The extraction method exhibited recoveries greater than 50 % for the majority of analytes in 
both aqueous and particulate phases; typical of previously reported methods (Jahnke et al., 
2004; Koh et al., 2008; Lara-Martin et al., 2012).  The detection limits reported herein are 
comfortably below the EQS guideline for NP of 300 ng l
-1 
(European Commission, 2000) and 
are suitable for the analysis of typical NPEO concentrations encountered in wastewaters (Koh 
et al., 2008; McAdam et al., 2011).  Nonylphenol monoethoxylate had the greatest detection 
limit of the ethoxylates due to its poor ionisation (Lara-Martin et al., 2012).  A well-known 
problem of extracting trace amounts of a compound from wastewater is the influence of 
sample matrix on analyte signal strength.  The full scan of settled sewage showed NP1EC co-
elutes with the majority of the matrix causing ~30 % signal suppression.  Jahnke et al (2004) 
reported substantial signal suppressions of >39 % for all analytes using similar mobile phase 
compositions.  The use of UPLC here may have aided the reduction of matrix effects by the 
improvement in the efficiency of chromatographic separations (Petrie et al., in press).  
However, differences in extraction methodology may contribute to this variation.  An added 
advantage of using UPLC instead of HPLC is the reduced run time that it offers.  Many 
studies which report similar method performances often require run times of between 40 and 
60 minutes (Jahnke et al., 2004; Loos et al., 2007; Koh et al., 2008).  Run time is often a rate 
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limiting step on sample number and turnover.  A run time of 26 minutes using UPLC 
generally offers double the sample throughput in comparison to conventional HPLC systems.    
The relative distribution of NP moieties in settled sewage and final effluents is similar to that 
observed by Ahel et al (1994), albeit at significantly lower concentrations.  The concentration 
of NP determined in settled sewage was 2,146 ng l
-1
, similar to that reported previously by 
other authors in the UK (Rule et al., 2006; McAdam et al., 2011), across the rest of Europe 
(Farré et al., 2002; Gunnarsson et al., 2009) and in the US (Kolpin et al., 2002; Loyo-Rosales 
et al., 2007).  Care must be taken with the interpretation of findings from Kolpin et al (2002).  
Till (2003) identified possible shortcomings in the way in which data was processed.  To 
demonstrate, reporting a median concentration for only those samples where chemicals were 
detected suggests higher median concentrations than actually present.  Furthermore, the use of 
data with reported concentrations in field blanks overestimates the actual concentrations of 
these chemicals in real matrices (Till, 2003).  The apparent partition coefficients of NP in 
settled sewage (4.09) and final effluent (5.27) are similar to the log octanol-water coefficient 
(log Kow) of 4.48 (Corvini et al., 2006).  Sorption to the biofilm and secondary sedimentation 
of particulate matter can contribute to the removal of NP by a trickling filter.  However, 
biodegradation is considered to be the main removal mechanism of NP in secondary 
wastewater treatment processes (Tanghe et al., 1998; Langford et al., 2005).  Removals of NP 
by trickling filters in the literature vary substantially from negative removals (Gomez et al., 
2007; Ifelebuegu, 2011) to >80 % (Leusch et al., 2006; Barber et al., 2012).  Without 
information of parent chain removal it is difficult to diagnose this variation in NP removal.  
Generally the trickling filter here showed poor removals of total nonylphenolic compounds 
with only an 8 % reduction in the total molar load causing a downward shift in the chain 
length distribution.  The use of concentration (i.e., ng l
-1
) overestimates total nonylphenolic 
removal.  Ethoxylate chain shortening causes a loss of mass without effecting nonylphenolic 
molar load.  The bulk of the load in final effluent consisted of NP1-2EO rather than the longer 
chained compounds found in settled sewage.  This is of concern because shortening of 
ethoxylate chain length increases estrogenicity (White et al., 1994; McAdam et al., 2011; 
Lara-Martin et al., 2012).  Similar removals were observed by Barber et al (2012) where a 
reduction of NP coincided with an increase in short chained NP precursors.  The negative 
NP1-4EO removals across the trickling filter indicates sequential shortening of the long 
chained NPEOs through removal of ethoxy groups as previously proposed (Giger et al., 1984; 
Soares et al., 2008; McAdam et al., 2011).  During the study only a small increase in NPECs 
was observed across the filter.  Previous studies of biological processes have shown a large 
production of NPECs in comparison to the other compounds (Komori et al., 2006; Koh et al., 
2008; Koh et al.,2009; McAdam et al., 2011; Barber et al., 2011).  This increase in NPECs 
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coincided with a greater removal of the long chained NPEOs.  Komori et al (2006) showed 
NP1-5EC contributed the greatest portion of the mass balance in final discharges from 20 
WwTWs in Japan with only small concentrations of NP1-10EC found in settled sewage.  
Carboxylate production coincided with low observed ethoxylate chain shortening.  This 
suggests that NPECs are produced following shortening of the ethoxylate chain and/or are 
more resistant to biological breakdown than their respective ethoxylates.  The lack of NPEC 
production in this study indicates that their formation occurs following ethoxylate chain 
shortening.  The proposed degradation pathway of long chained NPEOs during trickling 
treatment is outlined (Figure 4.7).   
 
 
 
Figure 4.7.  Proposed degradation pathway of long chained NPEOs during trickling filter 
treatment, adapted from (Warhurst, 1994; Soares et al., 2008) 
 
Here reasonable removals of NP corresponded with poor removals of total nonylphenolic 
load.  It is postulated that the transformation of parent compounds had not reached the critical 
level at which NP is produced at a faster rate than it is removed.  This supports studies 
conducted under controlled loading/feed conditions which have shown NP has a high 
susceptibility to biological removal during wastewater treatment (Tanghe et al., 1999; 
Stasinakis et al., 2008; Stasinakis et al., 2010).  However, removal is reduced substantially 
under environmental conditions by the production of NP from the biotransformation of its 
precursors.  Negative removals of NP have been observed during activated sludge treatment 
(Farré et al., 2002; Koh et al., 2009; McAdam et al., 2011) which, compared to trickling filter 
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treatment, is generally expected to achieve a greater removal of hazardous chemicals such as 
steroid estrogens (Koh et al., 2009; Petrie et al., in press).  Longer residence time’s 
characteristic of activated sludge may facilitate effective biotransformation of NPEOs and 
NPECs to NP, accounting for its poor removal and in some cases, its production.  This will 
improve contact between NPEOs and bacterial cells; a process known to be critical for 
biodegradation to occur (Langford et al., 2005).  During trickling filter treatment the contact 
time between an organic solute and a fixed bacterial cell is comparatively short.  Whilst in 
this study the trickling filters were operated in single pass, effluent recycling which is 
common in some trickling filter assets, will improve biofilm contact potentially enabling 
greater biodegradation.  It should also be noted that NP has a vapour pressure of 2.07 x 10
-2
 
Pa and a Henry’s law constant of 8.39 x 10-1 Pa m3 mol-1 illustrating a semi-volatile nature 
(Soares et al., 2008).  Consequently, NP can be removed by volatilisation during both 
trickling filter and activated sludge treatment.      
The application of a simple model of chemical transport and degradation, in which readily 
biodegradable intermediate compounds are assumed to transform to NP (Soares et al., 2008; 
McAdam et al., 2011), suggests that under the environmental conditions considered, the NP 
EQS may be breached even though the initial NP concentration at the outfall is below the 
EQS. This is due to subsequent biotransformation of precursors to NP downstream of the 
outfall. Currently, many process performance evaluations have been undertaken using only 
NP data as the benchmark (Leusch et al., 2006; Gomez et al., 2007; Ifelebuegu, 2011). Whilst 
the intermediate compounds are not expected to be regulated in the short term (European 
Commission, 2000), this semi-quantitative assessment demonstrates that measurement of 
these intermediate compounds in parallel with NP could be advantageous in establishing 
compliant operation of existing wastewater treatment assets. There is a paucity of data 
currently available in the literature regarding the kinetic behaviour of NP and the short chain 
precursors under field conditions (e.g., rivers).  Further work to underpin this preliminary fate 
evaluation to ascertain specific rates of degradation and transformation would therefore be 
advantageous.  However, from this work it is clear that the analytical method is capable of 
detecting both NP and its precursors in environmentally relevant matrices and as such can 
support future field evaluations in addition to the optimisation of existing wastewater 
treatment assets through an enhanced understanding of intermediate compound fate and 
behaviour.              
  
4.5. CONCLUSION 
A significant reduction in total nonylphenolic concentrations has been observed since 
restrictions on the production of NPEOs was introduced.  Nonetheless NP is still observed in 
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WwTW effluents and river waters at concentrations above the EQS of 300 ng l
-1
.  A paucity 
of information remains on NP fate and behaviour within WwTWs and in receiving 
environments which needs to be addressed by monitoring for a full range of nonylphenolic 
moieties.  This is illustrated by the prediction of a transformation of NP precursors into NP 
which resulted in a breach of the NP EQS over several kilometres of a hypothetical river in 
some scenarios considered.   
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Cranfield Water Science Institute, Cranfield University, Bedfordshire, MK43 0AL 
 
Abstract 
Recent trends of reducing analysis times and automating analytical methodologies has led to a 
lack of pharmaceutical analysis undertaken in the particulate phase of wastewaters.  However, 
to better understand pharmaceutical fate and behaviour, determination here is essential.  
Reported is a multi-residue method for the determination of ten pharmaceuticals and the 
personal care product triclosan in the aqueous and particulate phases of wastewater.  This was 
used to attain a complete process mass balance for a pilot-scale activated sludge plant 
operated under controlled, steady state conditions.  Crude sewage was found to contain 63 % 
and 68 % of the antibiotics ofloxacin and ciprofloxacin within the particulate phase.  Their 
high affinity to particulate matter and relatively low octanol-water coefficient (<1) indicates 
that electrostatic attractions are responsible for their solid partitioning.  The mass balance 
revealed the chemicals studied were separable into three groups based on their dominant fate 
pathways (biological degradation, sorption onto activated sludge and no removal from the 
aqueous phase).  Interestingly, diclofenac and fluoxetine are hydrophobic in nature (octanol-
water coefficients >4) but exhibited no removal from the aqueous phase during treatment.  
Their charged nature in wastewater suggests they may be retained in the aqueous phase by 
dissolved organics (e.g., colloids).  In final effluents, concentrations of triclosan, ofloxacin 
and ciprofloxacin were within the particulate phase at >10 % of their total concentration.  
Particulate concentrations were equivalent to 68.4, 104.5 and 25.7 ng l
-1
 respectively, 
providing a route for their release into the environment which often go unmonitored.  Finally, 
the removal performance of activated sludge was directly compared to a trickling filter 
receiving the same influent sewage.  This was used to assess the resilience of trickling filter 
treatment (characterised by very short contact times) for the removal of this diverse range of 
chemicals.  The trickling filter demonstrated to be as effective as the ASP for the removal of 
most chemicals studied which rely on very different removal pathways.   
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5.1. INTRODUCTION 
A large number of pharmaceuticals and personal care products, of varying concentrations are 
observed in river waters (Kasprzyk-Hordern et al., 2008; López-Serna et al., 2011), posing 
potential threats to aquatic biota (Kidd et al., 2007) and for water re-use (Martin et al., 2008).  
Their presence in surface waters is mainly attributed to their incomplete removal during 
wastewater treatment.  Diagnosing wastewater treatment effectiveness for the removal of 
these organic contaminants relies on the application of analytical methodologies suitable for 
their determination at very low concentrations (ng l
-1
) within complex organic matrices.  
Recent analytical trends generally focus on the development of methods for the rapid 
determination of a high number of chemicals (≥47) within the aqueous phase of wastewaters 
(Gracia-Lor et al., 2011; López-Serna et al., 2011; Gros et al., 2012).  However, to better 
understand their fate, determination within the particulate fraction is essential (Petrie et al., 
2013b).  Although methods are available for particulate phase determinations (Radjenovic et 
al., 2009a; Baker and Kasprzyk-Hordern, 2011a), very little analysis is undertaken here due to 
the laborious sample collection and further extraction requirements.  For example, one gram 
of dried solids is often required for each analysis (Radjenovic et al., 2009a).  Although this is 
relatively straight forward to obtain for sludge samples where high solids concentrations are 
observed, the solids content typical of crude sewage (~200 mg l
-1
), settled sewage (~100 mg l
-
1
) and final effluent (~20 mg l
-1
) underlines the time and effort needed to collect suitable 
quantities of solids for analysis.  As a result there is a paucity of information on the 
distribution of pharmaceuticals within the particulate phase of various wastewater matrices.  
Consequently, complete process mass balances have not been attainable which are essential to 
understand the pathways of their removal.     
Trickling filters and activated sludge are widely used treatment methods which can remove 
pharmaceuticals and other hazardous chemicals to varying extents (Baker and Kasprzyk-
Hordern, 2013; Petrie et al., 2013a; Petrie et al., 2013b; Petrie et al., in press).  Removal by 
these biological processes is considered to be achieved mainly by biomass sorption and 
biodegradation (Andersen et al., 2005; Langford et al., 2005) which are thought to be 
influenced by their physico-chemical properties.  It has been traditionally considered that 
hydrophobicity is a reasonable predictor of sorption.  This assumption is applicable for some 
chemicals such as the steroid estrogens (Gomes et al., 2011; Petrie et al., submitted).  
However, it is inadequate to describe the behaviour of pharmaceuticals which exhibit a broad 
range of physico-chemical properties (Table 5.1).  For example, recent research found 
hydrophobicity alone was insufficient to describe the sorption behaviour of pharmaceuticals 
and other interactions such as electrostatic attractions are important, particularly for charged 
chemicals (Hyland et al., 2012).  Furthermore, it has been suggested that predicting sorption 
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cannot be fully ascertained using the properties of the sorbate.  This is because sorption is also 
influenced by the specific properties of the sorbent (Sathyamoorthy and Ramsburg, 2013).  
These chemicals also vary significantly in their biodegradability.  For example, ibuprofen is 
highly susceptible to biodegradation whereas carbamazepine and diclofenac are considered 
relatively resistant to biological attack (Petrie et al., 2013b).  This study was aimed at 
identifying the dominant removal pathways for a diverse range of organic hazardous 
chemicals during biological wastewater treatment.  A multi-residue method for the 
determination of ten pharmaceuticals and the personal care product triclosan which represent 
a broad range of physico-chemical properties is reported.  The method was used to assess 
their partitioning behaviour across a complete process mass balance for a pilot-scale activated 
sludge plant (ASP) operated under controlled steady state conditions.  Furthermore, the 
removal performance of a trickling filter was directly compared to the ASP, whilst receiving 
identical influent sewage.  This enabled the direct impact of process type on the removal of 
these chemicals to be assessed.  Previous research has made the broad comparison between 
full-scale trickling filters and ASPs which receive varying compositions of influent sewage 
(Baker and Kasprzyk-Hordern, 2013).  Therefore the direct impact of process type on the 
removal of trace organic contaminants has been difficult to ascertain. 
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Table 5.1. Physico-chemical properties of target chemicals (EPI suite, 2013) 
Chemical of interest Chemical class Chemical structure 
MW 
(g mol
-1
) 
Water solubility 
(mg l
-1
) 
Henry’s law 
(atm m
3
 mol
-1
) 
VP 
(mm Hg) 
pKa Log Kow Log Koc 
Ibuprofen NSAID 
 
206.30 21.0 1.52.10
-7
 1.86.10
-4
 4.91
a
 3.79-3.97 2.35 
Diclofenac NSAID 
 
296.15 2.4 4.73.10
-12
 2.18.10
-6
 4.15
a 
4.02-4.51 2.61 
Naproxen NSAID 
 
230.26 15.9 3.39.10
-10
 1.27.10
-6
 4.15
a 
3.10-3.18 1.97 
Acetaminophen Aniline analgesic 
 
151.17 14.10
3
 6.42.10
-13
 1.94.10
-6
 9.38
a
 0.46 1.32 
Carbamazepine Anti-epileptic 
 
236.27 112.0 1.08.10
-10
 8.80.10
-8
 13.90
a
 2.25-2.45 2.23 
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a
Pubchem, 2013 
b
de Freitas et al., 2010 
Key: MW, molecular weight; VP, vapour pressure; pKa, acid dissociation constant; Log Kow, octanol-water coefficient; Log Koc, organic carbon-water coefficient.
Bezafibrate Lipid regulator 
 
361.82 7.9 2.12.10
-15
 6.12.10
-11
 - 4.25 2.31 
Propranolol Beta-blocker 
 
259.35 61.7 7.98.10
-13
 9.44.10
-8
 9.42 2.60-3.48 2.45 
Fluoxetine Anti-depressant 
 
309.33 60.3 8.90.10
-8
 2.52.10
-5
 10.05
b
 4.05-4.65 4.97 
Ofloxacin Antibiotic 
 
361.37 2.8.10
4
 4.98.10
-20
 9.84.10
-13
 6.24
a
 <0 1.09 
Ciprofloxacin Antibiotic 
 
331.35 3.0.10
4
 5.09.10
-19
 2.85.10
-13
 6.09
a
 0.28 0.99 
Triclosan 
Anti-bacterial/ 
anti-fungal agent 
 289.55 10 4.99.10
-9
 4.65.10
-6
 7.90
a
 4.76 3.93 
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5.2. MATERIALS AND METHODS 
5.2.1. Chemicals 
The reference standards acetaminophen, carbamazepine and fluoxetine hydrochloride were 
purchased from Sigma-Aldrich (Dorset, UK) and were of ≥95 % purity.  The standards 
bezafibrate, bezafibrate-d6, carbamazepine-d10, ciproﬂoxacin, ciprofloxacin-d8, diclofenac, 
diclofenac-d4, fluoxetine hydrochloride-d5, ibuprofen, ibuprofen-d3, naproxen, naproxen-d3, 
oﬂoxacin, ofloxacin-d3, propranolol, propranolol-d7, triclosan and triclosan-d3 were obtained 
from QMX laboratories (Thaxted, UK).  The solvents methanol (MeOH) and acetonitrile 
(ACN) were purchased from Rathburn Chemicals (Walkerburn, UK) and were high-
performance liquid chromatography (HPLC) grade.  Formic acid and 
ethylenediaminetetraacetic acid disodium salt (Na2EDTA) were obtained from Fisher 
Scientific (Loughborough, UK).  Ultra-pure (UP) water of 18.2 MΩ quality (Elga, Marlow, 
UK) was used for the preparation of mobile phases.  Ammonium acetate and Sigmacote® 
(silanising reagent for glass surfaces) was also purchased from Sigma-Aldrich (Dorset, UK).  
Sigmacote® was used to de-activate all glassware before use.  Both individual stock standard 
and deuterated standard solutions of 1 mg ml
-1
 were prepared in MeOH and stored at -20 °C.  
Fresh stock solutions of the antibiotics were prepared monthly.  Ten mixed working standard 
solutions ranging from 0 to 1,000 ng ml
-1
 (containing 200 ng ml
-1
 of each deuterated 
surrogate) were prepared daily in UP water: ACN: MeOH (90: 8: 2). 
 
5.2.2. Wastewater treatment works 
Samples for analysis were collected from a full-scale trickling filter works and a pilot-scale 
ASP situated in the East of England.  These received municipal sewage of the same source 
containing indigenous concentrations of all chemicals.  The trickling filter works serves a 
population equivalent of 3,000 and has an average flow of 650 m
3
 d
-1
.  The works consisted of 
a roughing filter for bulk organics removal and two duplex filters for nitrification.  
Corresponding grab samples of settled sewage and final effluent was collected over three 
consecutive days in 2.5 l borosilicate glass bottles with Teflon lined caps.  The pilot-scale 
ASP consisted of a primary sedimentation tank (0.18 m
3
), an aerated basin (0.36 m
3
) and a 
final clarifier (0.10 m
3
).  This was operated at a 30 day SRT whilst at a constant HRT of 24 
hours.  Samples of crude sewage, settled sewage, final effluent and return activated sludge 
(RAS) were collected on three consecutive days.  
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5.2.3. Extraction procedure 
Samples (200 ml) for aqueous phase extraction were filtered using 0.7 µm GF/F filters (Fisher 
Scientific, Loughborough, UK) to remove particulates within 15 minutes of collection.  
Samples had Na2EDTA added to achieve a concentration of 0.1 % (w/w) to improve 
extraction recoveries of the antibiotics (Hernandez et al., 2007).  Each sample was then 
spiked with deuterated surrogates to achieve a concentration of 500 ng l
-1
.  To determine 
extraction efficiency, selected samples were spiked with an additional 500 ng l
-1
 of all 
reference standards.  This was then subjected to solid phase extraction (SPE) using 200mg: 
6cc Oasis HLB cartridges (Waters, Elstree, UK).  The extraction protocol was similar to that 
described by Gros et al (2006).  Cartridges were pre-conditioned with 5 ml MeOH followed 
by 5 ml UP water at a constant flow rate of 1 ml min
-1
.  Samples were then loaded at 5 ml 
min
-1
 and cartridges were rinsed with 5 ml UP water.  These were then dried for 30 minutes 
under vacuum to remove excess water.  Analytes were eluted on the same day using two 4 ml 
aliquots of MeOH at 1 ml min
-1
.  Extracts were then evaporated to dryness using a miVac 
Duo concentrator (Genevac, Ipswich, UK).  These were then reconstituted in 0.5 ml UP 
water: ACN: MeOH (90: 8: 2) and transferred to auto-sampler vials.  Extracts were stored at 4 
ºC and analysed within 24 hours.   
For particulate extractions, large volumes of sample (crude sewage, settled sewage, final 
effluent and RAS) were centrifuged at 1,500 x g for 10 minutes and filtered to obtain the 
suspended solids.  These were frozen immediately and then freeze-dried.  Replicates of 0.3 to 
0.5 grams were spiked with a mixed solution of deuterated standards in MeOH (absolute 
concentration of each individual chemical was 100 ng) and left for a minimum of 5 hours.  
Selected samples were also spiked at an additional 120 to 200 ng g
-1
 of the reference 
standards to assess extraction recovery.  Samples were then mixed with ~20 g of Ottawa Sand 
obtained from Fisher Scientific (Loughborough, UK) and packed into 33 ml Dionex 
accelerated solvent extraction (ASE) cells.  Two or three 2-4 µm Dionex glass fibre filters 
(Fisher Scientific, Loughborough, UK) were then packed into both ends of the cell.  
Extractions were performed using a Dionex ASE 200 (California, USA).  The extraction 
pressure was set to 1,500 psi whilst at a temperature of 80 °C.  The solvent mixture for 
extraction was UP water: MeOH (65: 35). For each cell, two extraction cycles were 
conducted with the following settings: pre-heat period (for the first cycle only) of 5 minutes, 
heating for 5 minutes, static extraction of 5 minutes, solvent flush volume of 60 % and a 
nitrogen purge time of 60 seconds. Extracts were combined and diluted with UP water to 
achieve a MeOH concentration of <5 % and then subjected to SPE as an aqueous sample. 
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5.2.4. UPLC-MS/MS analysis 
Chromatography was performed using an Acquity ultra-performance liquid chromatography 
(UPLC) system (Waters, Manchester, UK). To maximise chromatographic resolution and 
sensitivity, chemicals were separated into two separate runs similar to that described by Gros 
et al (2012). Those chemicals exhibiting greater sensitivity in negative ion mode were 
separated on a reversed-phase BEH C18  column (2.1 mm 100 mm, particle size 1.7 µm) 
(Waters, Manchester, UK) using a gradient elution of 5 mM ammonium acetate in UP water 
(A) and an organic mixture of ACN: MeOH (80: 20) (B). Starting conditions were 10 % B 
which were maintained for 1.0 min. This was then increased linearly over 4.5 min to 80 % 
and maintained for 1.5 min before returning to starting conditions. The total run time was 9.0 
minutes.  Chemicals analysed in positive ion mode were separated using an Acquity HSS T3 
column (2.1 mm × 30 mm, particle size 1.8 µm) (Waters, Manchester, UK) and mobile phases 
consisting of 5 mM ammonium acetate in UP water containing 0.1 % formic acid (A) and an 
organic mixture of ACN: MeOH (80:20) (B). The elution started at 10 % B and was then 
linearly increased to 80 % B in 6.0 minutes, then maintained for 1.0 minute before returning 
to starting conditions. The total time of analysis was 10.0 minutes. In both runs, the ﬂow rate 
was 0.35 ml min
-1
 with an injection volume of 10 µl. The columns were maintained at a 
constant 35 ºC and the sample manager at 4 ºC.  The UPLC was coupled to a Waters Quattro 
Premier XE mass spectrometer with a Z-spray electrospray ionisation interface (Micromass, 
Watford, UK).  The multiple reaction monitoring (MRM) transitions monitored for each 
chromatographic run are detailed (Table 5.2).  The operational parameters for the mass 
spectrometer were: capillary voltage, 3.20 kV; multiplier voltage, 650 V; desolvation gas 
flow, 1000 l h
-1
; cone, -25 V; RF lens, 0.2 V; cone gas flow, 50 l h
-1
; desolvation temperature, 
350 °C and source temperature, 120 °C. 
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Table 5.2.  Optimised UPLC-MS/MS parameters for target chemicals analysed using the two different chromatographic runs 
Chemical 
Precursor ion 
(m/z) 
SRM1 
Cone 
voltage 
(V) 
Collision 
Energy 
(V) 
SRM2 
Cone 
voltage (V) 
Collision 
Energy (V) 
Dwell 
time 
(seconds) 
Retention 
time 
(minutes) 
IDL 
(pg) 
Column: C18 Mobile phase A: 5mM ammonium acetate in UP water. Mobile phase B: 80: 20 ACN: MeOH 
Acetaminophen 151.80 [M+H]
+
 92.90 30 20 109.90 30 15 0.1 1.63 15 
Naproxen 228.90 [M-H]
-
 169.90 15 15 184.90 15 8 0.1 3.59 22 
Naproxen-d3 231.90 [M-H]
-
 172.95 15 15 - - - 0.1 3.59 - 
Bezafibrate 360.00 [M-H]
-
 274.05 30 30 153.90 30 20 0.1 3.85 13 
Bezafibrate-d6 366.00 [M-H]
-
 274.10 30 20 - - - 0.1 3.85 - 
Diclofenac 293.80 [M-H]
-
 250.00 20 10 - - - 0.1 4.35 17 
Diclofenac-d4 297.85 [M-H]
-
 254.05 20 10 - - - 0.1 4.35 - 
Ibuprofen 204.90 [M-H]
-
 161.00 20 8 - - - 0.1 4.42 13 
Ibuprofen-d3 207.90 [M-H]
-
 164.00 20 8 - - - 0.1 4.42 - 
Triclosan 286.80 [M-H]
-
 286.80 20 3 - - - 0.1 6.51 239 
Triclosan-d3 289.80 [M-H]
-
 289.80 20 4 - - - 0.1 6.50 - 
Column: T3 Mobile phase A: 5mM ammonium acetate, 0.1 % formic acid in UP water. Mobile phase B: 80: 20 ACN: MeOH 
Oﬂoxacin 361.90 [M+H]+ 261.10 42 25 318.20 40 20 0.1 3.31 15 
Ofloxacin-d3 364.90 [M+H]
+
 321.20 40 20 - - - 0.1 3.32 - 
Ciproﬂoxacin 332.10 [M+H]+ 288.15 36 20 245.10 36 16 0.1 3.37 13 
Ciprofloxacin-d8 340.10 [M+H]
+
 296.20 36 20 - - - 0.1 3.37 - 
Propranolol 260.10 [M+H]
+
 183.00 35 18 116.00 35 15 0.1 4.73 12 
Propranolol-d7 267.10 [M+H]
+
 189.10 35 18 - - - 0.1 4.73 - 
Carbamazepine 237.00 [M+H]
+
 194.00 32 35 179.00 32 18 0.1 5.39 7 
Carbamazepine-d10 247.05 [M+H]
+
 204.10 34 20 - - - 0.1 5.38 - 
Fluoxetine 310.10 [M+H]
+
 148.05 25 10 44.10 25 8 0.1 6.00 12 
Fluoxetine-d5 315.10 [M+H]
+
 153.05 25 8 - - - 0.1 5.99 - 
Key: SRM, selected reaction monitoring, IDL, instrument detection limit 
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5.3. RESULTS 
5.3.1. Method performance 
Mean recoveries of all chemicals ranged from 36 to 134 % and from 43 to 129 % in all 
matrices for aqueous and particulate phases, respectively (Figure 5.1).  The influence of 
remaining matrix within sample extracts was quantified according to the algorithm reported by 
Vieno et al (2006).  Matrix suppressions ranged from -51 (signal enhancement) to 67 % and 
from -50 to 78 % for aqueous and particulate phases (Figure 5.1).  The chemicals analysed in 
negative ion mode (naproxen, bezafibrate, diclofenac, ibuprofen and diclofenac) all exhibited 
signal enhancement for some matrices.  Method detection limits (MDLs) were calculated 
according to (Petrie et al., 2013b; Petrie et al., in press): 
M)(100
100
.
(R.C)
IDL.100
MDL
-
        (5.1) 
where IDL is the instrument detection limit (ng l
-1
), R is recovery (%), C is the concentration 
factor and M is the matrix suppression (%).  Pharmaceutical MDLs ranged from 2.3 to 22.4 ng 
l
-1
 in aqueous wastewater fractions whereas those for triclosan ranged from 46.4 to 86.5 ng l
-1 
(Figure 5.1).  In particulate fractions, MDLs ranged from 2.4 to 29.0 ng g
-1
.  The MDLs of the 
personal care product triclosan were comparatively higher for both aqueous (46.4 to 86.5 ng l
-
1
) and particulate (52.5 to 86.8 ng g
-1
) phases of all matrices studied.  Chromatography for 
extracted environmental matrices exhibited Gaussian distribution for all target chemicals 
(Figure 5.2).  However, poor peak shape was observed for acetaminophen when formic acid 
was present within the aqueous mobile phase.  Consequently, this chemical was analysed using 
the mobile phase compositions for negative ion chemicals. 
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Figure 5.1.  Method recoveries (aqueous – A, particulate – B), analyte signal suppressions 
(aqueous – C, particulate – D) and method detection limits (aqueous – E, particulate – F) for 
target chemicals in final effluent, settled sewage, crude sewage and RAS matrices. 
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Figure 5.2.  Multiple reaction monitoring chromatograms of target chemicals extracted from the 
particulate phase of crude sewage for chromatographic runs 1(BEH C18 column with mobile 
phases 5 mM ammonium acetate in UP water and 80: 20 MeOH: ACN) and 2 (HSS T3 column with 
mobile phases 5 mM ammonium acetate, 0.1 % formic acid in UP water and 80: 20 MeOH: ACN) 
 
5.3.2. Distribution within the particulate phase 
In crude sewage, the antibiotics ofloxacin and ciprofloxacin exhibited greater distribution (63 
and 68 %) within the particulate phase (Figure 5.3A).  These correspond to partition 
coefficients (log Kd’s) of 3.96 and 4.07, respectively.  Propranolol, triclosan and fluoxetine all 
showed reasonable affinity to suspended solid material with relative distributions in the 
particulate phase of 15, 29 and 37 %, respectively.  The remaining chemicals (acetaminophen, 
ibuprofen, bezafibrate, naproxen, carbamazepine and diclofenac) were all found to be 
distributed by <10 % in the particulate phase.  Primary sedimentation resulted in a 71 % 
reduction in suspended solids concentration.  Consequently, the contribution of particle bound 
chemicals to the total concentration was reduced (Figure 5.3B).  Ofloxacin now exhibited the 
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greatest distribution within the particulate phase of settled sewage (41 %).  Following a further 
77 % reduction of suspended solids during secondary treatment, most chemicals were 
distributed mainly in the aqueous phase (>99 %) of final effluents (Figure 5.3C).  Nevertheless, 
fluoxetine (5 %), ciprofloxacin (11 %), ofloxacin (24 %) and triclosan (28 %) still showed a 
reasonable proportion of their total concentration to be within the particulate phase.  Despite 
the concentration of suspended solids being 12.5 mg l
-1 
in final effluents.  The relatively high 
distribution of these chemicals in the particulate phase corresponded to log Kd’s of 3.58, 3.98, 
4.41 and 4.51, respectively.   
 
 
 
Figure 5.3.  Relative distribution of target analytes within the dissolved (□) and particulate (■) 
phases of crude sewage (A), settled sewage (B) and final effluent (C) 
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5.3.3. Fate pathways 
Attaining complete process mass balances enabled each chemical to be broadly separated into 
three groups, based on their respective fate pathway.  These are chemicals predominantly 
removed by biodegradation (acetaminophen, ibuprofen, bezafibrate, and naproxen), by 
sorption onto activated sludge (triclosan, ofloxacin and ciprofloxacin) and those exhibiting no 
removal from the aqueous phase (carbamazepine, diclofenac, propranolol and fluoxetine), 
respectively (Figure 5.4).  Each chemical was separated according to aqueous and particulate 
concentrations across crude sewage, settled sewage, RAS and final effluent.  For example, 
secondary removal of ibuprofen was 97 % with no accumulation within the particulate phase 
of RAS suggesting its predominant removal pathway was biodegradation (Figure 5.5A).  
Interestingly, 55 % removal was observed from the aqueous phase of wastewater during 
primary sedimentation alone.  In contrast, triclosan showed no removals from either the 
aqueous or particulate phases during primary sedimentation (Figure 5.5B).  However, during 
secondary treatment 84 % removal was observed.  An accumulation of triclosan within the 
particulate phase of RAS (2,469 ng g
-1
) confirmed its removal by sorption.  Considering the 
comparatively higher concentrations of ofloxacin (15,112 ng g
-1
) and ciprofloxacin (3,964 ng 
g
-1
) within RAS (and poorer secondary removal achieved) (Figure 5.4) suggests that triclosan 
is also removed by biodegradation.  In contrast, dissolved concentrations of fluoxetine were 
similar in all sampling positions of the process mass balance (Figure 5.4C).  Nevertheless, an 
accumulation of fluoxetine was observed in the particulate phase of RAS which corresponded 
to the removal of suspended solids (and particulate bound fluoxetine) during secondary 
treatment. 
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Figure 5.4.  Mass balance information for target chemicals separated by their predominant 
removal pathways from the aqueous phase - biodegradation (A) and sorption (B) and those 
chemicals not removed by sorption or biodegradation (C), ■-sampling points 
 
 
 
 
 
 
 
 
 
 
 
Q = 15 l h-1 
SRT = 30 days 
HRT = 24 hours 
Q = 8 l h-1 
Carbamazepine 86 ng l-1 
Diclofenac         97 ng l-1 
Propranolol      141 ng l-1 
Fluoxetine          23 ng l-1 
 
  
Carbamazepine 90 ng l-1 
Diclofenac      316 ng l-1 
Propranolol     223 ng l-1 
Fluoxetine       110 ng l-1 
 
 
Secondary Removal 
 
Carbamazepine          -10% 
Diclofenac    3% 
Propranolol -8% 
Fluoxetine  13% 
 
Carbamazepine 81 ng l-1 
Diclofenac       103 ng l-1 
Propranolol      120 ng l-1 
Fluoxetine          41 ng l-1 
 
Carbamazepine 82 ng l-1 
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Fluoxetine          26 ng l-1 
 
Primary Removal 
 
Carbamazepine  0% 
Diclofenac   4% 
Propranolol               -10% 
Fluoxetine  35% 
 
(C) 
Q = 15 l h-1 
SRT = 30 days 
HRT = 24 hours 
Q = 8 l h-1 
 
Triclosan       239 ng l-1 
Ofloxacin       430 ng l-1 
Ciprofloxacin 240 ng l-1 
 
  
Triclosan          5,795 ng l-1 
Ofloxacin       35,321 ng l-1 
Ciprofloxacin   9,589 ng l-1 
 
 
Secondary Removal 
 
Triclosan  84% 
Ofloxacin  56% 
Ciprofloxacin 46% 
 
 
Triclosan     1,567 ng l-1 
Ofloxacin    1,933 ng l-1 
Ciprofloxacin 458 ng l-1 
 
 
Triclosan     1,515 ng l-1 
Ofloxacin    1,039 ng l-1 
Ciprofloxacin 450 ng l-1 
 
Primary Removal 
 
Triclosan  3% 
Ofloxacin  47% 
Ciprofloxacin   2% 
 
(B) 
Q = 15 l h-1 
SRT = 30 days 
HRT = 24 hours 
Q = 8 l h-1 
Acetaminophen 99 ng l-1 
Ibuprofen         200 ng l-1 
Bezafibrate         50 ng l-1 
Naproxen         232 ng l-1 
 
  
Acetaminophen 198 ng l-1 
Ibuprofen           799 ng l-1 
Bezafibrate          39 ng l-1 
Naproxen        1,025 ng l-1 
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Acetaminophen 99% 
Ibuprofen  97% 
Bezafibrate 86% 
Naproxen  90% 
 
Acetaminophen 15,215 ng l-1 
Ibuprofen           14,740 ng l-1 
Bezafibrate              401 ng l-1 
Naproxen            3,151 ng l-1 
 
Acetaminophen 9,635 ng l-1 
Ibuprofen           6,566 ng l-1 
Bezafibrate            375 ng l-1 
Naproxen            2,321 ng l-1 
 
Primary Removal 
 
Acetaminophen 36% 
Ibuprofen  55% 
Bezafibrate   8% 
Naproxen  24% 
(A) 
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Figure 5.5.  Aqueous and particulate concentrations of ibuprofen (A), triclosan (B) and fluoxetine 
(C) in crude sewage, settled sewage, return activated sludge and final effluents 
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5.3.4. Efficacy of trickling filter treatment 
Corresponding settled sewage and final effluent samples were collected from a trickling filter 
to directly compare removal performance with activated sludge (Figure 5.6).  Both treatment 
processes were monitored simultaneously whilst receiving the same influent sewage at 19 ºC.  
Pharmaceutical removal by the trickling filter ranged from -48 ±26 % for propranolol to >99 % 
for acetaminophen.  Similar removal performance to activated sludge treatment was observed 
for the majority of target chemicals.  This includes the antibiotics whose removal is attributable 
to sorption.  Removals of ofloxacin were 56 ±12 % and 54 ±6 % and ciprofloxacin were 46 ±7 
% and 42 ±15 % for activate sludge and trickling filter treatment respectively.  However, 
secondary removals of bezafibrate and triclosan were comparatively lower by trickling filter 
treatment.  Bezafibrate was removed by 86 ±2 % and 61 ±9 % for activated sludge and 
trickling filter treatment, respectively.  Moreover, triclosan removals were 84 ±3 % (activated 
sludge) and 74 ±5 % (trickling filter).  The remaining chemicals were all removed similarly by 
activated sludge and trickling filter treatment.   
 
 
 
Figure 5.6. Comparison of target chemical secondary removal by activated sludge and trickling 
filter treatments receiving municipal sewage of the same source.  Target chemicals separated by 
dominant removal mechanism - biodegradation (A), and sorption (B), and those chemicals not 
removed by sorption or biodegradation (C) 
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5.4. DISCUSSION 
Chemicals were separated into two chromatographic runs (positive and negative ionisation 
modes) to achieve maximum sensitivity and lower MDLs (Figure 5.1).  Those analysed in 
positive ion mode had 0.1 % formic acid added to the aqueous mobile phase.  This was used to 
enhance their ionisation efficiency and sensitivity (Gros et al., 2012).  Method detection limits 
were <10 ng l
-1
 for the majority of chemicals in final effluents (Figure 5.1).  The MDLs of 
triclosan were comparatively higher (46 to 86 ng l
-1
).  This was due to its lack of product ions 
during MS/MS fragmentation.  To illustrate, previous reported LC-MS/MS methods monitor 
for product ions with a mass to charge (m/z) ratio of 35 (Hyland et al., 2012; Bayen et al., 
2013; Boleda et al., 2013) or the precursor ion again at a low collision energy (Behera et al., 
2011; Zhao et al., 2010; Zhao et al., 2011) (replicating single MS mode).  The latter approach 
was adopted here due to the mass range of the MS/MS used in this study.  The comparatively 
lower signal to noise ratios for triclosan resulted in greater MDLs observed.  Nevertheless, this 
enabled triclosan to be included in the method, without the need to run a separate LC-MS or 
gas chromatography method for its analysis.  Furthermore, the MDLs achieved by this 
approach were adequate to monitor for triclosan at the concentrations encountered in all 
matrices studied.  Analyte signal suppressions broadly ranged from -51 % (signal 
enhancement) to 78 % for all chemicals and matrices (Figure 5.1).  This is caused by the 
influence of the complex heterogeneous composition of environmental matrices on analyte 
signal strength whilst using electro-spray ionisation, highlighting the necessity of including 
deuterated standards within the analysis. 
The determination of the trace organic contaminants in both the aqueous and particulate phases 
of wastewaters revealed significant concentrations associated with particulates (Figure 5.3).  
Propranolol, triclosan, fluoxetine, ofloxacin and ciprofloxacin were all distributed in the 
particulate phase of crude wastewater at >10 % (15, 29, 37, 63 and 68 % of the total 
concentration, respectively).  Consequently, determination in the particulate fraction of 
wastewater is essential for these chemicals to better understand fate and process performance 
for their removal (Petrie et al., 2013b).  Interestingly, both ofloxacin and ciprofloxacin have 
log Kow’s <1 (Table 5.1) illustrating their sorption is driven by other mechanisms such as 
electrostatic attractions.  The remaining six chemicals were found in the particulate phase at 
<10 % of the total concentration.  This broad range of distribution supports previous findings 
for a variety of illicit drugs and pharmaceuticals in crude sewage (Baker and Kasprzyk-
Hordern, 2011a).  However, distribution within final effluents has previously been unknown.  
This is due to the additional demands on sample collection and preparation caused by the very 
low suspended solids concentrations encountered.  Nevertheless, this study revealed that 
significant concentrations of specific trace organic contaminants can be found within the 
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particulate phase of final effluents, even at low suspended solids concentrations (12.5 mg l
-1
) 
(Figure 5.3).  Triclosan, ofloxacin and ciprofloxacin were all within the particulate phase at 
>10 % of the total concentration, corresponding to particulate concentrations equivalent to 
68.4, 104.5 and 25.7 ng l
-1
, respectively.  This is significant as relatively large quantities of 
these chemicals are released into the environment unmonitored and specific knowledge on the 
fate of particulate bound organic contaminants within the environment is unknown.   
The complete process mass balance revealed that the chemicals studied were broadly separable 
into three groups based on their fate pathways (Figure 5.4); chemicals removed by 
biodegradation, those predominantly removed by sorption and chemicals which exhibited no 
removal from the aqueous fraction (Figure 5.5).  The chemicals mainly removed by 
biodegradation exhibited no notable accumulation within the particulate phase of RAS despite 
significant secondary removal (≥86 %).  Naproxen, acetaminophen and ibuprofen all exhibited 
removal from the aqueous phase (24 % to 55 %) during primary sedimentation (Figure 5.4A).  
This suggests that bacteria in receiving crude sewage biodegrade these contaminants during 
primary treatment.  In contrast triclosan, ofloxacin and ciprofloxacin accumulated within the 
particulate phase of RAS confirming their removal by sorption (Zhou et al., 2013). Their 
concentrations were 2,469, 15,112 and 3,964 ng g
-1
, respectively.  The high partitioning of the 
antibiotics to RAS has been previously observed with concentrations of ofloxacin up to 24, 760 
ng g
-1 
(Chen et al., in press).  Interestingly, diclofenac and fluoxetine have log Kow’s >4 yet no 
removal from the aqueous phase was observed during treatment.  Shen et al (2012) 
successfully showed that the steroid estrogen estrone (log Kow 3.13 to 3.43 – EPI Suite, 2013) 
could effectively be retained in solution by humic acid, a small molecular weight charged 
species.  Both diclofenac (negative) and fluoxetine (positive) are charged at the pH typical of 
municipal wastewaters (Hyland et al., 2012).  Therefore, knowledge of the behaviour of 
pharmaceuticals with charged colloidal species present within wastewater is required.  This 
may help elucidate the poor removal of relatively hydrophobic chemicals during wastewater 
treatment. 
Monitoring organic contaminant removal performance of activated sludge and trickling filter 
treatment simultaneously, whilst receiving the same influent sewage enabled the direct impact 
of process type to their removal to be evaluated.  Previous research made the comparison 
between numerous full-scale processes (Baker and Kasprzyk-Hordern, 2013), which makes the 
impact of process type to removal difficult to ascertain.  Findings here revealed that trickling 
filter treatment was as effective as activated sludge treatment for the removal of most 
chemicals which rely on very different removal pathways (Figure 5.6).  For example, 
ibuprofen was considered to be removed by biodegradation and removals were 97 ±1 % and 98 
±1 % for activated sludge and trickling filter treatment, respectively.  The antibiotics which are 
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removed by sorption exhibited removals of 46 to 56 % by activated sludge and from 42 to 54 
% by trickling filter treatment, with no significant differences observed.  Only removals of 
triclosan and bezafibrate were notably greater by ASP treatment.  Furthermore, the ASP was 
operated at a long hydraulic retention time (HRT) which is considered favourable for enhanced 
organic contaminant removal (Petrie et al., in preparation).  This demonstrates the 
effectiveness of trickling filter treatment to remove these organic contaminants which rely on 
very different removal pathways whilst operating at very short HRTs.  It should be noted that 
the determination of metabolites must also be undertaken to better understand fate and removal 
(Huerta-Fontela et al., 2010; Ferrando-Climent et al., 2012).  For example, there is a paucity of 
information available on ibuprofen metabolites, despite this being one of the most studied 
pharmaceuticals (Petrie et al., 2013b).  Recent work by Ferrando-Climent et al (2012) revealed 
that at least three metabolites of ibuprofen exist at µg l
-1
 concentrations.  These were found to 
be present in influent and effluent wastewater at higher levels than the parent chemical 
(Ferrando-Climent et al., 2012).  Consequently, future work to assess chemical fate and 
process performance for their removal must include metabolites.         
 
5.5. CONCLUSION 
It is unlikely there will be a reduction of pharmaceuticals seen entering crude sewage due to 
their essential medical usage.  Consequently, it is essential to better understand their fate and 
behaviour during wastewater treatment.  It was found that these chemicals exhibit a range of 
dominant removal pathways (biological and physical) during activated sludge treatment.  
Interestingly, trickling filter treatment was as effective as activated sludge treatment for the 
removal of the majority of the organic contaminants studied.  Nevertheless, significant 
concentrations of some chemicals were present within the particulate phase of final effluents 
which provide a route into the environment which commonly goes undetermined.    
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CHAPTER 6 
DIAGNOSTIC INVESTIGATION OF STEROID ESTROGEN REMOVAL BY 
ACTIVATED SLUDGE AT VARYING SOLIDS RETENTION TIME 
 
SUBMITTED: Chemosphere 
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6. DIAGNOSTIC INVESTIGATION OF STEROID ESTROGEN REMOVAL 
BY ACTIVATED SLUDGE AT VARYING SOLIDS RETENTION TIME 
 
Bruce Petrie, Ewan J. McAdam, Francis Hassard, Tom Stephenson, John N. Lester, Elise 
Cartmell 
Cranfield Water Science Institute, Cranfield University, Bedfordshire, MK43 0AL 
 
Abstract  
The impact of solids retention time (SRT) on estrogen removal in an activated sludge plant 
(ASP) was examined using a pilot plant to closely control SRT.  Ex-situ analytical methods 
were simultaneously used to enable discrimination of the dominant mechanisms governing 
estrogen removal following transitions in SRT from short (3 day) to medium (10 day) and long 
(27 day) SRTs which broadly represent those encountered at full-scale.  Total estrogen (∑EST) 
removals were 70 ±8, 95 ±1 and 93 ±2 % at 3, 10 and 27 day SRTs respectively.  The 
improved removal observed following increasing SRT from 3 days to 10 days SRT was 
attributable to the augmented biodegradation of the natural estrogens estrone and 17β-estradiol.  
Interestingly, estrogen biodegradation per bacterial cell increased with SRT.  These were 499, 
1,361 and 1,750 ng∑EST 1 x 10
12
 viable cells
-1
 d
-1
.  This indicated an improved efficiency of the 
same group or the development of a more responsive group of bacteria.  In this study no 
improvement in absolute ∑EST removal was observed in the ASP when SRT increased from 10 
days SRT to 27 days SRT.  However, batch studies identified an augmented biomass sorption 
capacity for the more hydrophobic estrogens 17β-estradiol and 17α-ethinylestradiol at 27 days, 
equivalent to an order of magnitude.  The limited influence on ASP operation can be ascribed 
to the receiving concentrations of the influent sewage being inadequate to challenge the 
system.  However, this indicates that high SRT operation could be beneficial for wastewater 
characterised by higher receiving concentrations of the more hydrophobic estrogenic 
compounds 17β-estradiol and 17α-ethinylestradiol. 
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6.1. INTRODUCTION 
The fate and behaviour of steroid estrogens in wastewater treatment works (WwTWs) is of 
great importance due to their detrimental environmental impact (Lai et al., 2002a; Lai et al., 
2002b; Green et al., 2013) and possible adverse implications for water re-use (Martin et al., 
2008). This is a consequence of their high estrogenic potency (Kidd et al., 2007) and ubiquity 
in municipal wastewaters (Joss et al., 2004; Clara et al., 2005; Koh et al., 2009; McAdam et 
al., 2010.  Natural estrogens; estrone (E1), 17β-estradiol (E2) and estriol (E3) constitute the 
majority (typically ≥99 %) of free steroid estrogens observed in wastewaters (Gomes et al., 
2009; Koh et al., 2009; McAdam et al., 2010).
  The synthetic estrogen 17α-ethinylestradiol 
(EE2) is present in much lower concentrations (Koh et al., 2009; McAdam et al., 2010; Baynes 
et al., 2012) but is arguably of greater concern due to its higher potency and the difficulty it 
poses to removal during conventional wastewater treatment.  Such is the concern both E2 and 
EE2 were proposed to be included as priority hazardous chemicals under the Water Framework 
Directive (of the European Union) with suggested Environmental Quality Standards (EQS) of 
0.4 ng l
-1
 and 0.035 ng l
-1
, respectively (European Commission, 2012).  However, as currently 
configured secondary WwTWs fail to consistently meet these proposed guidelines (Koh et al., 
2009; McAdam et al., 2010).  Activated sludge is a widely implemented secondary biological 
process with an established ability to remove numerous anthropogenic (Stoveland et al., 1979; 
McAdam et al., 2011; Helbling et al., 2012) and complex natural chemicals including 
estrogens to varying extents (Kreuzinger et al., 2004; Clara et al., 2005; Koh et al., 2009; 
McAdam et al., 2010).  To ensure effluent quality exceeds proposed EQS’s, optimisation of 
process operation is therefore required.  Achieving this relies on understanding the 
mechanisms which drive removal at different operations.  An extended solids retention time 
(SRT) is generally considered necessary to achieve enhanced removal of estrogens (Kreuzinger 
et al., 2004; Clara et al., 2005; McAdam et al., 2010).  It has been considered that an increase 
in SRT enables the enrichment of a more diverse biocenosis which augments steroid estrogen 
biodegradation (Kreuzinger et al., 2004).  It has also been suggested that the k-strategist 
concept maybe applicable (Graham and Curtis, 2003; Koh et al., 2009), hypothesising that 
micro-organisms characterised by low half saturation coefficients biodegrade estrogens as a 
primary carbon substrate at extended SRTs.  The activity of nitrifying micro-organisms has 
long been associated with improved estrogen removal (Vader et al., 2000).  However, the role 
of nitrifiers in environmentally representative conditions has been questioned (Gaulke et al., 
2008) and it has been proposed that heterotrophic bacteria scavenging a broad spectrum of 
organics perform estrogen biodegradation in conditions conducive to nitrification (Bagnall et 
al., 2012).   
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Despite extensive research, the site of steroid estrogen biodegradation within the biomass 
matrix remains unknown.  It is hypothesised that biological removal of organic chemicals can 
occur as an extracellular process within the bulk medium or, on the surface and/or within the 
activated sludge floc itself (Joss et al., 2004).  Nitrifiers are known to produce extracellular 
ammonia mono-oxygenase (AMO) enzymes capable of co-oxidising a variety of organic 
chemicals (Vader et al., 2000).  Thus, biodegradation may occur in the bulk medium outside 
activated sludge flocs.  Khunjar and Love
 
(2011) suggested a requirement for sorption to occur 
prior to biological breakdown being initiated.  Pharmaceuticals which failed to sorb to 
extracellular polymeric substances (EPS) were not biodegraded.  Thus sorption may be a 
prerequisite to the biodegradation process.  Chemical hydrophobicity (log Kow) is considered a 
reasonable predictor of sorption equilibrium (Gomes et al., 2011).  McAdam et al (2010) 
highlighted the possible importance of changing floc physiology with SRT to estrogen 
sorption.  Activated sludge biomasses ranging in age from 4 to 20 days have been observed to 
differ in their surface properties such as charge and, EPS and protein content (Liao et al., 
2001).  Both EPS and proteins concentration are thought to influence EE2 sorption.  For 
example, when EPS was removed EE2 sorption coefficients were reduced by ~50 % (Khunjar 
and Love, 2011).  Furthermore, EE2 was shown to sorb preferentially to EPS protein over 
carbohydrate.  Activated sludge floc size is also likely to impact estrogen uptake as their size 
typically varies from 100 to 500 µm (Joss et al., 2004).  On the basis of equivalent dry weight, 
activated sludge comprised of smaller floc size has an inherently greater surface area for 
sorption.  To our knowledge no previous study has examined the impact of closely controlled 
SRT to estrogen removal.  Research has traditionally compared full-scale activated sludge 
plants (ASPs) where receiving sewage differs between sites and process control is poor 
(Kreuzinger et al., 2004; Clara et al., 2005; Koh et al., 2009; McAdam et al., 2010).
 
 This 
study utilised municipal wastewater of the same source to circumvent variations in receiving 
sewage composition.  Furthermore, a pilot-scale ASP was operated to enable close control of 
SRT.  The implication of poor process control is a dynamic and highly variable SRT making 
the interpretation of its impact to estrogen removal difficult.  This study specifically examined 
the impact of SRT on steroid estrogen removal.  Supportive analysis was used to understand 
and assess the contribution of sorption and biodegradation to estrogen removal at each 
controlled condition.   
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6.2. MATERIALS AND METHODS 
6.2.1. Pilot-scale activated sludge plant 
A pilot-scale ASP was sited at a WwTWs in the east of England (3,000 population equivalent - 
PE) and consisted of a primary sedimentation tank, a 0.36 m
3
 aerated basin and a final clarifier.  
The system was seeded using biomass from a full-scale nitrifying ASP (280,000 PE) and 
supplied with municipal crude wastewater containing indigenous concentrations of estrogens.  
The influent flow rate (1.08 m
3
 d
-1
) was controlled to achieve a constant hydraulic retention 
time (HRT) of 8 hours.  Return activated sludge (RAS) was 0.55 of the influent flow (0.59 m
3
 
d
-1
).  Solids retention times of 3, 10 and 27 days were selected for monitoring and controlled 
by daily disposal of excess activated sludge (waste activated sludge (WAS)) following 
correction for loss of effluent solids.  The system was operated for at least three SRTs prior to 
monitoring to ensure steady state conditions were established.  Steroid estrogens and sanitary 
determinands were sampled once daily from influent settled sewage, final effluent and RAS (in 
duplicate) over seven consecutive days at each condition.  Samples were collected in 2.5 l 
borosilicate glass vessels with Teflon lined caps and processed immediately. 
 
6.2.2. Batch-scale sorption and biodegradation studies 
To assess sorption, biomass of 3, 10 and 27 days SRT was collected and deactivated by 
pasteurisation at 65 °C for 15 minutes (Le Meur, 2011).  Biomass was allowed to cool, washed 
3 times using biochemical oxygen demand (BOD) water (1.25 x 10
-4
 mg l
-1
 ferric chloride; 
0.028 mg l
-1
 calcium chloride; 0.025 mg l
-1
 magnesium sulphate in a buffered aqueous 
solution) and stored overnight at 4 °C.  Biological inactivity was confirmed by monitoring 
soluble chemical oxygen demand (sCOD, 1.2 µm filtered) concentrations following spiking 
with a readily biodegradable carbon substrate (glucose) at 18 °C.  Biomass was normalised to 
five different suspended solids concentration at 18 (+/- 0.5) °C using BOD water; 200, 400, 
600, 800 and 1,000 mg l
-1
.  These were prepared in sacrificial 2 l borosilicate vessels and 
continually mixed using an orbital shaker (Stuart, Stone, UK) at 90 rpm.  Each vessel was 
spiked with 100 ng l
-1
 of each steroid estrogen and 500 ml sample aliquots were taken after 8 
hours.  For the experimental design utilised here, the data was fitted to the Langmuir isotherm, 
enabling adsorption maxima to be determined (Del Bubbu et al., 2003; Schwarzenbach, 2003): 







a
C
a.b
1
q
C ee
        (6.1) 
Here a = maximum achievable surface concentration of a given estrogen (ng g
-1
), b = 
Langmuir constant, Ce = the equilibrium concentration of estrogen in solution (ng l
-1
) and q = 
concentration of estrogens sorbed per weight of biomass (ng g
-1
).  During the development 
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process, equilibrium time was established by monitoring estrogen concentrations at 0, 0.5, 1, 4, 
8 and 24 hour time intervals for biomass concentrations of 200 and 1,000 mg l
-1
.  This also 
ensured no desorption occurred over the time period studied.   
Biodegradation batch tests were also prepared with biomass of 3, 10 and 27 days SRT.  This 
was achieved using borosilicate 10 l vessels (Fisher Scientific UK LTD, Loughborough, UK) 
containing 8 l of biomass.   Initially biomass was washed with BOD water then normalised to a 
suspended solids concentration of 1,000 mg l
-1
 with filtered settled sewage to achieve an initial 
food: micro-organism (F: M) ratio of 0.12 ±0.01 g sCOD gVSS
-1
.  To assess the role of 
extracellular activity a test vessel containing 8 l of filtered (1.2 μm) nitrifying biomass was 
prepared (Langford et al., 2005).  Furthermore, an additional vessel was prepared containing 5 
mg l
-1
 allylthiourea (ATU) to inhibit nitrification (Zhou and Oleszkiewicz, 2010).  Each vessel 
was spiked with an additional 100 ng l
-1
 of each steroid estrogen.  The biomass was kept 
completely mixed using a magnetic stirrer and continuously aerated at 18 (+/- 0.5) °C.  The test 
was initiated within 2 hours of collecting the biomass.  Representative 500 ml samples were 
taken in triplicate at the following time intervals; 0 (immediately following estrogen spiking), 
1, 4, 8 and 24 hours.  All estrogens were determined in both aqueous and particulate phases.  
At each interval ammonium nitrogen (NH4
+
-N), nitrate (NO3
-
) and COD were also monitored.
  
6.2.3. Biomass characterisations 
Biomass at the three SRTs was characterised by extracting EPS and soluble micro products 
(SMP) fractions.  This was achieved using a method similar to that described by Le-Clech et al 
(2006).  Initially 50 ml of biomass was centrifuged at 1,500 x g for 5 minutes.  The supernatant 
was filtered through 0.2 μm filters to obtain the SMP fraction.  The biomass was re-suspended 
in 50 ml of deionised water and placed in an oven at 105 °C for 1 hour (allowing the sample to 
reach 80 °C for 10 minutes).  Once at room temperature the sample was centrifuged at 1,500 x 
g for 5 minutes and filtered (0.2 μm) to obtain the extracted EPS.  Chemical oxygen demand 
measurements were taken as a means of quantifying organic composition.  Protein and 
carbohydrate concentrations were quantiﬁed using the phenol–sulphuric acid method (Zhang et 
al., 1999) and modiﬁed Lowry method (Frølund et al., 1995), respectively.  Charge (zeta 
potential) was measured using a Zetasizer 2000 (Malvern Instruments LTD, Worcestershire, 
UK) and biomass particle size by a Mastersizer 2000 (Malvern Instruments LTD, 
Worcestershire, UK).   
Numbers of viable (intact) and dead (non-intact) cells in all biomasses was quantified using a 
modified method of that outlined by Ziglio et al (2002).  Grab samples of biomass were taken 
from the aeration stage of the pilot-scale ASP and analysed immediately. The sample was 
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homogenised using a mechanical blender for 3 minutes. A 5 ml sample was then disaggregated 
using a homogeniser 125 (Fisher Scientific UK LTD, Loughborough, UK) at speed setting 4 
(24,500 1/min). The samples were then diluted 1:20 (v/v) with a 0.22 µm filtered sodium 
chloride (NaCl) solution (0.085%) (Boulos et al., 1999).  A further 5 minutes disaggregation 
step was undertaken to obtain maximum bacterial numbers without impacting viability. The 
bacterial cells were separated from the debris by differential centrifugation according to the 
method by Lunau et al
 
(2005).  Samples were centrifuged at 180 x g for 1 minute and the 
supernatant containing the cells was retained. The optical density (OD) of the cells was 
measured at 600 nm using a visible light spectrophotometer (Jenway 630) and the sample 
diluted to give an appropriate bacterial number per microscope field of view (FOV) 
(approximately 60 cells per FOV) with filtered NaCl solution (0.085%).  Bacterial samples 
were stained with LIVE/DEAD® BacLight™ (Invitrogen, Glasgow, UK) according to 
manufacturer’s guidelines. The BacLight test is an indirect measure of membrane viability 
based on the ability of cells with intact membranes to exclude propidium idodide. The total cell 
count is a measure of the non-specific SYTO -9 and the dead or membrane compromised cells 
are stained red by propidium iodide. The dyes dissolved in dimethyl sulfoxide were mixed 
together (1:1 (v/v)) and diluted in filtered NaCl solution (0.085%). During the staining 
procedure bacteria were incubated at 20º C for 15 minutes in a dark room prior to filtration 
(Boulos et al., 1999). A known volume of sample was then vacuum filtered onto a black 
polycarbonate membrane filter (0.22 µm pore size, 25 mm diameter; Nucleopore, Whatman, 
UK). The filter was washed with filtered NaCl solution (0.085%) and was placed (still wet) on 
a clean microscope slide, a drop of LIVE/DEAD® BacLight™ mounting oil was applied and a 
clean coverslip was placed over the filter.  The corners were fixed with clear nail polish 
(Rimmel, London). Cells were viewed under oil immersion (63x) on an LSM 510 META 
confocal laser scanning microscope (CLSM) (Carl Zeiss, Inc.) and the Axiovision software 
(Carl Zeiss, Inc.).  Images for cell counts were acquired using a Zeiss LSM camera (Carl Zeiss, 
Inc.).  The imageJ program
 
(Abràmoff et al., 2004) was used to prepare images for counting. 
Images were calibrated using a digital scale using the line selection tool and the command 
(Analyze > Set scale). Background corrections were made and converted into 8bit single 
colour images (Image > Colour > Split Channels) which split the image in the 3 channels, the 
blue was discarded. The bacteria were quantified using the image analysis software, CellC 
(Selinummi et al., 2005; Tempere University of Technology, 2012) and MatLab software (The 
Mathworks, Natick, MA, USA). This program counts particles on the basis of their relative 
fluorescent density compared with the background via thresholding, size discrimination and a 
cluster division algorithm. The relative proportion and absolute cell number of the viable 
(green) and dead (red) microbiota was then calculated taking into account dilutions.  
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6.2.4. Chemical analysis 
Estrogen standards (>98 % purity) were purchased from Sigma Aldrich (Dorset, UK).  
Deuterated internal standards; estrone-2,4,16,16-d4, 17β-estradiol-2,4,16,16,17-d5, estriol-
2,4,17-d3 and 17α-ethynylestradiol-2,4,16,16-d4 were obtained from QMX Laboratories 
(Thaxted, UK).  The HPLC grade solvents; methanol, dichloromethane, ethylacetate and 
hexane were purchased from Rathburn Chemicals (Walkerburn, UK).  Ammonium hydroxide 
was ACS grade and obtained from Sigma Aldrich (Dorset, UK).  Chemical oxygen demand, 
NH4
+
-N and NO3
-
 were determined using proprietary cell test kits purchased from VWR 
International (Leicestershire, UK).  Steroid estrogen determination involved a three stage 
extraction and clean up procedure for determination in aqueous and particulate phases of 
wastewaters.  Quantification was by ultra-performance liquid chromatography (Acquity, 
Waters, Manchester, UK) coupled to a Waters Quattro Premier XE triple quadrupole mass 
spectrometer with a Z-spray electro-spray ionisation interface.  Full description of the 
methodology is available in Chapter 3. 
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6.3. RESULTS 
6.3.1. Removal of estrogens at varying SRT 
Total estrogen (∑EST) concentrations in settled sewage were 344 ±26, 344 ±20 and 331 ±9 ng l
-
1 
during the 3, 10 and 27 day SRT sampling campaigns, respectively (Table 6.1).  Variations in 
individual natural estrogen concentrations fluctuated by <10 % between SRT sampling 
campaigns.  Total estrogen removals were 70 ±8 % at a 3 day SRT (Figure 6.1).  During 10 
and 27 day SRTs no significant differences in ∑EST removals were observed.  Removals were 
95 ±1 % and 93 ±2 %, respectively.  Mixed liquor volatile suspended solids (MLVSS) 
concentrations were 972, 1,301 and 1,284 mg l
-1
 over the three studies (Table 6.2).  Despite 
increasing sludge age, the concentration of estrogens in RAS reduced with SRT (Figure 6.1).  
Total estrogen concentrations in RAS were 372, 325 and 227 ng l
-1
 for 3, 10 and 27 day SRTs 
respectively.  Individual estrogens exhibited greater removal with increased SRT except for 
E1.  Removals of E1 were 93 ±4 % and 84 ±4 % for 10 and 27 day SRTs, respectively.  The 
recalcitrant nature of EE2 was confirmed by its comparatively poor removal at all SRTs.  
Removals were 29-30 % for 3 and and 10 day SRTs.  The highest removal (41 %) was 
observed at the longest SRT.   
 
 
 
Figure 6.1. Process diagram inclusive of steroid estrogen mass balance data of varying SRT; 3, 10 
and 27 days (n=7), sampling points (■) 
 
 
3 day SRT   
∑EST 371 μg d
-1
; COD 267 mg l
-1
 NH4
+
-N 44 mg l
-1 
10 day SRT 
∑EST 372 μg d
-1
; COD 256 mg l
-1
 NH4
+
-N 38 mg l
-1 
27 day SRT 
∑EST 357 μg d
-1
; COD 291 mg l
-1
 NH4
+
-N 28 mg l
-1 
 
 
Removal    
3 day SRT  
∑EST 70 %; COD 62 %; NH4
+
-N 6 % 
10 day SRT 
∑EST 95 %; COD 80 %; NH4
+
-N >99 % 
27 day SRT 
∑EST 93 %; COD 82 %; NH4
+
-N >99 % 
 
Q = 1.08 m
3
 d
-
1 
V = 0.36 m
3 
HRT = 8 h 
3 day SRT 
∑EST 223 μg d
-1
   
10 day SRT 
∑EST 195 μg d
-1  
27 day SRT 
∑EST 136 μg d
-1 
3 day SRT   
∑EST 111 μg d
-1
; COD 101 mg l
-1
 NH4
+
-N 41 mg l
-1 
10 day SRT 
∑EST 19 μg d-1; COD 52 mg l-1 NH4+-N <1 mg l-1 
27 day SRT 
∑EST 26 μg d-1; COD 51 mg l-1 NH4
+
-N <1 mg l
-1 
 
Q = 0.59 m
3
 d
-
1 
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Table 6.1. Steroid estrogen sorption and biodegradation information from pilot plant and batch studies  
Steroid 
estrogen 
SRT (d
-1
) 
Pilot plant studies (continuous flow) Sorption batch studies Biodegradation batch studies 
Settled sewage 
(ng l
-1
) 
RAS log Kd  
Final effluent 
(ng l
-1
) 
Total removal
a
 
(%) 
a (ng g
-1
) r
2
 k
b
 (h
-1
) r
2
 
E1 3 91.7 ±14.4 2.3 74.5 ±24.9 19 1.4 x 10
4
 0.97 0.33 0.62 
 10 100.5 ±12.2 2.3 7.1 ±2.7 93 3.3 x 10
4
 0.91 0.51 0.95 
 27 94.0 ±13.5 2.4 14.8 ±2.8 84 1.3 x 10
4
 0.88 0.43 0.85 
E2 3 30.1 ±4.8 2.7 9.7 ±2.9 68 3.3 x 10
4
 0.97 0.26 0.76 
 10 28.5 ±7.9 3.0 2.9 ±1.1 90 3.3 x 10
4
 0.86 0.53 0.71 
 27 30.4 ±6.2 3.7 2.4 ±0.8 92 2.0 x 10
5
 0.97 0.45 0.99 
E3 3 220.1 ±24.6 2.7 17.0 ±4.6 92 63 0.59 1.01 0.98 
 10 214.4 ±32.9 3.6 6.8 ±1.7 97 280 0.92 0.99 0.99 
 27 205.0 ±11.5 3.5 6.2 ±3.1 97 430 0.94 1.05 0.98 
EE2 3 1.8 ±1.2 4.4 1.3 ±0.8 30 5.0 x 10
4
 0.92 0.10 0.73 
 10 0.9 ±0.8 3.9 0.7 ±0.5 29 3.3 x 10
4
 0.86 0.09 0.96 
 27 1.5 ±0.9 4.0 0.9 ±0.6 41 2.5 x 10
5
 0.77 0.06 0.91 
a
Removal = (settled sewage-final effluent)/settled sewage x 100 % 
b
Biodegradation rate constant calculated for initial 8 hour period 
 
Key: SRT, solids retention time; RAS, return activated sludge; a, maximum achievable surface concentration of a given estrogen; k, biodegradation rate constant 
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Table 6.2. Physico-chemical biomass characteristics at varying SRT: 3, 10 and 27 days  
Physico-chemical 
property 
Biomass Soluble micro-products Extracellular polymeric substance 
3 day SRT 10 day SRT 27 day SRT 3 day SRT 10 day SRT 27 day SRT 3 day SRT 10 day SRT 27 day SRT 
Protein (mg gVSS
-1
) - - - 41.0 48.7 16.6 202.1 196.9 157.8 
Carbohydrate (mg gVSS
-1
) - - - 21.4 23.7 12.7 28.9 46.3 43.2 
P + C (mg gVSS
-1
) - - - 62.4 72.4 29.3 231.0 243.2 201.0 
P: C - - - 1.9 2.1 1.3 7.0 4.3 3.7 
COD (mg gVSS
-1
) - - - 72.4 29.5 21.6 438.2 387.0 315.3 
Zeta potential (mV) -12.7 -12.2 -10.8 -8.7 -9.4 -6.1 -25.2 -18.2 -18.4 
pH 8.0 7.0 7.4 - - - - - - 
Temperature (°C) 13.1 17.3 10.8 - - - - - - 
MLVSS (mg l
-1
) 972 1,301 1,284 - - - - - - 
d10 (µm) 79 74 52 - - - - - - 
d50 (µm) 358 274 164 - - - - - - 
d90 (µm) 1,163 692 408 - - - - - - 
SSVI (ml g
-1
) 217 84 105 - - - - - - 
Key: P, protein; C, carbohydrate; COD, chemical oxygen demand; MLVSS, mixed liquor volatile suspended solids; d10, 10 % of particles lie below this diameter; d50, median 
diameter; d90, 90 % of particles lie below this diameter; SSVI, stirred sludge volume index 
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6.3.2. Function of SRT upon estrogen sorption and biodegradation 
Activated sludge sorption capacity of varying SRT was determined in batch at normalised 
suspended solids concentrations.  Equilibrium for all estrogens was achieved within 30 
minutes of spiking.  Estrogen sorption conformed well to log Kow following EE2>E2>E1>E3 
(Table 6.1).  Sorption of those more hydrophilic estrogens was relatively unaffected by SRT.  
However, sorption of the more hydrophobic estrogens (E2 and EE2) was influenced by SRT.  
Sorption of E2 and EE2 to biomass of varying age was 27 day SRT>3 day SRT>10 day SRT.  
The maximum achievable surface concentration (a) for both E2 and EE2 was around an order 
of magnitude greater for the 27 day SRT biomass (Table 6.1).  To demonstrate, EE2 a’s were 
5.0 x 10
4
, 3.3 x 10
4
 and 2.5 x 10
5
 l g
-1
 for 3, 10 and 27 day SRTs.  However, this significantly 
greater sorption was not reflected in improved degradation in biodegradation batch studies.  
In biodegradation batch tests where the F: M ratio was normalised for each SRT, rate of 
biodegradation was E3>E1≥E2>EE2 (Table 6.1).  Biodegradation rate constants (k) of E3 and 
EE2 were unaffected by SRT.  Biodegradation of E3 was comparatively high in all biomasses 
with k’s ~1 h-1 ( r2 0.97-1.00).  In contrast, biodegradation of EE2 was slow and similar at each 
SRT, exhibiting k’s <0.10 h-1 ( r2 0.78-0.99).  Biodegradation rates of E1 and E2 were lowest 
for the 3 day SRT biomass.  In the nitrifying biomasses (10 and 27 day SRTs) biodegradation 
was augmented.   
  
6.3.3. Impact of SRT on sludge morphology and physico-chemical properties 
At 3 days SRT, 6 % NH4
+
-N removals were observed with reasonable COD removals (70 %) 
indicative of a biomass dominated by heterotrophic metabolism (Figure 6.1).  High removal 
of NH4
+
-N (>99 %) was achieved at 10 and 27 day SRTs.  Nevertheless, numbers of viable 
bacterial cells in activated sludge reduced with SRT and was 1.45 x 10
12
, 5.49 x 10
11
 and 4.09 
x 10
11
 counts gVSS
-1 for 3, 10 and 27 day SRTs respectively.  This was used to estimated ∑EST 
biodegradations in pilot plant studies of 499, 1,361 and 1,750 ng∑EST 1 x 10
12
 viable cells
-1
 d
-1
 
 
for 3, 10 and 27 day SRTs respectively (Figure 6.2).  In addition to viable cell number, SRT 
also impacted activated sludge physico-chemical composition.  Concentrations of EPS ranged 
from 438 (3 day SRT) to 315 mg gVSS
-1
 (27 day SRT) (Table 6.2).  Also, total concentrations 
of proteins and carbohydrates extracted from the EPS were 231, 243 and 201 mg gVSS
-1
 for 
3, 10 and 27 day SRTs respectively.  This corresponded with proteins to carbohydrates ratios 
of 7.0, 4.3 and 3.7.  Median activated sludge floc size (d50) was 358, 274 and 164 µm for 3, 10 
and 27 day SRTs, respectively.  No significant differences in charge (zeta potential) were 
observed.  Zeta potential of all biomasses was broadly similar and ranged from -12.7 to -10.8 
mV.    
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Figure 6.2.  Impact of SRT to viable cell numbers in activated sludge and the quantity of total 
estrogens biodegraded per cell 
 
6.3.4. Identification of the site and modus of estrogen biodegradation 
The removal of cellular bound material and intact cells by filtration was used to assess the 
role of free extracellular enzymes in estrogen biodegradation.  Filtration of the biomass 
resulted in the cessation of steroid estrogen biodegradation (Figure 6.3).  Extracellular free 
enzymes present in the biomass medium did not facilitate any estrogen biodegradation.  
Initially, concentrations of total natural estrogens (E1, E2 and E3) and EE2 were 290 ±3 ng l
-1
 
and 94 ±3 ng l
-1
, respectively.  Following 8 hours, concentrations of 296 ±1 ng l
-1
 and 100 ±4 
ng l
-1
 were observed.  In the presence of intact cells, initial concentrations of total natural 
estrogens and EE2 were 338 ±10 ng l
-1
 and 119 ±15 ng l
-1
, respectively.  Concentrations of 29 
±1 ng l
-1
 (natural estrogens) and 74 ±6 ng l
-1
 (EE2) were observed after 8 hours treatment.  
This corresponded with biodegradation rates of 0.28 h
-1
 (r
2
 0.93) for natural estrogens and 
0.06 h
-1
 (r
2
 0.79) for EE2. 
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Figure 6.3. Function of free extracellular enzymes (A+B, □ 1.2 µm filtered biomass, ▲ unfiltered 
control) and oxygenase activity of ammonia oxidising bacteria (C+D, ○ ATU treated, ● non ATU 
treated control) in the biodegradation of E1+E2+E3, and EE2 in batch studies 
 
6.3.5. Evaluation of the role of oxygenase activity during nitrification 
The inhibition of nitrification by ATU was confirmed in the test vessel by the cessation of 
NH4
+
-N removal and NO3
-
 production.  In the control vessel the starting concentration of 
NH4
+
-N (17.6 mg l
-1
) was completely transformed to NO3
-
 within 8 hours.  Heterotrophic 
activity was unaffected by the inhibition of nitrifying activity.  Over an 8 hour period, sCOD 
removals were 61 ±4 % (control) and 64 ±2 % (test) of the starting concentration of 95 mg l
-1
.  
Natural estrogen k’s were 0.53 h-1 (r2 0.94) and 0.53 h-1 (r2 0.94) in nitrifying biomass 
(control) and biomass treated with ATU (test), respectively (Figure 6.3).  Biodegradation of 
EE2 was considerably slower with k’s of 0.07 h-1 (r2 0.91) and 0.07 h-1 (r2 0.95).  No 
differences were observed for natural estrogens or EE2 biodegradation between control and 
test vessels.   
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6.4. DISCUSSION 
Pilot-scale ASP operation at constant volumetric loading enabled the impact of SRT on 
estrogen removal to be evaluated.  At a short SRT of 3 days, 70 % ∑EST biodegradation was 
achieved.  This is consistent with previous observations of a full-scale ASP operated at a short 
SRT to enable oxidation of organics rather than to support nitrification (McAdam et al., 
2010).  However, in this study the removal of natural estrogens E1 and E2 was lower at the 
short SRT.  Increasing SRT to 10 days facilitated NH4
+
-N removal and a concomitant increase 
in E1 and E2 removal specifically (Figure 6.1, Table 6.1).  Despite increasing mixed liquor 
concentrations typical of lengthening SRT, sludge sorption was not responsible for greater 
removal here.  To demonstrate, the quantity of ∑EST associated with RAS reduced with 
increased SRT.  This was supported by sorption batch studies where no significant 
improvement in estrogen sorption was observed (Table 6.1).  If sorption was driving 
increased removal at the 10 day SRT condition, an accumulation of sludge bound estrogens 
would be expected.  These findings support those of Andersen et al (2005) which estimated 
<2 % of ∑EST to be removed in excess sludge if an equilibrium exists.  Thus, it can be 
postulated that biodegradation is the key mechanism for improved removal of natural 
estrogens E1 and E2 removal here.  This was corroborated by the enhanced biodegradation 
rates observed in batch studies at 10 days SRT (Table 6.1).  The coincident initiation of NH4
+
-
N removal at 10 days SRT infers nitrifier activity may be responsible for augmented natural 
estrogen biodegradation.  However, investigation into the governance of free extracellular 
activity on estrogen removal indicated that free enzymes play no role in the biodegradation of 
estrogens (Figure 6.3).  This suggests contact with activated sludge flocs was required for 
estrogen biodegradation.  Biodegradation was either mediated by extracellular enzymes 
outside the bacterial cell but still contained within the floc (i.e., within EPS) and/or 
intracellular enzymes within viable bacterial cells.  However, findings suggest that these are 
not nitrifiers as the inhibition of NH4
+
-N oxidation had no impact to estrogen biodegradation.  
Furthermore, it can be deduced that enzymatic reactions which follow NH4
+
-N oxidation (i.e., 
nitrite oxidation) do not contribute to estrogen biodegradation either.  These findings are 
consistent with other investigations operated with synthetic sewage testing the role of 
nitrifiers in batch
 
(Gaulke
 
et al., 2008) and continuous flow systems (Bagnall et al., 2012).  
These studies postulated that heterotrophic bacteria were responsible for estrogen 
biodegradation.   
In this study, viable cell quantitation revealed that cell specific estrogen biodegradation 
increased with SRT (Figure 6.2).  This indicated an improvement in the efficiency of either 
the same group, or a more responsive group of bacteria.  Larcher and Yargeau
 
(2013) 
demonstrated that different strains of heterotrophs commonly found in activated sludge varied 
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in their efficacy of EE2 removal.  Thus a shift in their relative abundance and their absolute 
numbers could explain increased cell specific biodegradation.  Such a shift may be induced by 
process operation.  For example, lengthening SRT provides conditions considered conducive 
to competitive exclusion (Saikaly and Oerther, 2004).  It is postulated that increasing biomass 
age enabled bacteria more capable of non-favoured carbon source utilisation (e.g., estrogens) 
to prosper.  This would explain increasing cell specific biodegradation with SRT.   
Collated full-scale data by Clara et al (2005) and McAdam et al (2010) suggested that ∑EST 
removal may continue to increase with SRT beyond 10 days.  To assess this, control at a SRT 
of 27 days was undertaken to encompass a broad range of typical full-scale operations.  At 27 
days SRT, removal of ∑EST showed no not further improvement and was 93 ±2 % (Figure 
6.1).  Nevertheless, the quantity of estrogen biodegraded per bacterial cell continued to 
increase as viable cell numbers further reduced.  At an SRT of 27 days evidence suggests this 
may be due to improved transport to viable cells within activated sludge.  This hypothesis is 
attributed to changes observed in the physico-chemical composition of biomass induced by 
increasing SRT (Figure 6.2).  For example, the 27 day SRT biomass had the smallest median 
floc size.  This results in shorter distances between bacteria and the floc surface suggesting 
shorter distances within the floc to be overcome by diffusion (Joss et al., 2004).  Furthermore, 
EPS concentration reduced with SRT (Table 6.2).  It has been suggested that EPS can behave 
as a selective barrier towards substrate diffusion, thereby limiting specific substrates to active 
bacteria (Lieleg and Ribbeck, 2011).  Therefore it can be postulated that at lower EPS 
concentrations there is less restricted passage of estrogens to viable bacterial cells for 
biodegradation.  Despite no increase in ∑EST removal in pilot studies, individually E2 and EE2 
did show a moderate improvement in removal (Table 6.1).  Biodegradation batch studies 
showed no increase in absolute biological removal between 10 and 27 day SRTs.  However, 
batch sorption studies exhibited significantly greater sorption capacity of the 27 day SRT 
biomass for E2 and EE2 (Table 6.1).  The smallest floc size observed here results in a greater 
total surface area for sorption to occur.  Nevertheless, enhanced sorption was not reflected in 
the pilot study as estrogen concentrations in RAS did not increase.  This is owed to the 
receiving concentrations of estrogens in this study.  The enhanced sorption capacity of a high 
SRT biomass is likely to be appreciable for sites where the estrogen composition of receiving 
sewage is greater.  For example, Clara et al (2005) reported mean receiving EE2 
concentrations up to 70 ng l
-1
.  Such concentrations are significantly greater than those 
observed in this study (~70 times) and are more likely to challenge the system.  Interestingly, 
>98 % removal was observed for a receiving EE2 concentration of 70 ng l
-1
 at an SRT of 48 
days (Clara et al., 2005).  Operation at a high SRT may therefore be beneficial for sites which 
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receive comparatively higher concentrations of the more hydrophobic estrogens E2 and EE2 
due to the enhanced sorption potential of the biomass. 
 
6.5. CONCLUSION 
 
Solids retention time was critical for steroid estrogen removal as it influenced biodegradation 
and sorption mechanisms.  Operation at a mid-ranged SRT was beneficial as it augmented 
biodegradation of the natural estrogens E1 and E2.  The synthetic estrogen EE2 was relatively 
resistant to removal at all SRTs studied.  However, the high sorption capacity of the high SRT 
(27 days) biomass may be beneficial to sites receiving comparatively higher concentrations of 
EE2.    
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Bruce Petrie, Ewan J. McAdam, John N. Lester, Elise Cartmell 
Cranfield Water Science Institute, Cranfield University, Bedfordshire, MK43 0AL 
 
Abstract  
It is proposed that wastewater treatment facilities meet legislated discharge limits for a range 
of hazardous chemicals. However, the heterogeneity of these hazardous chemicals in 
receiving wastewaters make separation efficiency difficult to predict since their chemistry is 
so diverse. In this study, a range of organic and inorganic hazardous chemicals that are known 
to be preferentially removed via different separation mechanisms were therefore selected to 
challenge the activated sludge process (ASP) and determine its potential to achieve 
simultaneous hazardous chemical removal. At a fixed hydraulic retention time (HRT) of 8 
hours, the influence of an increase in solids retention time (SRT) on removal was evaluated. 
Maximum achievable hazardous chemical removal was recorded for all chemicals (estrogen, 
nonlphenolics, metals) at the highest SRT studied (27 days). However, optimisation of HRT 
by extension to 24 hours further augmented organic biodegradation. Most notable was the 
enhancement in removal of the considerably recalcitrant synthetic estrogen 17α-
ethinylestradiol which increased to 65 ±19 %. Regression analysis indicates that this 
enhanced hazardous chemical behaviour is ostensibly related to the concomitant reduction in 
food: microorganism ratio. Interestingly, extended HRT also initiated nonylphenol 
biodegradation which has not been consistently observed previously in real wastewaters. 
However, extending HRT increased the solubilisation of particulate bound metals. This is 
significant as only the dissolved metal fraction is to be considered for environmental 
compliance. Consequently, identification of an optimum process condition for generic 
hazardous chemical removal is expected to favour a more integrated approach where, for 
example, the improvement of primary sedimentation is demanded to reduce loading of the 
particle bound metal fraction onto the ASP, thereby enabling longer HRT in the ASP to be 
considered. 
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7.1. INTRODUCTION 
Current operations of secondary wastewater treatment works (WwTWs) do not enable 
compliance to Environmental Quality Standards (EQSs) and proposed legislative targets for a 
wide variety of hazardous chemicals (Gardner et al., 2012).  However, the environmental and 
economic cost of implementing and operating advanced processes underpins the need to 
optimise these secondary processes (Jones et al., 2007a).  Activated sludge is a widely used 
secondary process with a proven ability to remove a variety of hazardous chemicals (Clara et 
al., 2005; Kreuzinger et al., 2005; Koh et al., 2009; McAdam et al., 2010; McAdam et al., 
2011).  Hazardous chemical removal by activated sludge can be attributed mostly to sorption 
and biodegradation mechanisms (Langford et al., 2005; Radjenovic et al., 2009b; Petrie et al., 
submitted).  Radjenovic et al (2009b) gave an excellent account of sorption and 
biodegradation behaviour for a variety of pharmaceuticals during full-scale activated sludge 
treatment.  Measuring removal performance and process optimisation is needed on hazardous 
chemicals exhibiting extremities of propensity to these mechanisms.  Natural and synthetic 
steroid estrogens, nonylphenolic surfactants (NPx) and metals encompass such diversity.  
These are describable as biodegradable and refractory organics (Petrie et al., submitted; Petrie 
et al., 2013a) and non-biodegradable inorganics (Santos et al., 2010), respectively.  These 
exhibit a broad range of physico-chemical properties (Table 7.1) which contributes to their 
differing fate and behaviour during wastewater treatment.  For example, hydrophobicity (log 
Kow) can be used as a reasonable predictor for sorption behaviour of estrogens (Petrie et al., 
submitted).  Nevertheless, biodegradation is accepted as their major removal pathway 
(Andersen et al., 2005).  The removal of NPx is more complex as this family of chemicals 
possess a variety of physico-chemical properties and breakdown pathways.  The relatively 
hydrophilic long chained NPx’s are highly susceptible to biological attack (McAdam et al., 
2011).  However, their biotransformation can result in the formation of shorter chained 
ethoxylates and NP (Petrie et al., 2013a).  These chemicals have log Kow’s >5 (Table 7.1) and 
a relatively high propensity to sludge partitioning is expected (Byrns, 2001).  In contrast, 
metals rely entirely on partitioning within the activated sludge matrix for removal.  This is 
considered to be driven by three major processes which are; physical entrapment of insoluble 
metals, binding of soluble metals to bacterial walls and extracellular polymers, and active 
cellular uptake by bacterial cells (Ziolko et al., 2011).   
Hazardous chemical removal is considered to be influenced by activated sludge process 
variables, solids retention time (SRT) and hydraulic retention time (HRT) (Svenson et al., 
2003; Johnson et al., 2005; Hamid and Eskicioglu, 2012; Maeng et al., 2013).  Despite a large 
volume of research undertaken on this subject area, it remains unclear whether operation can 
be optimised to achieve maximum removals of all hazardous chemicals simultaneously.  To 
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illustrate, an extended SRT (≥10 days) is considered necessary to augment removal of those 
biodegradable hazardous chemicals (Kreuzinger et al., 2005; Clara et al., 2005; McAdam et 
al., 2010).  This is thought to enable the enrichment of a more diverse bacterial community 
more capable of organic hazardous chemical biodegradation (Kreuzinger et al., 2005).   
However, such conditions are hypothesised to be detrimental to metals removal (Santos et al., 
2010).  It is anticipated that metals are solubilised by chelators produced by biomasses at 
SRTs >10 days and are therefore not available for removal within the activated sludge matrix 
(Santos et al., 2010).  Furthermore, there is a paucity of information on the impact of HRT to 
hazardous chemical removal.  It can be postulated that longer HRTs (and contact time) enable 
greater biodegradation of the organic hazardous chemicals.  Previous research in this field has 
traditionally focussed on the broad comparison of different full-scale activated sludge plants 
(ASPs) operating at various SRT and HRTs (Svenson et al., 2003; Clara et al., 2005; Johnson 
et al., 2005; Kreuzinger et al., 2005; Koh et al., 2009; McAdam et al., 2010; McAdam et al., 
2011).  However, full-scale processes tend to suffer from poor process control resulting in a 
dynamic system and considerable variations in both SRT and HRT.  To demonstrate, a full-
scale ASP designed to be operated at a 10 day SRT 8 hour HRT saw considerable variations 
in flow (50 to 600 m
3
 h
-1
) and therefore HRT over an eight week period (Aboobakar et al., 
2013) which based on a simple solids mass balance, implies and estimated SRT range of 
between 4 and 20 days.  Consequently, understanding the impact of process variables at full-
scale to hazardous chemical removal is challenging.  In this study, a pilot-scale ASP was 
operated to enable good process control and circumvent variations in receiving sewage 
composition and flow.  This enabled SRT and HRT to be de-coupled from one another and 
their individual impact to hazardous chemical removal assessed.  The pilot-scale ASP was 
operated at: (i) 3, 10 and 27 day SRTs whilst at a constant HRT (8 hours) and (ii) 8, 16 and 24 
hour HRTs at a constant SRT (27 days).  To measure ASP resilience for the removal of a 
wide range of hazardous chemicals of varied chemistry and preferred removal mechanisms 
under a range of operation conditions - steroid estrogens, NPx’s and metals were monitored.  
To our knowledge this is the first study which has closely controlled ASP operation and 
measured the impact to the removal of such a diverse range of chemicals simultaneously in 
municipal wastewater. 
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Table 7.1.  Physico-chemical properties of hazardous chemicals found in wastewaters (EPI Suite, 2013) 
Chemical of 
interest 
Organic chemical 
structure/metal 
electron configuration 
EQS/proposed 
legislative 
target (µg l
-1
) 
Molecular 
weight 
(g mol
-1
) 
Water 
solubility 
(mg l
-1
) 
pKa 
Vapour pressure 
(kPa) 
Henry’s law constant 
(atm m
3
 mol
-1
) 
Density 
(g cm
-3
) 
log Kow log Koc 
Estrone (E1) 
 
3.0 x 10
-3a
 270.37 30.0 10.50
c
 3.00.10
-8
 3.80.10
-10
 - 3.13-3.43 3.02-4.38 
17β-estradiol 
(E2) 
 
4.0 x 10
-4b
 272.39 3.6 10.71
c
 3.00.10
-8
 3.64.10
-11
 - 3.94-4.01 2.90-4.01 
Estriol (E3) 
 
- 288.38 441.0 - 9.00.10
-13
 1.33.10
-12
 - 2.45-2.81 1.62-3.08 
17α-
ethinylestradiol 
(EE2) 
 
3.5 x 10
-5b
 296.40 11.3 10.40
c
 6.00.10
-9
 7.94.10
-12
 - 3.67-4.15 2.71-4.65 
Estrone 
1-3sulfate  
(E1-3S) 
 
- 350.43 960.0 - 1.97.10
-11
 2.04.10
-12
 - 0.95 1.81 
OH
O
CH3
OH
OH
CH3
OH
OH
CH3
OH
OH
OH
CH
CH3
O
CH3
S
O
O
OH
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Nonylphenol 
(NP)  
0.3
d
 220.35 7.6 10.28
e
 4.39.10
-5
 4.30.10
-6
 0.95
e
 5.77 4.28 
Nonylphenol 
mono, di and tri-
ethoxylate  
(NP1-3EO) 
 
- 
264.41-
352.52 
0.5-1.8 - 2.38.10
-8
-5.24.10
-11
 1.25.10
-6
-5.73.10
-12
 - 5.03-5.58 4.28 
Nonylphenol 
polyethoxylates 
(NP4-12EO) 
R
O
O
OH
y
 
- 
396.57-
749.00 
3.3-248 - 3.04.10
-12
-5.43.10
-20
 1.23.10
-14
-5.35.10
-36
 - 2.56-4.75 1.35-3.17 
Nonylphenol 
carboxylates 
(NP1-3EC) 
 
- 
278.39-
366.50 
0.3-1.0 - 1.31.10
-6
-1.80.10
-10
 1.79.10
-7
-4.31.10
-11
 - 5.26-5.80 2.94-3.42 
Zinc (Zn) 
 
8-125
g
 65.39 3.4 x 10
5
 - - - 7.15
f
 - - 
Copper (Cu) 
 
1-28
g
 63.55 4.2 x 10
5
 - - - 8.90
f
 - - 
Lead (Pb) 
 
1.2
d
 207.20 9.6 x 10
3
 - - - 11.34
f
 - - 
R
OH
R
O
O
OH
x
R
O
O
O
OH
z
117 
 
Cadmium (Cd) 
 
0.08-0.25
d
 112.41 1.2 x 10
5
 - - - 8.70
f
 - - 
Nickel (Ni) 
 
4.0
d
 58.69 4.2 x 10
5
 - - - 8.90
f
 - - 
a
Environment Agency of England and Wales, 2000 
b
European Commission, 2012
 c
Liu et al., 2009 
d
European Commission, 2008
 e
Soares et al., 2008
 f
Lenntech, 2013 g Ziolko et al., 2011 
Key: EQS, environmental quality standard; pKa, acid dissociation constant; log Kow, octanol-water coefficient; log Koc, organic carbon-water coefficient 
0-50 mg l
-1
 calcium carbonate 
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7.2. MATERIALS AND METHODS 
7.2.1. Chemicals 
Estrogen standards (>98 % purity); estrone (E1), 17β-estradiol (E2), estriol (E3), 17α-
ethinylestradiol (EE2) and estrone sulphate (E1-3S) were purchased from Sigma Aldrich 
(Dorset, UK).  Deuterated internal standards; estrone-2,4,16,16-d4, 17β-estradiol-
2,4,16,16,17-d5, estriol-2,4,17-d3, 17α-ethinylestradiol-2,4,16,16-d4 and sodium estrone-
2,4,16,16-d4 sulfate were obtained from QMX Laboratories (Thaxted, UK).  Technical 4-NP, 
4-nonylphenol-monoethoxylate (NP1EO), the diethoxylate compound (NP2EO) and the long 
chain NPEOs were purchased from Sigma Aldrich (Dorset, UK).  Long chain NPEOs were 
purchased as the technical mixtures CO210, CO520 and CO720.  Nonyl-phenoxy acetic acid 
(NP1EC) was obtained from QMX laboratories (Thaxted, UK).  Single element metal 
solutions; zinc (Zn), copper (Cu), lead (Pb), nickel (Ni), cadmium (Cd) and rhodium (internal 
standard), and OPTIMA trace metal grade nitric acid were obtained from Fisher Scientific 
(Leicestershire, UK).  The high performance liquid chromatography grade solvents; acetone, 
methanol, dichloromethane, ethylacetate and hexane were purchased from Rathburn 
Chemicals (Walkerburn, UK).  Ammonium hydroxide was ACS grade and obtained from 
Sigma Aldrich (Dorset, UK) and ultrapure water of 18.2 MΩ quality (Elga, Marlow, UK) was 
used in the preparation of mobile phases. Chemical oxygen demand (COD), ammoniacal 
nitrogen, nitrate, nitrite and total nitrogen proprietary cell test kits were purchased from VWR 
International (Leicestershire, UK). 
 
7.2.2. Pilot plant operation 
A pilot-scale ASP was sited at a WwTWs in the east of England (3,000 population 
equivalent) and consisted of a 0.18 m
3
 primary sedimentation tank, a 0.36 m
3
 aerated basin 
and a 0.10 m
3
 final clarifier (Petrie et al., submitted).  The plant was seeded with biomass 
from a full-scale ASP (280,000 population equivalent) and operated with municipal crude 
sewage containing indigenous concentrations of all hazardous chemicals.  The influent flow 
rate was controlled to achieve a constant HRT.  Return activated sludge (RAS) was 0.55 of 
the influent flow in all studies.  Solids retention time was controlled by daily wastage of 
sludge following correction for loss of effluent suspended solids.  The system was operated 
for at least three SRTs prior to monitoring at each different condition to ensure a steady state 
environmental was established. Once under steady state conditions sampling was undertaken 
over seven consecutive days for the determination of all hazardous chemicals and sanitary 
determinands at all ASP operations.  The impact of SRT was investigated by maintaining a 
constant 8 hour HRT of the secondary treatment stage.  Solid retention times of 3, 10 and 27 
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days were assessed.  In HRT studies the SRT was maintained at 27 days and HRTs of 8, 16 
and 24 hours examined.   
 
7.2.3. Sanitary determinand analysis 
Chemical oxygen demand, soluble COD, ammoniacal nitrogen, nitrate, nitrite and total 
nitrogen were determined using proprietary cell test kits (VWR International, Leicestershire, 
UK) and subsequent detection by spectrophotometry.  The soluble fraction of wastewater was 
obtained by filtration through a 1.2 µm filter (Whatman, Maidstone, UK).  Suspended solids, 
volatile suspended solids (VSS) and biochemical oxygen demand (BOD) were determined 
using standard methods (APHA, 1998).  Biomass of each operational condition were 
characterised by separating extracellular polymeric substance (EPS) and soluble micro 
products (SMP) fractions (Le-Clech et al., 2006).  Briefly, 50 ml of biomass was centrifuged 
at 1,500 x g for 5 minutes and the supernatant filtered (0.2 μm) to obtain the SMP fraction.  
The solid fraction was re-suspended in 50 ml of deionised water and placed in an oven at 105 
°C for one hour.  The extracted EPS was obtained by allowing the sample to cool to room 
temperature, centrifuging at 1,500 x g for 5 minutes and filtering (0.2 μm).  Protein and 
carbohydrate concentrations were quantiﬁed using the phenol–sulphuric acid method (Zhang 
et al., 1999) and modiﬁed Lowry method (Frølund et al., 1995) respectively.  Charge (as zeta 
potential) was determined using a Zetasizer 2000 (Malvern Instruments LTD, Worcestershire, 
UK) whereas activated sludge floc size was measured using a Mastersizer 2000 (Malvern 
Instruments LTD, Worcestershire, UK).  Further details of biomass characterisations can be 
found in Chapter 6. 
 
7.2.4. Hazardous chemical analysis 
Steroid estrogen analysis involved a three stage extraction and clean up procedure with 
analysis by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-
MS/MS) as previously described in Chapter 3.  Nonylphenolic analysis utilised a single stage 
solid phase extraction and quantitation by UPLC-MS/MS which has been detailed in Chapter 
4.  Sample preparation for metals analysis was similar to that reported by Santos et al (2010).  
Glass and plastic ware used for collection, storage, filtering and digestion of samples was 
soaked for a minimum of 24 hour in an aqueous 2.5 % v/v Decon 90 solution (Fisher 
Scientific, Loughborough, UK) and then rinsed with UP water three times. Subsequently they 
were soaked for a minimum of 24 hours in 2.5 % v/v OPTIMA trace metal grade nitric acid.  
Glass and plastic ware was then rinsed a minimum of five times with UP water before being 
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air dried.  Total metal analysis was achieved by acid digestion.  Samples for total metal 
analysis should contain a maximum of 100 mg of solids; if samples contained more than 100 
mg of solids, dilution with acidified ultrapure water was used to reduce the solids content to 
≤100 mg (Santos et al., 2010).  Samples (30 mL) were placed in digestion tubes and acidified 
with 1.5 mL OPTIMA trace metal grade nitric acid.  The samples were digested using a 
MARS Xpress microwave digester (CEM Microwave Technology, Buckingham, UK) using 
sample dissolution EPA method 3015 (US EPA, 2007).  The samples were then transferred to 
10 mL centrifuge tubes for analysis and spiked with the internal standard rhodium to achieve 
a concentration of 50 µg l
-1
.  All samples were analysed in duplicate and selected samples 
were spiked at low (20 µg l
-1
) and high (100 µg l
-1
) concentrations to determine recoveries.  
For dissolved metal analysis, each sample was vacuum-filtered through a Millipore all-glass 
three piece vacuum filtering set (Millipore, Cambridge, UK) using a 0.45 μm pore size 
cellulose nitrate membrane filter (Anachem Ltd, Luton, Bedfordshire, UK).  A 10 mL aliquot 
of the sample filtrate was then placed in a 10 mL centrifuge tube and acidified with 0.75 ml 
OPTIMA trace metal grade nitric acid and internal standard added.  All samples were then 
refrigerated at 4 °C prior to analysis.  Samples were then analysed by an ELAN 9,000 
inductively coupled plasma-mass spectrometer (Perkin Elmer, Beaconsfield, UK).  The RF 
power was 1 kW with a nebuliser flow rate: 0.77 l min
-1
.  Plasma, auxiliary gas and sheath gas 
flow rates were all automatically controlled.  The sample cone had a 1.1 mm diameter orifice 
and the skimmer cone with a 0.9 mm diameter orifice.  The dwell time was 50ms/AMU and 
scan mode was peak hopping.  The samples were determined in “dual detector mode” and 
“steady state mode” to introduce the sample continuously.  Metal MDLs ranged from 0.10 to 
0.54 µg l
-1
.     
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7.3. RESULTS 
7.3.1. Impact of solids retention time on hazardous chemical removal 
Removal of total estrogens (∑EST) at the 3 day SRT condition (8 hour HRT) was 70 ±7 % 
(Figure 7.1).  Increased SRT (i.e., 10 or 27 days) was needed to achieve augmented removals.  
However, no improvement in ∑EST removal was observed when SRT was increased from 10 
to 27 days.  Removal of ∑EST was 94 ±1% and 90 ±2 % respectively.  These higher ∑EST 
removals here were driven by improved natural estrogen (E1, E2 and E3) removals (Table 
7.2).  Removal of total nonylphenolic chemicals (∑NPx) was comparatively lower with the 
greatest being 37 ±5 % (Figure 7.1) which was achieved at the 27 day SRT condition.  All 
ASP operations initiated NPEO chain shortening with removals of NP4-12EO ≥79 % for all 
SRTs studied (Table 7.2).  This resulted in a substantial accumulation of NP1-3EC.  The 
lowest production of NP1-3EC was achieved at a SRT of 27 days and was -212 ±98 %.  
However, no net removal of the daughter chemical NP was observed with removals ranging 
from -6 to -39 %.  The concentrations of both ∑EST and ∑NPx in RAS (aqueous and particulate 
fractions) reduced with increasing SRT (Figure 7.1).  This included those individual 
chemicals which are relatively hydrophobic in nature (log Kow’s > 3.5 - E2, EE2, NP, NP1-
3EO, NP1-3EC Table 7.1).  In contrast to the organic hazardous chemicals, total metal 
(∑METAL) removals increased moderately with each SRT increase.  Removals were 34 ±19, 51 
±10 and 59 ±11 % for 3, 10 and 27 day SRTs respectively (Figure 7.1).  Improving removal 
was reflected in increasing concentrations observed in the particulate fraction of RAS for the 
three SRTs.  Specifically, Cu removals were improved by increasing SRT and were 38 ±15, 
53 ±9 and 82 ±4 % (Table 7.2).  However, metal concentrations in the dissolved fraction of 
wastewater increased during treatment (Table 7.2).  Nevertheless, the lowest dissolved 
∑METAL concentration was observed for the 27 days SRT final effluent and was 34 ±8 µg l
-1
.  
The concentrations of mixed liquor volatile suspended solids (MLVSS) concentrations were 
972 ±100, 1,301 ±305 and 1,284 ±71 mg l
-1
 for 3, 10 and 27 day SRTs, respectively (Table 
7.3).  Also, in terms of biomass physiology both median activated sludge floc size and EPS 
concentration reduced with increased SRT (Table 7.4).  
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∑EST 1.40 µmol m
-3 
∑NPx 62 µmol m
-3 
∑METAL 17,725 µmol m
-3 
  
∑EST 1.28 µmol m
-3 
∑NPx 22 µmol m
-3 
∑METAL 1,869 µmol m
-3 
 
Q = 1.08 m3 d-1 
SRT = 3 days 
HRT = 8 hours 
Q = 0.60 m3 d-1 
  
∑EST 0.39 µmol m
-3 
∑NPx 19 µmol m
-3 
∑METAL 1,179 µmol m
-3 
 
Temp. 13 °C 
Secondary Removal 
∑EST 70 %
 
∑NPx 11 %
 
∑METAL 37 %
 
 
(A) 
Q = 1.08 m3 d-1 
  
∑EST 1.29 µmol m
-3 
∑NPx 18 µmol m
-3 
∑METAL 1,933 µmol m
-3 
 
SRT = 10 days 
HRT = 8 hours 
Q = 0.60 m3 d-1 
  
∑EST 0.07 µmol m
-3 
∑NPx 19 µmol m
-3 
∑METAL 948 µmol m
-3 
 
  
∑EST 1.27 µmol m
-3 
∑NPx 55 µmol m
-3 
∑METAL 47,149 µmol m
-3 
 
Temp. 17 °C 
Secondary Removal 
∑EST 94 %
 
∑NPx -4 %
 
∑METAL 51 %
 
 
(B) 
Q = 1.08 m3 d-1 
  
∑EST 1.29 µmol m
-3 
∑NPx 22 µmol m
-3 
∑METAL 1,700 µmol m
-3 
 
SRT = 27 days 
HRT = 8 hours 
Q = 0.60 m3 d-1 
  
∑EST 0.13 µmol m
-3 
∑NPx 14 µmol m
-3 
∑METAL 691 µmol m
-3 
  
∑EST 0.89 µmol m
-3 
∑NPx 26 µmol m
-3 
∑METAL 77,836 µmol m
-3 
 
Temp. 11 °C 
Secondary Removal 
∑EST 90 %
 
∑NPx 37 %
 
∑METAL 59 %
 
 
(C) 
Q = 0.54 m3 d-1 
  
∑EST 1.39 µmol m
-3 
∑NPx 17 µmol m
-3 
∑METAL 1,062 µmol m
-3 
 
SRT = 27 days 
HRT = 16 hours 
Q = 0.30 m3 d-1 
  
∑EST 0.10 µmol m
-3 
∑NPx 23 µmol m
-3 
∑METAL 590 µmol m
-3 
  
∑EST 0.95 µmol m
-3 
∑NPx 37 µmol m
-3 
∑METAL 40,000 µmol m
-3 
 
Temp. 15 °C 
Secondary Removal 
∑EST 93 %
 
∑NPx -35 %
 
∑METAL 44 %
 
 
(D) 
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Figure 7.1.  Mass balance data for estrogens, NPx and metals at varying operational conditions 
(A, 3 day SRT 8 hour HRT; B, 10 day SRT 8 hour HRT; C, 27 day SRT 8 hour HRT; D, 27 day 
SRT 16 hour HRT; E, 27 day SRT 24 hour HRT; ■, sampling points) 
 
 
Q = 0.36 m3 d-1 
  
∑EST 1.30 µmol m
-3 
∑NPx 18 µmol m
-3 
∑METAL 669 µmol m
-3 
 
SRT = 27 days 
HRT = 24 hours 
Q = 0.20 m3 d-1 
  
∑EST 0.05 µmol m
-3 
∑NPx 33 µmol m
-3 
∑METAL 460 µmol m
-3 
 
  
∑EST 0.51 µmol m
-3 
∑NPx 37 µmol m
-3 
∑METAL 31,930 µmol m
-3 
 
Temp. 6 °C 
Secondary Removal 
∑EST 96 %
 
∑NPx -83 %
 
∑METAL 31 %
 
 
(E) 
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Table 7.2.  Hazardous chemical quantitative information for SRT and HRT pilot plant studies 
Chemical 
of interest 
Crude 
sewage 
conc. (µg l
-1
) 
Crude 
sewage log 
Kd  
SRT 
(days) 
HRT 
(hours) 
Settled 
sewage 
conc. (µg l
-1
) 
Settled 
sewage log 
Kd  
Primary 
removal
a
 
(%) 
RAS conc. 
(µg l
-1
) 
RAS log 
Kd  
Final 
effluent 
conc. (µg l
-1
) 
Final 
effluent log 
Kd  
Secondary 
removal
b
 
(%) 
Zn 91.3 4.29 
3 8 73.1 4.68 
14
d
 
568 3.92 46.3 5.64 37 
10 8 88.5 4.33 1,566 3.89 44.1 3.94 50 
27 8 75.1 4.41 2,856 3.99 38.0 4.07 49 
27 16 41.2 4.65 55 1,074 4.09 27.7 4.01 33 
27 24 25.8 4.46 72 941 4.07 22.1 3.95 14 
Cu 45.8 5.11 
3 8 45.6 5.13 
16
d
 
548 4.72 28.3 4.96 38 
10 8 36.2 5.02 1,389 4.95 16.9 4.99 53 
27 8 34.0 5.14 2,131 4.89 6.2 4.94 82 
27 16 27.0 5.39 41 1,418 4.99 10.3 4.82 62 
27 24 17.1 5.21 63 1,101 4.84 7.5 4.66 56 
Pb 3.6 4.33 
3 8 2.1 4.17 
70
d
 
24.5 4.04 1.5 4.34 31 
10 8 1.0 4.29 79.4 4.46 0.7 4.41 29 
27 8 0.2 - 60.6 4.75 <0.1 - >49 
27 16 0.8 4.28 78 47.3 4.48 0.4 3.81 48 
27 24 0.8 3.72 78 10.8 4.23 0.6 4.07 28 
Cd - - 
3 8 0.2 - 
- 
1.9 3.67 0.1 - 43 
10 8 0.2 - 6.3 4.04 <0.1 - >40 
27 8 0.2 - 6.4 4.05 <0.1 - >48 
27 16 <0.1 - - - - <0.1 - - 
27 24 <0.1 - - - - <0.1 - - 
Ni - - 
3 8 1.3 4.03 
- 
16.1 3.69 1.0 4.16 25 
10 8 0.2 3.92 52.5 4.48 0.2 4.54 15 
27 8 0.8 3.86 46.6 3.51 0.7 4.35 22 
27 16 <0.1 - - - - <0.1 - - 
27 24 <0.1 - - - - <0.1 - - 
E1 - - 
3
c
 8 0.0917 2.43 
- 
0.1903 2.28 0.0745 2.07 19 
10
c
 8 0.1005 2.64 0.1937 2.32 0.0071 3.39 93 
27
c
 8 0.0940 2.35 0.1307 2.38 0.0148 3.00 84 
27 16 0.1017 2.15 - 0.1678 2.46 0.0146 3.17 86 
27 24 0.0737 2.62 - 0.0615 3.63 0.0049 3.21 93 
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E2 - - 
3
c
 8 0.0301 3.20 
- 
0.1058 2.70 0.0097 3.43 68 
10
c
 8 0.0285 3.34 0.0892 3.02 0.0029 3.92 90 
27
c
 8 0.0304 2.99 0.0583 3.70 0.0024 3.54 92 
27 16 0.0407 3.32 - 0.0407 2.91 0.0033 3.43 92 
27 24 0.0417 3.78 - 0.0362 3.62 0.0022 4.08 95 
E3 - - 
3
c
 8 0.2201 1.72 
- 
0.0430 2.65 0.0170 2.62 92 
10
c
 8 0.2144 2.02 0.0220 3.62 0.0068 3.65 97 
27
c
 8 0.2050 1.82 0.0229 3.48 0.0062 3.57 97 
27 16 0.2335 2.43 - 0.0175 3.73 0.0039 2.92 98 
27 24 0.2328 1.45 - 0.0220 3.27 0.0041 2.89 98 
EE2 - - 
3
c
 8 0.0018 4.25 
- 
0.0329 4.42 0.0013 4.57 30 
10
c
 8 0.0009 3.81 0.0203 3.92 0.0007 3.48 29 
27
c
 8 0.0015 4.11 0.0148 4.01 0.0009 4.15 41 
27 16 0.0006 3.82 - 0.0113 4.76 0.0003 4.21 55 
27 24 0.0004 4.54 - 0.0133 4.63 0.0001 4.36 65 
E1-3S - - 
3 8 0.0224 2.20 
- 
0.0183 2.51 0.0047 2.57 79 
10 8 0.0238 1.83 0.0286 2.68 0.0035 2.50 85 
27 8 0.0410 1.57 0.0233 1.99 0.0147 1.88 64 
27 16 0.0197 1.80 - 0.0276 1.86 0.0056 2.34 71 
27 24 0.0242 1.96 - 0.0111 2.52 0.0044 2.65 82 
NP - - 
3 8 1.58 3.70 
- 
2.50 2.81 1.74 3.70 -10 
10 8 1.06 4.01 3.32 3.33 1.38 4.30 -30 
27 8 1.66 3.53 1.59 2.65 1.76 4.15 -6 
27 16 0.25 3.06 - 1.17 1.59 0.07 5.51 70 
27 24 0.63 3.45 - 1.04 2.92 0.24 2.94 63 
NP1-3EC - - 
3 8 0.15 2.83-3.40 
- 
8.54 2.39-3.22 1.32 1.57-2.90 -763 
10 8 0.17 2.80-3.37 6.41 2.50-3.38 2.44 1.71-2.48 -1,416 
27 8 0.18 2.50-2.73 0.36 1.61-2.46 0.55 1.85-2.43 -212 
27 16 3.12 0.99-2.17 - 8.94 2.00-2.71 6.92 1.01-1.58 -128 
27 24 2.53 1.22-2.11 - 9.16 0.85-1.45 10.1 0.83-1.33 -297 
NP1-3EO - - 
3 8 2.53 2.99-3.74 
- 
5.49 2.08-2.96 1.80 2.88-3.19 32 
10 8 2.16 3.77-4.19 5.02 3.55-4.03 1.14 3.88-3.99 49 
27 8 2.10 3.62-3.77 4.94 3.02-3.70 1.03 3.72-4.60 52 
27 16 0.30 1.65-2.96 - 0.02 4.11-4.20 0.02 2.87-3.78 93 
27 24 0.55 1.61-4.00 - 0.41 1.82-3.48 0.02 2.88-3.72 96 
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NP4-12EO - - 
3 8 2.74 3.10-3.69 
- 
2.33 2.58-4.79 0.49 2.94-4.58 79 
10 8 2.68 3.12-4.00 1.77 2.79-4.80 0.27 3.85-4.28 89 
27 8 3.55 2.68-3.27 0.46 2.45-3.38 0.27 3.76-5.16 92 
27 16 2.95 2.68-3.32 - 1.05 4.10-5.84 0.23 4.29-4.95 93 
27 24 3.07 3.28-3.81 - 1.09 2.17-4.31 0.25 3.63-3.95 92 
a
Primary removal (%) = (crude – settled)/crude x 100 bSecondary removal (%) = (settled – effluent)/settled x 100 cPetrie et al., submitted dMean primary removal from 3 
sampling campaigns 
Key: SRT, solids retention time; HRT, hydraulic retention time; RAS, return activated sludge; -, not determined 
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Table 7.3. Physico-chemical properties of activated sludge, and extracted soluble micro-products 
and extracellular polymeric substances of varying SRT and HRT  
Physicochemical 
property 
SRT 
(days) 
HRT 
(hours) 
Activated 
sludge 
Soluble micro-
products 
Extracellular 
polymeric substance 
Protein  
(mg gVSS
-1
) 
3 8
a 
- 41 202 
10 8
a
 - 49 197 
27 8
a
 - 17 158 
27 16 - 13 133 
27 24 - 12 154 
Carbohydrate  
(mg gVSS
-1
) 
3 8
a 
- 21 29 
10 8
a
 - 24 46 
27 8
a
 - 13 43 
27 16 - 10 22 
27 24 - 5 19 
COD  
(mg gVSS
-1
) 
3 8
a 
- 72 438 
10 8
a
 - 30 387 
27 8
a
 - 22 315 
27 16 - 37 333 
27 24 - 38 347 
Zeta potential 
(mV) 
3 8
a 
-13 -9 -25 
10 8
a
 -12 -9 -18 
27 8
a
 -11 -6 -18 
27 16 -16 -9 -16 
27 24 -18 -8 -12 
MLVSS  
(mg gVSS
-1
) 
3 8
a 
972 - - 
10 8
a
 1,301 - - 
27 8
a
 1,284 - - 
27 16 1,067 - - 
27 24 1,125 - - 
d50 
 (μm) 
3 8
a 
358 - - 
10 8
a
 274 - - 
27 8
a
 164 - - 
27 16 369 - - 
27 24 236 - - 
a
Petrie et al., submitted 
Key: SRT, solids retention time; HRT, hydraulic retention time; COD, chemical oxygen demand; 
MLVSS, mixed liquor volatile suspended solids; d50, median floc size 
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Table 7.4.  Sanitary determinand quantitative information for SRT and HRT pilot plant studies  
Sanitary 
determinand 
SRT 
(days) 
HRT 
(hours) 
Settled sewage 
(mg l
-1
) 
Final effluent 
(mg l
-1
) 
Secondary 
removal (%) 
COD 
3 8 266 101 62 
10 8 258 52 80 
27 8 291 51 82 
27 16 252 43 83 
27 24 216 42 81 
sCOD 
3 8 109 42 62 
10 8 76 24 68 
27 8 103 30 71 
27 16 132 29 78 
27 24 103 34 67 
BOD 
3 8 104 27 74 
10 8 100 12 88 
27 8 105 5 96 
27 16 93 5 94 
27 24 59 2 96 
Ammonium 
3 8 44 41 6 
10 8 38 <0.5 >99 
27 8 28 <0.5 >99 
27 16 31 <0.5 >99 
27 24 30 <0.5 >99 
Nitrate 
3 8 <1 <1 - 
10 8 <1 35 <-3,400 
27 8 <1 29 <-2,780 
27 16 <1 34 <-8,425 
27 24 <1 30 <-5,857 
Nitrite 
3 8 <1 6 <-520 
10 8 <1 3 <-230 
27 8 <1 1 <-20 
27 16 5 <1 >79 
27 24 3 <1 >65 
Total nitrogen 
3 8 59 53 10 
10 8 52 47 10 
27 8 44 34 23 
27 16 42 38 9 
27 24 47 40 14 
Suspended solids 
3 8 110 69 37 
10 8 119 29 76 
27 8 139 18 87 
27 16 88 22 74 
27 24 64 17 67 
Key: SRT, solids retention time; HRT, hydraulic retention time; COD, chemical oxygen demand; 
sCOD, soluble chemical oxygen demand; BOD, biochemical oxygen demand 
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7.3.2. Effect of hydraulic retention time to hazardous chemicals removal 
Lengthening HRT of the secondary aerobic treatment stage (whilst at a constant SRT of 27 
days saw a concomitant decrease in food to microorganism (F: M) ratios.  Ratios were 0.25, 
0.13 and 0.05 gBOD gVSS d
-1
 for 8, 16 and 24 hour HRTs, respectively.  Reducing F: M ratio 
correlated well (r
2
 0.91) with increased secondary removal of ∑EST (Figure 7.2).   
 
 
Figure 7.2.  Significance of the food: microorganism ratio to secondary removal of ∑EST’s (A, ■) 
and short chained NPx (NP+NP1-3EO+NP1-3EC) (B, □) in HRT studies
 
 
Removals of ∑EST’s were 90 ±2 %, 93 ±1 % and 96 ±2 % for 8, 16 and 24 hour HRTs, 
respectively (Figure 7.1).  Individually each estrogen showed improving removal with longer 
HRT.  Most notably EE2 exhibited removals of 65 ±19 % at the 24 hour HRT condition 
(Table 7.2).  However, lengthening HRT resulted in an apparent increase in ∑NPEO molar 
concentration with removals of 57 ±6%, -35 ±18% and -83 ±12% observed (Figure 7.1).  A 
negative correlation (r
2
 0.94) was observed between reduced F: M ratio and short chained 
NPx removal (NP+NP1-3EO+NP1-3EC) (Figure 7.2).  This was mainly attributed to increased 
concentrations of NP1-3EC observed in final effluents (Table 7.2).  Nevertheless, this counter-
intuitively resulted in the greatest removals of NP.  Positive removals of 70 ±16 % and 63 ±15 
% were observed at 16 and 24 hour HRTs respectively (Figure 7.3).   
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Figure 7.3.  Secondary removal of individual nonylphenolic chemicals at varying HRT. Inset, 
individual removals of NP and NP1-12EO 
 
In contrast, lengthening HRT initially resulted in increased removal of ∑METAL’s observed 
during primary sedimentation.  This was because a high proportion of metals found in crude 
sewages were associated with particulates.  To demonstrate, the percentage of Zn and Cu 
within the particulate fraction (>0.45 µm) of crude wastewater was 88 ±4 % and 97 ±2 %, 
respectively (Figure 7.4).  Suspended solids concentration of crude sewage was 366 ±154 mg 
l
-1
 and reduced to 123 ±15 mg l
-1
, 88 ±7 and 64 ±13 mg l
-1
 in settled sewage for primary 
sedimentation times of 4, 8 and 12 hours respectively (Table 7.4).  This corresponded well to 
∑METAL’s behaviour.  To demonstrate, ∑METAL concentrations in crude sewage were 141 ±29 
µg l
-1
 with the majority of this attributed to Zn (91 ±27 µg l
-1
) and Cu (46 ±11 µg l
-1
) (Figure 
7.4).  In settled sewage Zn concentrations were 79 ±18, 41 ±6 and 26 ±5 µg l
-1 
corresponding 
to primary sedimentation residence times of 4, 8 and 12 hours (Table 7.2).  Similarly, total Cu 
concentrations were reduced to 39 ±8, 27 ±4 and 17 ±2 µg l
-1 
in settled sewage.  Primary 
removals of ∑METAL’s were 69 ±8 % at the 12 hours sedimentation time.  Interestingly though, 
dissolved metal concentrations (to which EQS’s are applied) were unaffected by primary 
treatment and were similar to, or below their proposed legislative targets for consent in settled 
sewages (Figure 7.4).   
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Figure 7.4.  Effect of primary sedimentation tank residence time on Zn (A) and Cu (B) 
concentration in settled sewage.  
a
EQS is applied to the dissolved concentration (i.e., pre-filtered) 
and is dependent on water hardness (European Commission, 2008).  Note: error bars represent 
the standard deviation of the total concentration.  
 
However, secondary treatment at longer HRT resulted in further increases in dissolved metal 
concentrations (Figure 7.5).  To illustrate, dissolved metals removals were -88 ±9 % at an 8 
hour HRT whereas removals at 16 and 24 hour HRTs were -176 ±9 % and -128 ±6 % 
respectively.  Secondary removal of ∑METAL’s decreased with longer HRT, explained by a 
linear correlation (r
2
 0.92) between reduced ∑METAL concentrations in settled sewage  with 
secondary removal (Figure 7.5). 
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Figure 7.5.  Impact of ∑METAL concentration (aqueous + particulate) in settled sewage to 
secondary removal of total metals and dissolved metals during HRT studies  
 
 
7.3.3. Final effluent quality 
The steroid estrogens E1, E2 and EE2 were at their lowest concentration in the final effluent 
of the 27 day SRT 24 hour HRT condition.  Total concentrations of the natural estrogens E1 
and E2 were 4.9 ±2.6 and 2.2 ±1.2, respectively (Table 7.2).  In comparison, the synthetic 
estrogen was found here at a concentration of 0.14 ±0.07 ng l
-1
.
  
Noteworthy estrogen 
concentrations were found in the particulate fraction of final effluents. To demonstrate, the 
most hydrophobic estrogens E2 and EE2 had final effluent log Kd’s of 4.1 and 4.4, 
respectively.  Total concentrations of NP in final effluent were below its EQS of 300 ng l
-1
 
(Table 7.1) at 16 and 24 hour HRT conditions.  However, molar concentrations of ∑NPx in 
these final effluents were 23 ±8 and 37 ±6 µmol m
-3
 respectively (1.4 µmol m
-3 
of NP is 
equivalent to 300 ng l
-1
) (Figure 7.1).  Similar to E2 and EE2, substantial NP concentrations 
were observed in the particulate fraction exhibiting log Kd’s up to 5.5.  Overall, the 
concentration of ∑METAL’s in final effluents reduced with increased SRT and longer HRT 
(Figure 7.1).  At the 27 day SRT 24 hour HRT condition ∑METAL concentrations were 30 ±2 
µg l
-1
.  Despite total concentrations reducing with longer HRT, concentrations in the aqueous 
fraction (0.45 µm filtered) increased.  This is demonstrated by the general trend of reducing 
final effluent log Kd’s for Cu and Zn with longer HRT (Table 7.2).  Lowest dissolved 
concentrations were at the 27 day SRT 8 hour HRT ASP operation.  To assess the likelihood 
of achieving compliance for each hazardous chemical within the receiving aqueous 
environment, the level of final effluent dilution required for consent was determined (Figure 
7.6).  This denotes the minimum river dilution requirement to achieve the EQS or proposed 
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legislative target for each ASP final effluent for EE2, NP and Cu.  These chemicals were 
selected as they required the most dilution within the groups; steroid estrogens, NPx’s and 
metals.  Compliance was unequivocally assured for a dilution factor of 10 by the 27 day SRT 
24 hour HRT operation.  Modifying ASP operation had the greatest impact to the dilution 
requirement for EE2.  This was due to EE2 having very low proposed legislative target of 
0.035 ng l
-1
 (Table 7.1) and it being more responsive to changes in HRT.  Dilution of ≥20 
times was needed to ensure consent for ASPs where SRT was investigated (Figure 7.6).  
Conversely, at 16 and 24 hour HRTs the dilution required was ≤10 due to the increased EE2 
removals.  In comparison, the required dilution for consent for both NP and Cu was <10 for 
all ASP final effluents.  However, the high SRT operation (27 day SRT 8 hour HRT) required 
significantly lower dilutions for Cu (2.4 ±0.4 times). 
 
 
 
Figure 7.6.  Riverine dilution required to ensure consent to EQS and proposed legislative targets 
for EE2 (proposed legislative target = 3.5 x 10
-5
 µg l
-1
, respectively, NP (EQS = 0.3 µg l
-1
) and Cu 
(proposed legislative target = 1-28 µg l
-1
) at each ASP operation. 
a
Default riverine dilution factor of 10 as described by the European Commission (European 
Commission 2003b)  Note: Dilution factor required for consent is calculated from the dissolved 
(i.e., pre-filtered) concentration only (European Commission 2008).  Hazardous chemical 
concentration already present in dilution water is assumed to be zero as their presence will increase 
the water dilution requirement.  For metals, a calcium carbonate concentration of 0-50 mg l
-1
 is 
assumed as EQSs are dependent on water hardness.
Default riverine dilution factor
a
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7.4. DISCUSSION 
The highest SRT studied (27 days) achieved the greatest collective hazardous chemical 
removals.  The SRT range studied broadly encompassed typical full-scale operations (Koh et 
al., 2009; McAdam et al., 2010; McAdam et al., 2011).  Solids retention times of 10 and 27 
days were required to achieve highest removal of ∑EST (≥90 %) (Figure 7.1).  Despite 
increasing SRT, the quantity of estrogens within the dissolved and particulate fractions of 
RAS reduced.  This relationship corresponded with that of NPx’s.  The majority of organic 
hazardous chemical removal was therefore attributed to biodegradation (Andersen et al., 
2005; Petrie et al., submitted).  This is supported by reducing concentrations of estrogens and 
NPx in RAS as SRT increased.  Interestingly, secondary removal of ∑NPx was negligible at 
SRTs of 3 and 10 days (Figure 7.1).  Nevertheless, substantial long chained ethoxylate 
removal was observed.  This resulted in the accumulation of short chained intermediates 
(specifically NP1-3EC) consistent with full-scale observations (Koh et al., 2009; McAdam et 
al., 2011).  Operation at the highest SRT condition (27 days) was beneficial as ∑NPx removal 
was increased to 37 ±5 % (Figure 7.1).  This demonstrates an improvement across the NPx 
removal pathway by assimilation and oxidation of breakdown intermediates.  At 27 days 
SRT, higher ∑NPx removal was driven by an improved removal of NP1-3ECs.  The specific 
difficulty associated with this chemical type is the complexity of biotransformation reactions 
that this family of chemicals exhibit prior to NP biodegradation.  To demonstrate, a number of 
structural changes (e.g., ethoxylate shortening, oxidations etc) are undertaken before cleavage 
of the NP ring takes place (Warhurst, 1994; Petrie et al., 2013a).  In this study, removals of 
the daughter chemical NP ranged from -6 % to -39 % over the three SRTs studied (Table 7.2).  
As an independent chemical under controlled conditions, NP is known to be susceptible to 
biodegradation (Tanghe et al., 1998; Stasinakis et al., 2008), even at low SRT (Stasinakis et 
al., 2010).  This suggests its production during activated sludge treatment by precursor 
biotransformation here was sufficient to compensate for its removal (i.e., net removal is zero).  
In contrast, ∑METAL’s exhibited moderate improvements in removal with each increase in SRT 
(Figure 7.1).  Partitioning within the biomass matrix was confirmed as the main removal 
pathway for metals as increased concentrations were observed in the particulate fraction of 
RAS as SRT increased (Figure 7.1).  The moderate improvement (8 %) in ∑METAL removal 
between the 10 and 27 SRTs coincided with similar MLVSS concentrations (Figure 7.1, 
Table 7.3).  This suggests an improvement in metal partitioning within the biomass matrix, 
likely to be induced by a physiological change to the biomass composition.  For example, 
Laurent et al (2009) reported that smaller floc size was critical for increased Cd sorption.  
Activated sludge (of similar dry weight) comprised of smaller flocs has better availability of 
binding sites due to increased floc surface area.  In this study median floc sizes reduced from 
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274 µm to 164 µm between SRTs of 10 and 27 days (Table 7.3).  This may explain improved 
removal achieved by the 27 day SRT biomass.  Although operation at a higher SRT improved 
simultaneous hazardous chemical removal, it has traditionally been associated with 
significantly greater aeration demands.  However, it has been demonstrated that operation at a 
higher SRT achieves improved oxygen transfer due to smaller activated sludge floc size and 
better uniformity (Leu et al., 2012).  Consequently, aeration requirements are not as great as 
previously considered.   
Longer HRT substantially improved the biodegradation of ∑EST and NP.  Steady state HRTs 
of 8, 16 and 24 hours were monitored to represent typical full-scale (dry weather flow) 
operational conditions (Koh et al., 2009; McAdam et al., 2010; McAdam et al., 2011), whilst 
at a fixed SRT of 27 days as this exhibited best overall removal performance previously.  
Longer HRT resulted in greater contact times and reduced F: M ratios.  Reduced F: M 
correlated well with improved removal of ∑EST (r
2
 0.91) (Figure 7.2).  A lower F: M ratio is 
suggestive of a substrate limitation which may lead to the biodegradation of less-favoured 
carbon substrates (e.g., steroid estrogens).  Coupled with increased contact time for 
biodegradation this may explain the observed improvement in biodegradation at longer HRTs 
(Figure 7.1).  However, longer HRT resulted in an apparent increase of ∑NPx molar 
concentration (Figure 7.1).  This illustrates that all chemicals within the NPx chemical family 
are not encompassed by current analytical methods.  For example, longer chained NPEOs 
(Petrie et al., 2013a) and NPECs (Komori et al., 2006), and carboxylated carboxylates 
(CNPECs) (Jonkers et al., 2001) can be present.  Without analytical reference standards 
available for their quantitation and inclusion in the nonylphenolic mass balance, their fate 
during treatment and resultant impact to NP removal remains unknown.  Interestingly the 
high production of NPECs at the 16 and 24 hour HRT conditions resulted in good removals 
(63-70 %) of NP (Figure 7.3).  The high removal of all NPEOs observed at 16 and 24 hour 
HRTs (Table 7.2) indicates that ethoxylate biotransformation is the dominant pathway for the 
production of NP during ASP treatment.  Therefore longer HRT was advantageous as this 
initiated improved biotransformation across the NPx removal pathway resulting in significant 
NP removal.  However, longer HRT during secondary treatment was detrimental to dissolved 
metal removal (Figure 7.5).  To demonstrate, dissolved concentrations of Cu and Zn in crude 
and settled sewages were similar to their proposed legislative targets for consent (Figure 7.4).  
However, concentrations following secondary treatment were above these limits.  Secondary 
HRTs of 16 and 24 hours resulted in the greatest increase of dissolved metals with removals 
of -176 ±9 % and -128 ±6 % respectively.  These longer contact times may facilitate further 
oxidation of particulate organic matter (Ziolko et al., 2011).  As a result metals were 
distributed more in the aqueous fraction of final effluents at longer HRT (Table 7.2).  This is 
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significant as only the filtered (i.e., aqueous) fraction of water matrices are considered for 
EQS compliance (European Commission, 2008).  Therefore, maximising particulate bound 
metals removal during primary sedimentation to circumvent their solubilisation during 
secondary treatment is essential.  This is critical for sites which have low dilution ratios or 
where the receiving concentrations of metals are comparatively greater.  For example, Cu and 
Zn are commonly found in crude wastewaters at concentrations >100 µg l
-1
 (Rule et al., 2006; 
Ziolko et al., 2009; Gardner et al., 2013).  This study successfully demonstrated that primary 
treatment can effectively enhance metal removal prior to secondary treatment (Figure 7.4).  
However, enhancing suspended solids removal by existing assets may not be achievable 
without the continual dosing of coagulants.  For example, there may not be sufficient space 
available onsite to increase primary sedimentation tank size to facilitate HRTs similar to those 
utilised in this study.  As a trade off, the alternative or complimentary use of micro-screens 
can yield improved suspended solids removal at a comparatively smaller footprint (Salsnes 
Filter, 2011).     
In this study, with the receiving concentrations observed, environment compliance was 
achieved for all hazardous chemicals by the 27 day SRT 24 hour HRT ASP when a default 
dilution factor of 10 was applied to final effluents (European Commission, 2003b) (Figure 
7.6).  Altering ASP operation had the greatest impact to the level of dilution needed for the 
steroid estrogen EE2.  This is due to the very low proposed legislative target for consent of 
0.035 ng l
-1
 (European Commission, 2012), and its comparative difficulty to remove during 
ASP treatment (Petrie et al., submitted).  The more responsive removal of this chemical (65 
%) at the 27 day SRT 24 hour HRT resulted in a <10 fold dilution requirement.  In contrast, 
all ASP final effluents for NPx and metals were below a dilution threshold of 10.  
Nonylphenol is the only chemical within the NPx group which has an EQS but it has been 
successfully demonstrated that the biotransformation of readily degradable NP precursors in 
the environment (which are not legislated for) could theoretically lead to a breached EQS 
(Petrie et al., 2013a).  It is therefore advantageous to operate the ASP at conditions which 
enhance biotransformation across the NPx family of chemicals (i.e., high SRT and long HRT 
conditions).  However, the majority of existing full-scale ASPs are designed to operate at 
mid-ranged conditions (i.e., circa 10 day SRT 8 hour HRT) at yearly average flows 
(Aboobakar et al., 2013).  Yet these tend to receive significant variations in sewage flow 
resulting in a dynamic system with significant variations in SRT and HRT.  Therefore 
significant improvements in full-scale performance are achievable by better process control to 
improve process continuity and reduce variations in both SRT and HRT.  For example, the 
use of in-situ suspended solids probes and real-time flow measurements could help avoid 
variability in SRT.  Although achieving a significant improvement to HRT will require 
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infrastructure development.  The extent of HRT alteration achievable for an existing process 
will depend on the available space onsite for expansion.  Where sufficient space is not 
available to achieve a required HRT, remote holding tanks could be used as a buffer to 
counter-balance fluctuations in receiving sewage flow.  This would enable steady state 
process conditions to be maintained whilst operating at a longer HRT.  Furthermore, any 
operational change to lengthen secondary HRT requires suitable provisions for primary 
treatment to ensure greater removal of suspended solids are achieved.  This will circumvent 
particle bound metals solubilisation which could lead reach to a breach of EQS.   
 
7.5. CONCLUSION 
Prospects of achieving EQS compliance through ASP operation improvements are highly site 
specific, governed by receiving hazardous chemical concentrations in crude sewage, available 
dilution water and quality, and available onsite space for infrastructure development.  Solids 
retention times of 10 and 27 days were essential for augmented ∑EST removal and an increase 
of SRT from 10 to 27 days was beneficial to ∑NPx and ∑METAL removal.  Longer HRT of the 
aerobic treatment stage was vital for achieving increased biodegradation of ∑EST (specifically 
EE2) and suitable precursor biotransformation such that positive NP removals were achieved.  
Enhanced removal of particulates from crude wastewater during primary sedimentation was 
critical for improved ∑METAL removals and avoiding increased concentrations of dissolved 
metals following secondary treatment.  This study has identified that the broad range of 
hazardous chemical chemistries do result in trade-offs which should be considered for future 
studies. 
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8. THESIS DISCUSSION 
Previously reported method detection limits (MDLs) for some hazardous chemicals have been 
insufficient to consistently monitor their concentrations in wastewaters.  Consequently, there 
has been a paucity of information on their fate and removal during wastewater treatment.  A 
well-known example is the synthetic estrogen 17α-ethinylestradiol (EE2).  This research 
involved improving current analytical methodologies mainly by the application of ultra-
performance liquid chromatography (UPLC) to lower detection capabilities.  Improved 
detection capabilities enabled hazardous chemicals to be monitored at environmentally typical 
concentrations over wastewater treatment works (WwTWs).  Nevertheless, widely 
implemented secondary WwTWs such as activated sludge are not designed for the removal of 
hazardous chemicals.  As a result these processes fail to meet environmental compliance for a 
wide range of hazardous chemicals.  To achieve compliance more consistently with such 
processes, improvements in their operation is needed to specifically target the removal of 
hazardous chemicals.  Therefore, understanding hazardous chemical pathways of removal and 
the impact of changing wastewater treatment operational conditions to these mechanisms was 
investigated.  This was done under controlled conditions utilising real sewage containing 
typically encountered hazardous chemical concentrations.  The information was then used to 
address the possibility of modifying the operation of activated sludge plants (ASPs) for the 
increased removal of hazardous chemicals.  Finally, the impact of the operational parameters 
solids retention time (SRT) and hydraulic retention time (HRT) in a continuous flow pilot-
scale system, to the removal of a diverse range of hazardous chemicals was assessed.        
 
8.1. METHOD DEVELOPMENT FOR HAZARDOUS CHEMICALS 
The determination of steroid estrogens in wastewater matrices was challenging due to the 
very low (ng l
-1
) concentrations observed in wastewaters comprising comparatively high 
concentrations of bulk organics.  It was particularly difficult for the synthetic estrogen 17α-
ethinylestradiol (EE2) as it is typically encountered in wastewater <1 ng l
-1
 (Koh et al., 2009; 
McAdam et al., 2010).  However, the MDLs achieved for steroid estrogens in settled sewages 
and final effluents ranged from 0.02 to 0.17 ng l
-1 
(Petrie et al., in press).  Most notably, the 
MDL of EE2 was 0.06 ng l
-1
, an improvement of >50 % from the previous lowest reported 
MDL (Koh et al., 2008).  The application of UPLC enabled improved separation of the target 
analytes from remaining matrix within the sample extract.  Consequently, reduced signal 
suppressions caused by the matrix aided the improved sensitivity observed.  The newly 
reported MDL enabled complete process mass balances for EE2 to be attained.  This helped 
in understanding their fate pathways and the influence of changing engineering conditions to 
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their removal at environmentally relevant receiving concentration.  Previously reported 
methods have been restricted in monitoring EE2 concentrations during wastewater treatment 
by their detection capabilities (Braga et al., 2005; Chimchirian et al., 2007; Stanford and 
Weinberg, 2007; Kumar et al., 2009; Zorita et al., 2009; Gabet-Giraud et al., 2010; Zhou et 
al., 2012).  However, the newly proposed legislative target for consent is 0.035 ng l
-1
 
(European Commission, 2012).  If this concentration became legislation in the future, 
additional improvements in analytical methodology would be needed, providing a challenge 
considering a significant improvement in sample extraction or chromatography is unlikely.  
More sensitive mass spectrometry detectors such as linear ion trap technology or new-
generation triple quadrupole detectors offer the possibility of improved sensitivities (Barcelo 
and Petrovic, 2007).  However, at present these are expensive restricting their widespread 
usage.  Nevertheless, the method reported here is a substantial step towards achieving a MDL 
of 0.035 ng l
-1
.    
In contrast, the nonylphenolic (NPx) analysis did not require such a large concentration factor 
(400 to 1,000 times compared to 5,000 times for steroid estrogens) due to the inherently 
greater concentrations observed (Leusch et al., 2006; Koh et al., 2009; Moreira et al., 2011).  
Consequently, the extraction was more straight forward and the MDLs achieved for NPx’s 
ranged from 1.4 to 45.3 ng l
-1
 (Petrie et al., 2013a).   These were comparable to those reported 
in the literature (Koh et al., 2008; Loos et al., 2007) and sufficient to monitor nonylphenol 
(NP) and its precursors below the NP environmental quality standard (EQS) of 300 ng l
-1
 
(European Commission, 2000).  The relatively high concentration of precursors in trickling 
filter effluent led to an exploratory investigation of the possible environmental implication of 
their discharge.  It was found that an initial dilution factor of 10 with river water would enable 
NP compliance.  However, the biotransformation of precursors could lead to a breach of EQS 
downstream, over several kilometres.  For example, NP concentrations could theoretically 
reach 362 ng l
-1
 in one river scenario studied (Petrie et al., 2013a).  The main improvement 
achieved with this analytical method over those previously reported was the time saving 
achieved.  For example, previously reported methods require run times of between 40 and 60 
minutes (Jahnke et al., 2004; Loos et al., 2007; Koh et al., 2008).  Run time is often a rate 
limiting step for such analysis, restricting sample number and turnover.  However, the use of 
UPLC enabled adequate chromatographic separations within a 26 minute run time.  This 
generally offers double the sample throughput in comparison to conventional high-
performance liquid chromatography.   
Method development for pharmaceuticals was more restrictive in sample extraction and 
clean-up.  Extensive clean-up of sample extracts was not possible due to the wide ranging 
physico-chemical properties this group of hazardous chemicals exhibit.  Otherwise, further 
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clean-up could be employed similar to the steroid estrogen method to achieve the required 
MDLs (Petrie et al., in press).  Nevertheless, MDLs were lowered by improving sensitivity of 
detection.  Chemicals were analysed in negative and positive ion modes separately, in 
different chromatographic runs.  For example, 0.1 % formic acid was added to the aqueous 
mobile phase for chemicals analysed in positive ion mode.  This improved their ionisation 
efficiency and therefore sensitivity of detection (Gros et al., 2012).  Furthermore, separating 
the analytes in two chromatographic runs also limited the number of acquisitions registered 
for at the same time which can result in the loss of sensitivity (López-Serna et al., 2011).  
Despite, dividing into two separate chromatographic separations, run times were 9 and 10 
minutes, respectively.  The MDLs achieved for this diverse range of hazardous chemicals 
were generally <10 ng l
-1
.  These were adequate to monitor for typically encountered 
pharmaceutical concentrations in wastewater effluents (Metcalfe et al., 2003; Clara et al., 
2005; Nakada et al., 2006; Zorita et al., 2009).  Nevertheless, some pharmaceuticals such as 
the antibiotics are known to be present within the particulate fraction of sludge at relatively 
high concentrations (Chen et al., in press).  Therefore to better understand their fate, 
determination in the particulate fraction of wastewaters was required (Petrie et al., 2013b).  
However, this provided a further challenge.  To collect sufficient suspended solids for 
analysis and ensure detectable concentrations of all chemicals studied, a large quantity of 
wastewater (0.5 to 25 litres dependent on the matrix) was required for each sample analysis.  
The samples were then centrifuged and filtered to obtain the suspended solids.  Nevertheless, 
the time spent on sample collection for particulate phase analysis was necessary as it enabled 
complete process mass balances to be attained which were used to reveal important 
information on removal pathways.  This was specifically investigated for the pharmaceuticals 
as these hazardous chemicals exhibit a broad range of physico-chemical properties and 
therefore an expectant range of preferred removal pathways.          
 
8.2. IDENTIFYING THE PATHWAYS OF HAZARDOUS CHEMICAL 
REMOVAL 
Hazardous chemical removal by activated sludge is commonly described as being removed by 
sorption and biodegradation (Racz and Goel, 2010; Petrie et al., 2013b).  However, there is 
limited evidence to support these assumptions due to the lack of particulate phase analysis 
undertaken.  The complete process mass balances attained revealed that the pharmaceuticals 
studied were broadly separable into three groups based on their fate pathways (biodegraded, 
sorbed onto activated sludge and those exhibiting no removal from the aqueous phase) (Petrie 
et al., in preparation).  Those chemicals mainly removed by biodegradation exhibited no 
142 
 
notable accumulation within the particulate phase of return activated sludge (RAS) despite 
significant secondary removal (≥86 %).  For example, the total concentration of ibuprofen in 
settled sewage was 6,566 ng l
-1
.  This was reduced to 200 ng l
-1
 in final effluents with only 
799 ng l
-1
 observed in RAS.  In contrast, total concentrations of triclosan were 1,515, 239 and 
5,795 ng l
-1
 for settled sewage, final effluent and RAS, respectively.  The majority of triclosan 
in RAS was distributed within the particulate fraction (95 %) confirming that partitioning into 
sludge was its dominant pathway of removal.  Sorption was also found to be the dominant 
removal pathway for the antibiotics ofloxacin and ciprofloxacin.  This supports previous 
research which has postulated sorption to be their dominant removal pathway based only on 
the observation of high concentrations within the particulate phases of sludge (Chen et al., in 
press).  The efficacy of trickling filter treatment to remove these chemicals which rely on very 
different mechanisms was directly compared to activated sludge.  Findings revealed trickling 
filter treatment to be as effective as activated sludge for the removal of most of these 
chemicals.  To demonstrate, ibuprofen was removed by 98 ±1 % and 97 ±1 % by trickling 
filter and activated sludge treatment, respectively.  The antibiotics which rely on sorption for 
their removal exhibited removals of 42 to 54 % by trickling filter treatment and from 46 to 56 
% by activated sludge, with no significant differences observed.  This revealed the 
effectiveness of trickling filter treatment to remove these organic hazardous chemicals whilst 
operating at conditions thought to be challenging (i.e., very short HRTs).  Considering the 
very different removal pathways observed for hazardous chemicals, specific knowledge of 
what drives these mechanisms and the impact of wastewater treatment operational conditions 
to these mechanisms is essential.  Steroid estrogens were investigated because their removal 
was known to be more responsive to changing wastewater treatment operation.           
 
8.3. DIAGNOSTIC INVESTIGATION OF STEROID ESTROGEN 
REMOVAL 
To investigate the impact of process operation on estrogen removal a pilot-scale activated 
sludge plant (ASP) was operated on the same source of influent sewage at steady state 
conditions at varying SRTs of 3, 10 and 27 days.  The activated sludge was then used in a 
series of controlled biodegradation and sorption batch studies.  These were normalised for 
suspended solids concentrations to enable the direct comparison of SRT and spiked at 
environmentally relevant estrogen concentrations.  Activated sludge of each SRT was also 
characterised (e.g., extracellular polymeric substances – EPS, floc size, cell viability etc) to 
establish whether a link could be made with estrogen biodegradation and sorption.  In 
biodegradation tests, removal was augmented in nitrifying biomasses (10 and 27 day SRTs).  
To demonstrate, biodegradation rates were 0.27 ±0.01, 0.32 ±0.01 and 0.30 ±0.01 h
-1
 for 3, 10 
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and 27 day SRT biomasses.  It has been previously reported that nitrifiers were responsible 
for increased biodegradation at higher SRTs (Vader et al., 2000).  Allylthiourea was used to 
inhibit the action of nitrifiers in batch studies.  However, no impact to estrogen removals were 
observed as degradation rates were 0.53 ±0.01 h
-1
 for activated sludge facilitating and 
inhibiting ammonia oxidation, respectively.  These findings raised questions as to the site of 
biodegradation within the biomass matrix.  It was unknown where biodegradation occurred 
within the activated sludge matrix (i.e., extracellularly or intracellularly) (Joss et al., 2004).  
This was investigated by monitoring the removal of estrogens in pre-filtered activated sludge 
in comparison to unfiltered sludge to establish the role of free extracellular enzymes to their 
biodegradation.  Removal of cellular bound material by filtration resulted in the cessation of 
steroid estrogen removal.  Starting concentrations of estrogens in filtered sludge were 384 ng 
l
-1
 and following 8 hours aeration, concentrations of 396 ng l
-1
 were observed.  In contrast, 
starting concentrations in unfiltered activated sludge was 448 ng l
-1
 which reduced to 103 ng l
-
1 
following treatment.  Consequently, steroid estrogen biodegradation was by extracellular 
enzymes contained within the floc or by intact bacterial cells.  Interestingly, the number of 
viable bacterial cells reduced with increased SRT.  These were 1.45 x 10
12
, 5.49 x 10
11
 and 
4.09 x 10
11
 counts gVSS
-1 
for 3, 10 and 27 day SRTs respectively.  This corresponded to 
increasing estrogen biodegradations of 499, 1,361 and 1,750 ng 1 x 10
12
 viable cells
-1
 d
-1
.  
These findings indicate an improved efficiency of the same group, or a more responsive 
bacteria species type.  Consequently, there is a need to elucidate these bacteria species for 
process performance improvement.  Findings also suggest that the improved efficiency of 
bacterial cells at the 27 day SRT may be caused by changes to the physico-chemical 
composition of the activated sludge, facilitating less restricted passage of estrogens to viable 
cells for biodegradation.  To demonstrate, 27 day SRT activated sludge had the smallest floc 
size (164 µm) resulting in shorter distances between the bacteria and the activated sludge floc 
surface suggesting shorter distances within the floc need overcome by diffusion (Joss et al., 
2004).  Furthermore, EPS concentration reduced with increased SRT from 438 to 315 
mgCOD gVSS
-1
.  It has been suggested that EPS can act as a selective barrier towards 
substrate diffusion (Lieleg and Ribbeck, 2011).  Therefore it can be hypothesised that lower 
EPS concentrations result in less restricted movement of estrogens to viable bacterial cells for 
biodegradation suggesting increased contact time could enable greater estrogen removal.  
Batch sorption studies exhibited significantly greater sorption capacity of the 27 day SRT 
biomass for the hydrophobic estrogens 17β-estradiol and EE2.  This corresponded to the 
smallest floc size observed (164 µm) resulting in a greater total surface area for sorption to 
occur.  It has been demonstrated that both SRT and HRT (contact time) can influence 
estrogen removal.  Therefore, the individual impact of SRT and HRT to hazardous chemical 
removal was evaluated in a continuous flow system.   
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8.4. THE IMPACT OF CHANGING ACTIVATED SLUDGE OPERATION 
ON HAZARDOUS CHEMICAL REMOVAL 
Previous research in this field has made the broad comparison of various full-scale ASPs 
operated at different SRT and HRTs (Svenson et al., 2003; Clara et al., 2005; Johnson et al., 
2005; Kreuzinger et al., 2005; Koh et al., 2009; McAdam et al., 2010; McAdam et al., 2011).  
However, full-scale processes suffer from poor control of operational variables resulting in a 
dynamic system and considerable variations in both SRT and HRT.  Operation of a pilot-scale 
ASP avoided these variations enabling the direct impact of SRT and HRT to hazardous 
chemical removal to be evaluated.  To measure ASP resilience for the removal of hazardous 
chemicals of varying chemistry and preferred removal mechanisms - steroid estrogens, 
nonylphenolics and metals were monitored.  Such a diverse range was chosen because it was 
unknown whether process conditions could be changed to effectively facilitate the removal of 
all hazardous chemicals collectively.  For example an SRT of ≥10 days is considered 
necessary to augment removal of those biodegradable hazardous chemicals (Kreuzinger et al., 
2005; Clara et al., 2005; McAdam et al., 2010).  However, such conditions are considered 
detrimental to metals removal (Santos et al., 2010).   In pilot plant trials investigating the 
impact of SRT whilst at fixed HRT, the highest SRT investigated (27 days) achieved the 
greatest removal of all hazardous chemicals collectively.  The impact of altering HRT whilst 
at a fixed SRT of 27 days revealed that longer HRT was beneficial to the biodegradation of 
the organic hazardous chemicals.  For example, total estrogen biodegradations were 90 ±2 %, 
93 ±1 % and 96 ±2 % for 8, 16 and 24 hour HRTs, respectively.  Furthermore, EE2 which is 
well-known for its recalcitrance (Petrie et al., in press) displayed its highest removal observed 
in this study of 65 ±19 % at the 24 hour HRT operation.  Removals of NP were also greater 
(63-70 %) at longer HRTs.  Interestingly, removals of steroid estrogens (r
2
 0.91) and 
nonylphenolics (r
2
 0.94) correlated well with the food: microorganism (F: M) ratio which 
reduced with increased HRT.  This may be significant as full-scale F: M ratios are generally 
lower due to the higher mixed liquor suspended solids concentrations achieved at equivalent 
SRTs.  To demonstrate, a full-scale works operated at a 13 day SRT 10-14 hour HRT had an 
F: M ratio of 0.09 to 0.10 gBOD gMLVSS d
-1
 (Koh et al., 2009).  Whereas, the pilot-scale 
ASP operated under comparable conditions (10 day SRT 8 hour HRT) achieved an F: M ratio 
of 0.23 gBOD gMLVSS d
-1
.  Consequently, higher removals of both steroid estrogens and 
nonylphenol may be observed at full-scale whilst under the same operational conditions.  
However, longer HRT resulted in increased solubilisation of particulate metals during 
secondary treatment.  Dissolved metals removals were -88 ±9 % at an 8 hour HRT.  At 16 and 
24 hour HRTs removals were -176 ±9 % and -128 ±6 % respectively.  This is of concern as 
145 
 
only dissolved concentrations are measured for environmental compliance.  Therefore careful 
consideration is required when implementing changes to ASP operation to ensure no 
detrimental impact is observed for a specific group of hazardous chemicals.        
 
8.5. IMPLEMENTING CHANGES TO ASP OPERATION 
Improvements in hazardous chemical removal required at full-scale ASPs to achieve 
environmental compliance are highly site specific.  This is governed by receiving hazardous 
chemical concentrations in crude sewage, available dilution river water and the quality of this 
dilution water.  Firstly, greater process control is needed.  Full-scale ASPs are often designed 
to operate at mid-ranged conditions (i.e., 10 days SRT 8 hour HRT) at average yearly flows 
(Aboobakar et al., 2013).  However, receiving flow can vary substantially resulting in a 
dynamic system with significant variations in both SRT and HRT.  Therefore the use of in-
situ suspended solids probes and real-time flow measurements would enable existing ASPs to 
be operated at a constant SRT.  This would facilitate more consistent removal performance 
and final effluent qualities.  The controlled pilot-plant studies revealed that the highest SRT 
studied (27 days) achieved greatest hazardous chemical removals collectively.  Consequently, 
SRT can be increased with the knowledge that it will enhance removal of all hazardous 
chemicals.  It has been traditionally considered that the aeration demands of high SRT 
operation are excessive for the benefits achieved.  Leu et al (2012) demonstrated that 
improved oxygen transfer is achieved at higher SRTs due to smaller floc size and more 
uniformed floc distribution.  Therefore, aeration costs are not as high as first thought for high 
SRT operation.  Operation at a high SRT also has the benefit of producing less waste 
activated sludge which offers potential savings in sludge treatment.  Longer HRTs may still 
be required to achieve compliance which is likely to require infrastructure development.  
Although this is unfavoured, the relatively high removal of EE2 achievable (65 %) could 
circumvent the need for controversial technologies (e.g., granular activated carbon) which 
have a proven ability to remove this chemical (Grover et al., 2011).  However, there is a 
tension in HRT extension for improved organic hazardous chemicals as it increases 
solubilisation of metals.  To overcome this, better solids removal at the primary sedimentation 
tank is needed.  For example, using micro-screens in parallel to primary sedimentation tanks 
to enhance solids rejection is possible.  An added advantage of producing more primary 
sludge is that it can be used to increase energy production through sludge treatment (Flores-
Alsina et al., 2014).  Overall, it has been demonstrated that ASP operation can be modified to 
specifically target the removal of hazardous chemicals exhibiting a range  of chemistry and 
preferred removal pathways.    
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9. CONCLUSIONS 
 The application of ultra-performance liquid chromatography for steroid estrogen analysis 
lowered method detection limits by ~50 % over high performance liquid chromatography 
enabling complete process mass balances to be determined for 17α-ethinylestradiol (EE2) 
with a method detection limit of 0.06 ng l
-1
. 
 The relatively high concentration of nonylphenol (NP) precursors in final effluents could 
theoretically lead to a breach of the NP environmental quality standard of 300 ng l
-1
within 
the receiving river, downstream from the point of discharge. 
 The determination of pharmaceuticals in the particulate fraction of wastewaters was 
essential for diagnosing their different removal pathways during activated sludge 
treatment.  Removal was dominated either by biological degradation or sorption to 
activated sludge. 
 Biodegradation of steroid estrogens proceeds by the action of extracellular enzymes 
contained within the structure of activated sludge flocs and/or within viable bacterial cells 
as an intracellular process.  Furthermore, these bacterial cells are not likely to be 
nitrifying micro-organisms.  
 Steroid estrogen biodegradations were 499, 1,361 and 1,750 ng 1 x 1012 viable cells-1 d-1 
for 3, 10 and 27 day SRTs, respectively.  This suggests the development of a specialised 
group of bacteria more capable of estrogen biodegradation or an improved response from 
bacteria already present within activated sludge at higher SRTs.  
 The capacity for 17β-estradiol and EE2 sorption was an order of magnitude greater for 
activated sludge of higher SRT (27 days) in comparison to lower SRT (3 or 10 days).  
This was driven by changing biomass physiology (i.e., reducing floc sizes of 358, 274 and 
164 µm at 3, 10 and 27 day SRTs, respectively). 
 Operation of an activated sludge plant (ASP) at high SRT conditions (27 days) achieved 
maximum collective removals for all hazardous chemicals studied (steroid estrogens, 
nonylphenolics and metals). 
 Longer hydraulic retention times (24 hours) augmented biodegradation of the organic 
hazardous chemicals, specifically NP and EE2.  However, increased solubilisation of 
metals was observed.  Consequently, improved solids removal during primary 
sedimentation is required to achieve maximum collective removals.   
 Existing activated sludge works can be modified to specifically target the removal 
hazardous chemicals which have varied chemistry and preferred removal pathways. 
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